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Chapterl 
Introduction: Structure, function and development of the 
peripheral nerve. 

Chapter 1 
1.1 General introduction and aim of this thesis 
The complex nervous system of higher animals has its evolutionary origins in the 
simple Beuro-effector system of lower animals. Tn these simple nervous systems only 
receptor-effector loops exist to respond to the ever-changing environment. Higher, and 
larger, animals have evolved a highly complex nervous (and endocrine) system to deal with 
the challenge to maintain a physiological steady state, COiTect body posture and, at the same 
time, allow the animal to respond quickly to acute changes in the ellviromnent. 
One absolute requirement for the evolutionary success of these higher animals was 
the introduction of fhst conducting nerve fibres. Some animals have responded to this 
challenge by increasing the diameter of their axons, thereby lowering the longitudinal 
resistance and increasing the speed of impulse propagation. These animals include present 
day invertebrates such as squid, jellyfish and molluscs. However, there is a limit to the 
increase of diameter of the axon and therefore to the conduction velocities that can be 
obtained in this way. Moreover, even rather simple neural circuits connected by large 
diameter axons require a considerable investment in space and energy. The real 
evolutionary breakthrough came with the 'invention' of the myelin sheath. The myelin 
sheath is a highly specialised laminar membranous organelle laid down in segments around 
axons. Myelinated axons propagate nerve impulses with a speed that is approximately two 
orders of magnitude faster than non-myelinated axons of comparable diameter. All present 
day higher vertebrates have adopted this innovation and have myelinated axons. 
However, with this ne\v invention also new vulnerabilities came, exemplified by 
the appearance of myelin related diseases in most well studied vertebrates (domesticated 
animals and man him/herself). In humans, destmction of the myelin sheath leads to severe 
neurological problems. Well-known examples are the inflammatory diseases such as 
multiple sclerosis and Guillain Barre syndrome and hereditary neuropathies, such as 
Pelizaeus Merzbacher disease, Charcot Marie Tooth disease and Dejerine Sottas syndrome. 
Two different glial cell types produce myelin: the oligodendrocyte which 
myelinates axons in the central division of the vertebrate nervous system and the Schwann 
cell which myelinates axons in the peripheral division. Work described in this thesis 
focuses on the biology of Schwann cells. 
Schwann cells are not only of fimctional importance in elaborating the myelin 
sheath but also playa cmcial role during peripheral nerve development and regeneration 1. 
Schwann cells in injured nerves produce factors that stimulate axonal regrowth aiding in 
the stmctural and functional recovery of peripheral nerves. This is in stark contrast to 
central glia (oligodendrocytes) cells, which do not support the regeneration of central nerve 
tracks (reviewed in 2-5). The potential of Schwann cells to support regeneration of 
demyelinated or lesioned central nerves is under active clinical exploration. Thus, it is of 
importance to understand the cellular events and molecular mechanisms that drive Schwann 
cell differentiation and myelination in health and disease. 
The continuous dialogue with the axon is pivotal for the underlying mechanism of 
the diverse functions of Schwann cells in development maintenance and regeneration of the 
peripheral nerves. Although a number of questions related to different aspects of this 
dialogue have been answered in some detail, many questions remain (reviewed in I). One 
main outstanding question in the field is how axons instruct Schwann cells to myelin ate or 
not. Whatever the exact nature of the axonal signal(s), it must be relayed to the Schwann 
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cell nucleus where transcription factors respond by co-ordinate regulation of sets of genes 
that mark and drive myelination. One such factor is the POU domain class transcription 
factor Oct-6 6. Two characteristics of the Oct-6 expression profile point to an important 
role of this protein in rendering a Schwann cell competent to start myelination. First, Oct-6 
expression is dependent on axonal contact during peripheral nerve development and 
regeneration in Schwann cells that will start the myelination process 6-8. Second, Oct-6 is, 
until now, the first factor activated upon this axonal contact, preceding expression of the 
major myelin genes 6,9, The precise function ofOct-6 in driving the myelination process in 
Schwann cells remains to be determined. Furthermore, since Oct-6 is, so far, the fIrst factor 
activated upon axonal contact, it is of importance to study how Oct-6 itself is regulated. 
This will lead to the elucidation of Schwann cell intra-cellular signals and eventually to the 
characterisation of the axonal signal(s) that induce myelination. Therefore, the principal 
objective of this thesis is to gain insight in the function and regulation of Oct-6 during 
Schwann cell differentiation and myelination. 
1.2 Outline of this thesis 
A general introduction on peripheral nerve structure, function and development 
will be given in Chapter 1. In the subsequent chapters I will describe experiments, which 
provide more insight in the function and regulation of the POU transcription factor Oct-6 
during Schwann cell differentiation. Chapter 2 describes the targeted deletion of the Oct-6 
gene in mice by homologous recombination. Data presented in this chapter demonstrate 
that Oct-6 is required for the timely initiation of myelination. Subsequently, in Chapter 3, 
we describe the expression profile ofOct-6 homologues in species other than mice. Data in 
this chapter demonstrate that Oct-6 expression is conserved in the Schwann cell lineage of 
chicken and zebrafish, pointing to a fimctional conservation of this gene in the Schwal1l1 
cell lineage. Chapters 4 and 5 will address the question of how Oct-6 itself is regulated. In 
Challter 4 we give a detailed characterisation of the Oct-6 promoter region and present 
evidence that the Oct-6 promoter by itself is not sufficient to mediate Schwal1l1 cell specific 
expression of the Oct-6 gene. Chapter 5 describes the identification of distal cis-acting 
regulatory elements in the Oct-6 locus that are required for Schwann cell specific 
expression of Oct-6 during development. Finally, in Chapter 6 these data and some future 
prospects will be discussed. 
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Figure J. Representation of a transverse section through a "small nerve" (surrounded by BCDEF), which is 
composed of a multitude of\'csseis, in which the lines or strokes denote the cavities in those vessels. This nerve is 
surrounded by five other nerves (GOOGO), of which only the external membranes are represented. (From: Van 
Leeuwenhoek; 1718) 
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1.3 Structural aspects of the peripheral nerves 
1.3.1 The peripheral nerve - a few historical notes 
"[ Itave often, with great pleasure, observed lite texture of the lIel1'eS, 
which are composed of vel)! minute vessels of an incredible thinness, 
alld which, rullning alollg by the sides of each other, constitute a 
lIell'e; the cavity of each of these slJlall vessels is about two-thirds its 
diameter; alld ill order to examine them I directed the spinal marrow 
of three cows alld sheep to be brought to 11Iy house, that I might 
extract /rom thence the nerves . ... And I 1101 Dilly smv the size oj 
circumference of these l'esse/s, (some hUlldreds of which go to the 
composition of a Ilen'e 1/0 longer than a hair of a man's beard), but 
some of their cm'ities I could as plainly disNlIgllish, as if we were fa 
pierce mall)' holes ill a paper with a small needle. and hold them up 
against the SIII1," 
The epigraph to this section is a translated quotation taken from Antoni van 
Leeuwenhoeks' paper published in 1718 10, Based on his microscopic observations, using a 
simple one lens microscope of his own making he gave the first morphologic description of 
nerve fibres (Fig. I). The invention of the light microscope and its use to study biological 
samples by many investigators caused a revolution in biology, Nevertheless, it took more 
than a century, before the Hvessels of incredible thinness" as described by van 
Leeuwenhoek, were actually identified as axons connected to a cell body, which together 
formed a single cell, the neuron, 
In the beginning of the nineteenth century the French scientist Dutrochet (1824) 
described nerve cell bodies (neurons), and found them attached to individual nerve fibres 
(axons). However, mainly by the observations made by Purkinje on the cerebellum and 
Remak on sympathetic ganglia (1837 and 1838) these two stmctures were demonstrated to 
belong to one entity. A year later, this entity was dubbed the cell when Theodor Schwann 
together with Matthias Schleiden formulated their cell theory, which basically states that all 
tissues are composed of cells. Both Remak and Schwarm described the presence of a 
medullary sheath surrounding the axons, which we know today as the myelin sheath 11,12. 
In addition, Remak described differences between individual fibres consisting either of 
tubili primitivi (myelinated axon fibres), or fibrae organicae (unmyelinated fibres). He also 
described nucleated corpuscles (nuclei) along the fibres, but did not associate these with 
cells. A year later, the observation of nuclei was confmlled by Schwann, who proposed that 
these nuclei did belong to a chain of cells along the axon who had coalesced to form a 
syncytium. Although not correct, his description gave him the credit, instead of Remak, 
when these cells were named after him: the Schwann cell. In 1872 Ranvier published a 
paper in which he described that cells in the medullar sheath are separate entities and do not 
form a syncytium 13, Further support for Ranviers theory came in 1889 when Vignal was 
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able to dissect individual Schwann cells from the axon and demonstrated that they ensheath 
the axon 14(Fig. 2). Vigna I also proposed that the Schwann cells actually produce the 
myelin sheath. This was a rather controversial issue, since another school of thought 
proposed that myelin was produced by the axon, a theory supported by Ramon y Cajal 15. 
The invention of the electron microscope in the middle of the twentieth century put an end 
to this debate, and demonstrated that the myelin sheath is a tongue of the Schwallll cell 
wrapped around the axon 16. As for light microscopy, the introduction of electron 
microscopy caused a giant leap forward in our knowledge about the fine structure of the 
pcripheraillerves. 
In the following section I will describe the various components of the peripheral 
nerve, as we know them to date. I will start with a description of the connective tissues of 
the nerve followed by a description of the glial cells in the peripheral nerve. 
Figure 2: The earliest depiction of an individual Schwann cell (Vignal, 1889). The axon (a) is shown ensheathed 
by Iwo Schwarm cells (b), Vignal dissected individual Schwann cells (e) off the axon, showing that they do not 
form a syncytium. (From MJacohsen, Developmental neurobiology, Plenum Press, New York, 1991) 
1.3.2 Histo-architecture of the peripheralllerve 
fndividual nerve fibres are protected from the environment by a compact 
connective tissue matrix, consisting of three distinguishable layers. These layers have been 
termed epineurium, perineurium, and endoneurium. The use of this terminology can be 
traced back to the work of Key and Retzius (1876) and Ranvier (1878) 17,18(Fig. 3). I will 
begin my description of the his to-architecture of the nerve with the nerve sheath. 
1.3.2.1 Epineurium 
The epineurium is a condensation of connective tissue loosely surrounding the 
fascicles in the peripheral nerve (Fig. 3). This loose fit makes the nerve tmnks relatively 
mobile. The epineurial sheath is thicker at regions were the nerve is exposed to pressure 
points, such as at the joints. The amount of epineurial tissue is also' greater when the 
number of fascicles increases. The cellular part of the epineurium. mainly consists of 
13 
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fibroblasts, which points to its mesodermal origin. The non-cellular part of the epineurium 
consists mainly of collagen (type I and ill), which are orientated longitudinally. Also, 
variable amounts of fat are present, which might have a function in cushioning the 
fascicles, and protecting them against damage by compression, especially at the joints. 
Blood is supplied via a network of arterioles and venules called the vasa nervomm, which 
has branches through the perineurium into the endoneuriallayer. The epineurium is also the 
only part of the peripheral nerve containing a lymphatic capillary network, which is 
connected to regional lymph nodes. 
1.3.2.2 Perineurium 
The perineurium is a multilayered cellular sheath surrounding individual fascicles 
of the nerve (Fig. 3). During development, the epithelial cells that fonn these sheaths 
originate from the mesenchyme surrounding the nerve fibres 19 20. The number of cell 
layers in the perineurium is proportional to the size of the fascicle. The layers consist of 
concentric sleeves of flattened epithelial cells that interdigitate and are connected by tight 
junctions at their margins. 
Bloodvessels transverse the perineurium and link the epineurial vasa nervonllll 
with the endoneurial capillary network. Tight junctions are also present between the 
endothelial cells of these capillaries, forming a blood-nerve barrier similar to the blood-
brain barrier in the CNS 21 
The non-cellular part of the perineurium consists of mainly collagen fibres, 
nnllling in between the cells of the perineurial sheath. Furthermore, both the most inner and 
outer cell layer of the sheath produce a basal lamina, consisting of a fine network of 
collagen IV fibres, fibronectin, heparane sulfate proteoglycan. However, the composition of 
the inner and outer basal lamina differs, which points to a st111ctural and functional 
polarisation of the perineurial sheath. 
The prescnce of tight junctions in thc perineurial sheath and blood vessels, 
together with the polarisation of this sheath are structural manifestations of the major 
perineurial sheath function. Which is: creating a physical barrier that limits the entry of 
biologically active proteins, infectious agents, and migration of blood bome cells into the 
nerve bundles. However, a selective transport mechanism exists, which allows transfer of 
molecules through the cellular sheath into the endoneurium. The presence of pinocytotic 
vesicles and caveolae in perineurial cells together with high ATPase and creatine kinase 
activity, are morphological and biochemical manifestations of this transport system. 
Thus, one major function of the perineurium is to protect the nerve by forming an 
effective diffusion barrier. In addition, the presence of collagen in the sheath points to a 
cushioning function. 
1.3.2.3 Endoneurium 
The endoneurium mainly consists of a thick layer of collagen fibrils rulming 
parallel along the nerves. This collagenous layer takes up ahnost fifty percent of the 
intrafascicular SPaCe, and. increases when animals age 22, Embedded .within the 
endoneurium, we find axons ensheathed by glial cells (Schwann cells) (Fig. 3). Schwaml 
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cells together with endoneuria I fibroblasts are the major cellular component of the 
intrafascicular space. These two cell types are the main producers of the collagens present 
in the endoneurium. 
The function of the endoneurium is mainly supportive and protective. 
Lumbosacral 
plexus 
Sciatic 
Peroneal 
Figure 3: A. Schematic representation of peripheral nerves visualised by an enzymatic staining method in the 
caudal part of a postnatal day (P) I mouse embryo. Both sensory and molor axons, which respectively cnler or 
leave the eNS at lumbar levels (t) 4 and 5, and sacral level (S) I and 20fthe spinal cord, are joined in the spinal 
nerves of the Sacral plexus. These nerves converge into the Sciatic nerve in the upper hind limb, which is the 
largest pcripheralncrve in vertebrates. Subsequently, more distal from the spinal cord, the Sciatic nerve bifurcates 
into the Peroneal, Sural and Tibial nerve. B represents a transverse section through the nerve presented in A. B. 
The nerve is filled with numerous axons surrounded by a myelin sheath (black circles). C. Schematic 
representation by Key and Retzius (1876) of region comparable to box C in Figure lB. Portion of a trans\'erse 
section through part of a peripheral nerve, showing the disposition of the epineurium, perineurium, and 
endoneuriUIll. Abbreviations: Ep, epineurium; Pe, perineurium; En, endoneurium. (From Key A. and Retzius, G.: 
Studien in def anatomie des nervensystems und des Bindesgewcbes. Stockholm, Samson & Wallin. 1876.) . 
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1.4 Glial cells in the peripheral nerve 
During evolution, glial cells appeared independently in the phyla of Protostomata 
(invertebrates) and Deuterostomata (vertebrates) (rcviewed in 23). Two types of glial cells 
can be distinguished in both phyla. First, non-myelinating glial cells are present in nerves of 
all members of both phyla. TIlese cells separate the individual axons by embedding them 
into the glial cell plasma membrane (see Fig 4). The second glial cell type spirals several 
times around the axon and produces a specialised insulating stmcturc, which is called the 
myelin sheath (see Fig. 5). 
All vertebrates except agnatha (lamprey, hagfish) have myelin forming glial cells, 
while invertebrates do not possess tl1lly myelinating cells. Although less thoroughly 
investigated, at least the higher invertebrates, such as annelids (earthworms), cnlstaceans 
(shrimps), and insects (flies) display multiple layers of glial ensheathments. Comparison of 
protein composition of the glial ensheathmellts from vertebrates and invertebrates suggests 
that evolution of glial sheath proteins in both phyla occurred independently 23. 
Curiously, families, in each phylum, having myelinated nerves dominate over 
families lacking myelination. A striking example of this has recently been described in 
crustaceans 24. Escape responses were compared between two families of copepods, which 
did or did not posses axons with a myelin-like sheath in their antennal nerves, The escape 
response of copepods with axons containing a myelin-like sheath is three folds faster than 
that of comparable axons lacking such a sheath in other copepod families. This improved 
performance of the copepod family having this myelin-like sheath reduces their reaction 
time to predatory attack. This results in an increased survival rate and allows them to 
dominate in open ocean communities 24. 
This remarkable observation provides a pointed illustration of how evolution of 
the myelin sheath allowed the development of fast conducting low calibre axons 
culminating in the complex compact nervous system of higher vertebrates. 
In the following section I will discuss the stmcture of non-myelinated and 
myelinated fibres as observed in most mixed nerves of the somatic division of the PNS. 
1.4.1 Non-myelinated peripheral axons 
Most peripheral nerves in vertebrates consist of a mix of myelinated and 11011-
myelinated fibres. hI contrast, nerves of the autonomic (sympathetic and para-sympathetic) 
nervous system contain predominantly non-myelinated nerve fibres. 
Non-myelinating Schwann cells segregate a variable number of small calibre axons, from a 
single axon to up to twenty, by sending out cytoplasmic processes in between the aligning 
axons (Fig. 4). TIlese processes might just be able to contact each other and seal off the 
axonal membrane from the endoneuria I space, or they stay apart and thus leave the axonal 
membrane and endoneuria I space only to be separated by Schwann cell basal lamina (Fig. 
4)25. Non-myelinating Schwallll cells overlap with neighbouring Schwarm cells (Fig 4A). 
This is probably the reason why they were erroneously thought to form a syncytium 25 
16 
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Figure 4: Schematic representation ofa non-myelinating Schwann cell (Sc) separating several small calibre axons 
(Ax) with its cytoplasmic processes. A longitudinal section corresponding to region A and transverse sections 
tluough regions Band C are presented below the scheme. (A) Two examples of overlapping cytoplasmic 
processes of neighbouring Schwann cells (Sc) along Axons (Ax). (ll) Section through a non·myclinating Schwalm 
cell at the level of the Schwann celillucleus (SC nueL), Arrowheads indicate the cytoplasmic processes separating 
the axons (Asterisks). (C) Similar section as in B, only away from the nucleus. Some axons are completely 
engulfed by the Schwalm cell processes, while others are only separated from the endoneurial space by the 
Schwann cell basal lamina (BL). Scale bar: 0,5 Jlm. 
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Fig. 5: Schematic representation of a myclinating Schwann cell associated with its axon (Ax). Two distinct areas 
can be distinguished in the Schwann cell membrane. which are compact and non-compact myelin. Non-compact 
myelin, the area still containing cytoplasm, can be subdivided into the paranodal regions, the outer collar (oel), the 
inner collar (icl), and the Schmidt-Lantcrmann incisures (SLI). Neighbouring myclinating Schwann cel1s do not 
overlap with each other, generating a naked axonal membrane, which is only separated by the basal lamina from 
the endoneurial space. This region is called the node of Ranvier. Electron micrographs of sections through the 
nerve fibre corresponding to areas A~F are presented below the drawing. 
18 
Chapter I 
1.4.2 Myelinated peripheral axons 
Large calibre axons (> I 11m diameter) are usually myelinated and these axons are 
fast conducting (Fig. 5). What immediately becomes evident upon studying micrographs of 
nerves is that; for unknown reasons, myelillating Schwann cells always associate with only 
one axon. A single myelinatillg Schwalm cell associated with its axon forms an intcl1lode 
(Fig. 5). This configuration stands in contrast to non-myelinating Schwann cells and their 
myelinating counterparts in the CNS, oligodendrocytes, which both can associate with 
mUltiple axons. Oligodendrocytes are capable of myelinating up to 30 internodes. During 
postnatal growth of an animal, the number of internodes in the peripheral nerves does not 
change, but as the nerve elongates, the internodal segments become lengthened. This 
lengthening might occur via passive stretching or by active remodelling of the myelin 
sheath 26,27. 
In a short region in between two internodes, the naked axon is exposed to the 
endoneuria I environment. This is the node of Ranvier, named after its discoverer (Fig. 5A). 
The regions of the internode flanking the node of Ranvier are the paranodal regions (Fig. 
5B). Both the node of Ranvier and the paranodal regions play an important role in the 
propagation of impulses along the axon (See box I). 
A fully matured internodal region is formed as the inner cytoplasmic lip of the 
Schwann cell has made many tums around the axon 28. Compaction of the myelin sheath 
occurs as the cytoplasm is squeezed out. The compact myelin region is fonned by close 
apposition of the intracellular layers of the plasma membrane, which generates the so-called 
major dense line in electron micrographs (Fig. 5D). Apposition of the two extracellular 
layers of the plasma membrane forms the intraperiod or intermediate line (Fig. SD). 
Cytoplasm only remains in regions of non compact myelin, such as the paranoClal 
loops near the nodes of Ranvier (Fig. 5B), the inner collar facing the axon and outer collar 
containing the nucleus (Fig 5), and the Schmidt-Lantennann incisures (Fig. 5F). The latter 
are canals of cytoplasm that spiral together with the compact myelin around the axon and 
,connect the hmer with the outer collar. The function of the Schmidt-Lanterman incisures is 
still unknown. 
The cytoplasmic cuffs of the paranodal loops and Schmidt-Lanterman incisures 
are connected via gap junctions. This allows a fast transport route for low molecular weight 
molecules directly through adjacent cytoplasmic cuffs, instead of the thousand fold longer 
circumferential route along the canals. The existence of inherited peripheral neuropathies in 
which a member of these gap junction proteins (connexin 32) is mutated, implies an 
important role for this fast transport route in myelinaling Schwallll cells (See section 
1.5.4.5). 
(FIg. 5 continued) (A) Section through a node of Ranvier (N) with the paranodaJ regions (P) of two neighbouring 
Schwalm cells. (B) High power magnification of a paranodal region in A. Arrows point to the paranodaJ loops 
contacting the axon (Ax). (my: compact myelin). (C) Section through the nerve fibre at the level of the Schwann 
cell nucleus (SC nuc!.). (D) High power magnification of the myelin sheath in C. Dark arrows point to the major 
dense lines. Open arrows point to the intraperiod lines. *: periaxonal space. <: inner collar. (E) Section through 
compact myelin away from the nucleus. The arrowhead points to the inner mesaxon. The white arrow points at the 
ollter mesaxon. Both mesaxons conlain tight junctions. BL: basal lamina. (F) Section tluough a Schmidt . 
Lantenllann incisure (arrows). 
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The transition from non-compact myelin to compact myelin at the inner and Qutcr 
collar of the Schwarm cell is marked by the presence of tight junctions. These junctions 
separate the extracellular space between opposing Schwann cell plasma membranes in 
compact myelin from the intercellular space between the non-compact myelin and the axon 
(pcriaxonal space) or basal lamina (endoneurial space). These stretches of tight junctions at 
the inner and outer collar are tenned the inner and outer mesaxon, respectively (Fig. SE) 29. 
In addition, myelinating Schwann cells produce a continuous basal lamina along 
the nerve fibrc (also over the nodes of Ranvier) consisting of among others collagen (type 
IV), laminin, and fibronectin (Fig. SE). 
Recapitulating, myelinating and non-myelinating Schwalm cells have highly 
distinct morphologies that relate to their diffcrences in function. At the molecular Icvel 
these differences manifest themselves in the expression of cell specific proteins required in 
each cell type (See section 1.5.3.3 and 1.5.3.4). As said, the major nmctional consequence 
of these stmctural differences is that impulses travel two orders of magnitude faster along a 
myelinated fibres than along non-myelinated ones (See box I). 
Nevertheless, both non-myelinating and myelinating Schwann cells originate from 
a conmlOn progenitor cell: the neural crest cell (see scction 1.5.1. and 1.5.2). Moreover, 
Schwaml cells are remarkably plastic in that they readily revcrt back to a more immature 
phenotype upon loss of axonal contact and that they can choosc again either of the two 
adult fates when axonal contact is restored 30,31. Thus the decision of a Schwann cell to 
adopt a myelinating or non-myelinating fate is influenced by the axon. 
Box 1 - Action potential propagation in peripheral nerves 
The ability of neurones to transduce signals relies on unique properties of the axonal and 
dendritic membrane. Impulses travel along axons as a depolarisation, disturbing the axonal resting 
potential. In a non-stimulated situation the axonal membrane has a resting potential, which is set up 
by the generation of an electrochemical gradient of mainly potassium (Kj and sodium (Na") ions 
across the membrane. Two mechanisms set up this gradient. First, a Na +/ K+-pump resides in the axon 
membrane, which actively transports two K+ ions into the axon and three Na + ions out (Fig. 6(a». 
This discrepancy between the number of equivalent charged ions going in and out of the cell, results 
in a negative charge within the axon. Secondly, this active transport mechanism is opposed by the 
passive diffusion of these ions along their electrochemical gradient (Fig. 6(b». Hov{ever, the 
penlleability of the axon membrane for K+ ions is 20 times higher than that for Na +, resulting in a net 
loss ofK+ ions from the axon by passive diffusion. Together the passive diffusion and active transport 
set up a negative charge within the axon. This results on average in most vertebrates in a resting 
potential of approximately -70mV. 
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Figure 6:Active and passive ionic movements 
associated with the production of a negative 
potential inside the axon. (a) The Na tlK+ pump 
actively and effectively exchanges 2 K+ ions from 
the outside against 3 NA + ions from the inside. 
Together with passive diffusion of mainly K' to the 
outside (b), the resting membrane potential in 
vertebrates is set around -70 mY. 
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(Box 1 " continued) 
Depolarisatiol1 of the axonal membrane, for instance after stimulation of one of the 
peripheral sensory organs results in a change iri the resting potential across the membrane. If the 
depolarisation reaches a certain threshold value, it will evoke an action potential in an all-or-nothing 
event. During an action potential the negative inside value of about -70 III V rises to a positive inside 
value of about +40mV. This polarity change is mainly brought about by voltage gated Na+ and K+ 
chmmeis, which are only opened after certain changes in membrane potential. Via these channels Na+ 
goes in and K+ out of the cell. Depolarisation causes the Na+-channels to open. This influx ofNa+ 
ions further depolarises the membrane allowing more Na+-chatmels to open up in a self-amplifying 
manner, until the net electrochemical driving force is zero, which is at a membrane potential of about 
+40 mV. At this p0int the Na+ channels are inactivated. At the same membrane potential K+ channels 
are opened allowing K+ ions to run out of the axon, repolarising the membrane potential rapidly back 
to its resting potential, where both channels are closed again. 
These events all occur in less than 0.5 millisecond. The self-amplifying depolarisation of 
the axon is sufficient to depolarise neighbouring regions of the axon membrane, which then go 
through the same cycle. Inactivation of the Na +-channels prevents re-excitation of the repolarised 
region, allowing the action potential to spread only in one direction along the axon from the sensory 
organ to the soma of the neuron. 
In non-rnyelinating axons the velocity of the propagated action potential depends on the 
longitudinal resistance of the axon cytoplasm. The resistance, in turn is related to the diameter of the 
axon such that the smaller the diameter the greater the resistance. This high resistance has an effect on 
the spread of current and reduces the length of local circuits so that only the region immediately in 
front of the action potential is involved in the local circuit. Many invertebrates, such as squids, have 
circumvented this problem by having very large diameter axons (up to lnun), which results in 
lowering of the resistance, increase of length of a local circuit and subsequently a higher conduction 
velocity. 
Vertebrates improved the speed of impulse propagation along the axon even further by 
myelinating their aXOl1s. In addition to the larger diameter of myelinated axons as compared to n9n-
myelinated ones, tills sheath has strong insulating capacities, \vhich allows an increase in the length of 
the local circuits. The length of these circuits is extended even further by the specific placement of ion 
channels along the axon. As mentioned before, the myelin sheath is fomled by Schwann cells, and has 
an intemlption in between every two adjacent Schwann cells, which is called the node of Ram'ier . 
. The Na+-channels are concentrated at these nodes. Because of this concentration of Na+-chanllels at 
the nodes, local circuits are set up and current flows only between two adjacent nodes. This resuits in 
the effect that the action potential 'jumps' from node to node and passes along the myelinated axon 
two orders of magnitude faster than with a series of smaller local currents in a non-myelinated axon 
of the same diameter (Fig. 7). This type of conduction is called 'saltatory' conduction. 
Figure 7: Diagrams showing the difference in 
lengths of the local circuits produced (a) in a 
myelinated axon and (b) a non-myelinated axon. In 
(a) conduction is described as saltatory since the 
action potential effectively 'jumps' from node to 
node. 
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1.5 Embryonic and postnatal development of peripheral 
nerve tissue 
The different components that make up the peripheral nerve tissue originate from 
different germ layers. During embryonic development, neurons (axons) and their associated 
glial cells derive from the neurectodenn, while the nerve sheath and nerve vasculature 
derive from the mesodenn. How these germ layers contribute to f011n the peripheral nerve 
is discussed in this chapter. 
First, I will review some aspects related to the biology of the neural crest. This will 
include a brief discussion of data related to the question of how the neural crest is specified 
(section 1.5.1), how delamination of the crest is initiated (section 1.5.2) and how neural 
crest. cells choose different fates (section 1.5.3), in particular a Schwarlll cell fate. In 
subsequent sections I will review what we knolY about Schwarlll cell development and the 
formation of myelin (Myelogenesis)(section 1.5.4). In recent years it has become clear that 
SchWalm cells playa central role in all aspects of nerve tissue development. These new 
developments will be discussed in sections 1.5.5, 1.5.6 and 1.5.7. 
1.5.1 Neural crest -'Specification 
During vertebrate development, Schwann cells originate from a multipotent 
migratory cell population derived from the dorsal aspect of the neural tube: the neural crest 
(Fig. 8). This cell population has been first described in chicken embry03 by Wilhelm His. 
He postulated that the neural crest is an organ famling gennillal zone, containing subsets of 
cells with restricted fates. Over the last few decades this rather simple scheme has been 
revised and much more detailed information has been added. In particular, the combination 
of classical tissue grafting teclmiques and more recent molecular biological techniques have 
led to the identification of protein factors involved in the induction, migration, and fate 
determination of neural crest cells. It has become clear that, contrary to what His thought, 
the neural crest population is a population of multipotent cells that realise different cellular 
fates depending on the cellular environment in which they migrate and differentiate. In this 
section I will present data relating to the question holY the neural crest is induced. 
The neural crest cell population is formed at the border between the neural plate 
and the presumptive epidermis, overlying the lateral plate mesoderm in a gastrulating 
embryo (Fig. 8). As gastmlation proceeds, neural folds will form, bend and fuse to generate 
the neural tube. During this process, cells emigrate from the dorsal ridges of the neural 
folds to foml the migratory population known as the neural crest (Fig. 8). Although, until 
this date, the question about how the neural crest is specified is still unanswered, several 
protein factors playing a role in this process have been put forward. 
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Figure 8: Schematic representation of neural tube fonnation. The ectodermal cells are represented either as 
precursors of the neural crest (dark grey) or the epidermis (light grey) or the neural tube (white). The ectodeml 
fuses in the most dorsal point, famling an outer epidermis, an inner neural tube, and a population of neural crest 
cells migrating into the embryo in between the epidennis, the neural tube, the dennatome and sclerotome, The 
latter two arc generated from the somites, which are ofmesodennal origin. 
The first step in the induction of neural crest is the specification of a homogenous 
layer of ectodermal cells in a gastrulating embryo into the neural plate (neurectoderm) and 
the epidermis, A substantial body of evidence suggests that members of the bone 
mOlphogenetic proteins (BMP), belonging to the transforming growth factor (TGF) -
~ family, play an important role in this process, Two members of this group, BMP-4 and 
BMP-7 (BMP-417) are expressed throughout the gastrula ectoderm except in the 
prospective neural plate 32 This expression patten! coincides with the presumptive 
epidermis. 
Other (1ctors, such as Noggin and Chordin, are produced and excreted by the 
notochord in a graded pattern and are only present where BMP-417 is absent (the 
presumptive neurectodenn) 33-35, Treatment of Xel/opus laevis animal cap explants with 
BMP-417 promoted the formation of epidernlis 36, In the same experimental setting it was 
shown that treatment with Noggin and Chordin induced neural tissues 33,34, In addition, it 
has been demonstrated that Chordin and Noggin bind and inactivate BMP-417 37, Taken 
together, these data suggest that the Noggin and Chordin inactivate the epidelmalising 
activity of BMP-417 by binding to it in the extracellular space, This prevents binding of 
BMP-417 to membrane-bound BMP receptors on the ectodermal cells, thereby blocking 
epidermalisation of the ceiL Hence, counteraction of BMP signalling by Chordin andlor 
Noggin results in specification of ectodenn into neurectodenn and epidermis. 
This model is supported by the structural and functional conservation of these 
molecules in invertebrates, The Drosophila Melal/ogaster homologue of BMP-4 is 
decapeJ/taplegic (dpp), Flies lacking dpp have an expanded neurectodennal region at the 
expense of epidermal tissues 38, Ectopic expression of dpp leads to epidermal expansion at 
the expense of neurectoderm 38, Thus dpp suppresses neurogenesis in the fruit fly, The 
Drosophila homologue of Chordin is short-gastrulatioJ/ (sag), Flies lacking sag have 
expanded epidemlis at the cost of loss of neurectoderm, while ectopic sag expression leads 
to formation of neurectoderm 39,40, Rescue of the Drosophila dpp phenotype by 
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expression of human BMP-4 and epidermalisation of Xel/opus animal cap cells by dpp 
demonstrate that dpp is the functional homologue of BMP-4 40,41. Furthermore, the facts 
that sag neuralises animal cap cells and ectopic Chordin expression in fmit flies leads to 
expansion of the neurectoderm, show that sag and Chordin are fUllctional hOlllologues 40, 
Genetic evidence for this model in mice is less compelling. Dismption of the 
BMP-4 gene resulted in defects during gastrulation and fonnation of the posterior body and 
ventral mesoderm 42 Unfortunately, neurectodermal defects were not addressed in these 
experiments. Targeted deletion of Noggin demonstrated that specification of the ectodenn 
was unaffected, suggesting that Noggin is not essential in this process 43. This -might be 
explained by the fact that Chord in or another unknown protein is either essential or has a 
redundant fimction during neural induction. Targeted deletion of the mouse Chordin gene 
has not been reported. 
However, null mutations of the Chord in homologue in zebra fish (Chordino) 
demonstrated that indeed Chordino is required for neurectodenn induction but is not the 
only neural inductive factor 44. Noggin is not expressed in the zebrafish notochord at the 
time the neural plate is specified, ruling out a role for noggin in this process 45. Other 
neural inducing genes in zebrafish, which are expressed at the right time and place have 
been identified but not characterised 46 Thus, although the picture is not complete yet, it is 
likely that inhibition of BMP activity by factors such as Chordin, and Noggin play an 
important role in patterning the ectoderm into neurectoderm and epidermis (Fig. 9). 
The second step in neural crest specification requires further patterning of the 
neural fold along the dorsal-ventral (D-V) axis. As gastl1llation proceeds, neural folds are 
formed and BMP-417 expression fades in the epidermis and becomes restricted to the neural 
folds. This restricted expression of BMP-417 marks the (D-V) patterning of the neural tube, 
which eventually will lead to specification of the neural crest 32 
Elegant experiments perfomled in the Jessel lab demonstrated that in chicken 
embryos, opposing effects of dorsal BMP-417 expression and a ventralising signal from the 
notochord are required for the D-V patteming of the neural tube 47. A good candidate for 
the ventralising signal is Sonic hedgehog (Shh), a secreted glycoprotein synthesised by the 
notochord 48. However, Shit cannot induce neural tissues from presumptive ectoderm celis, 
but can change the D-V pattern of pre-existing neural tissue 49. Nevertheless, Shh can 
induce expression of Noggin in ventral neural plate 50. Although Noggin is not essential 
for neural induction, it is required for the D-V patteming of the neural tube 43. Noggin -/-
mice have a loss of ventral neural cell fates, despite the presence of normal Shh expression 
in the notochord. Together these data suggest that after neural induction, Shh dependent 
Noggin expression in the presumptive ventral neural tube counteracts the dorsal BMP-417 
expression, resulting in the D-V patterning of the neural tube (Fig. 9). 
It has been suggested that during D-V patteming the concentration of BMP to 
which a neural plate cell is exposed defines its t:1te. This implicates that BMP-417 functions 
as a morphogen 47. Specifically it is thought that neural crest is generated by intermediate 
levels of BMP-417 in a BMP-417 gradient from high concentrations in the dorsal neural tube 
to low in the ventral neural hlbe 47,51. Although evidence favouring this model is 
accumulating, other data suggests that BMP-417 is not the only factor involved in neural 
crest specification. 
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For instance, expression of basic fibroblast growth factor (bFGF) seems to be 
required for neural crest induction. It is expressed, like BMP-4, in the ectoderm in a graded 
fashion, inducing neural crest fate at intermediate levels. Alternatively, it is possible that 
bFGF renders the neural crest competent to signals such as BMPs 52 
Next, members of the Wingless family of growth factors (Wnt) Wnt-1/3A have 
also been implicated in neural crest induction by co-operating with other neuralising signals 
(such as BMP-4 or bFGF) resulting in a robust activation of neural crest marker genes 53 
Finally, the mesoderm underlying the presumptive neural crest region has been 
demonstrated to be a source of all these factors (BMP-4, bFGF, Wnt_1/3A)51,54,55. These 
observations suggest a role for mesoderm in the induction of neural crest. 
In summary, these data indicate that induction of a neural crest cell t:1te might be 
specified by the position of a cell in a network of morphogen gradients, such as BMP-4, 
bFGF, Wntl/3A along each axis (rostral-caudal, dorsal-ventral and proximal-distal) in the 
developing embryo (reviewed in 56). 
1.5,2 Neural Cl'cst - delamination 
As gastrulation proceeds, the neural folds will fuse and form the neural tube, 
epidermis and cause delamination of neural crest cells (Fig. 8). To initiate migration, neural 
crest cells have to switch from an epithelial to a mesenchymal morphology. Recently, 
several factors have been identified that might be directly involved in mediating this 
morphological switch. 
First, in Xenopus, chick and mouse neural crest induction is marked by the 
expression of the zinc-fmger protein Slug, which is homologous to the Drosophila Snail 
gene. In chick and mouse embryos, dorsal midline cells express Slug before delamination 
of crest cells. It was hypothesised that Slug is important for the epithelial-to-mesenchymal 
transition that characterises the migration of neural crest, since treatment of chicken 
embryos with antisense oligonucleotides against Slug inhibited the emergence of neural 
crest from the neural hlbe 57. However, in mice ill which Slug (Slugh) is deleted, this 
transition occurs normally 58. It is possible that lack of a neural crest defect in Slug -/- mice 
is the result of redundant functions of other Snail or Slug family members 59. Thus, 
although Slug has proven to be a useful marker for presumptive neural crest cells, its 
involvement in crest inductJon and emigration has remained unclear. 
Second, after neural fold fltsion, BMP-4 and noggin are highly expressed in the 
dorsal aspect of the neural tube. Delamination of crest from the neural tube is initiated at 
the rostral end of the embryo in a rostro-caudal gradient marked by Slug positive migrating 
crest cells. The start of emigration coincides with the fading of noggin expression. 
Experiments from the Kalcheim lab have shown that ectopic noggin expression prevents 
crest emigration 60. Since noggin is an efficient inhibitor of B.MPA action, it is suggested 
that BMP-4 positively regulates the epithelial-mesenchymal transition that characterises 
crest delamination. Preliminary results from the same group further suggested that noggin 
expression is down regulated by signals emanating from the dissociating sclerotome 
(mesoderm). 
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Altogether, these results suggest that a co-ordinated activity of noggin and BMP-4 
in the dorsal neural tube trigger delamination of specified, Slug expressing neural crest 
cells. Thus, BMP-4 plays multiple and discemible roles at sequential stages of neural crest 
ontogeny, from specification (See section 1.5.1) through delamination and later 
differentiation of specific neural crest derivatives (See section 1.5.3)(Fig. 9). 
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Figure 9: BMP-4 plays multiple discernible roles at sequential stages of neural crest development, from 
specification (a) 10 delamination (b). For details see text section 1.5.1 and 1.5.2. Abbreviations: epi. epidcmlis; ne, 
Neural crest; neur, neurectoderm; dm, dermatome; sc, sclerotome. 
1.5.3 Neural crest - fate determination 
Classical grafting and chimera experiments, mainly perfonned in the quail-chick 
system, have generated a detailed fate map of the neural crest 61. Transplanting neural crest 
cells from a certain axial level of a quail embryo into a similar level of chick neural crest 
(homotypic grafts) made it possible to distinguish to which tissues the grafted region 
contributes. These experiments demonstrated that neural crest originating from various 
levels along the anterior-posterior (AP) axis generated distinct but also overlapping sets of 
derivatives (Fig. 10). For instance chromaffin cells of the adrenal gland originate only from 
a small population of tnmk neural crest cells, while Schwam! cells can be derived from 
neural crest along the entire length of the AP-axis of the animal (reviewed in 61). However, 
when neural crest is grafted into a different axial level than from which it originates 
(heterotypic grafts) it will generate, with a few exceptions, derivatives that are normally 
generated from the region it is grafted into. For instance, if neural crest from the tnmk 
region is transplanted into the more rostral vagal level, it will generate enteric neurons 
(reviewed in 61). In addition, neural crest cells emigrating from the same axial level along 
the neural tube at different developmental timepoints tend to give rise to distinct derivatives 
(reviewed in 62). Nevertheless, it has also been demonstrated that both early and late 
migrating crest have equivalent developmental potentials ill vivo 63. Thus, these results 
highlight the plasticity of the neural crest and show that it is the environment into which 
they migrate primarily detennines crest fate. 
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Figure 10: Variations in crest derivatives 
produced at difiercnt levels along the 
rostra-cuadal extent of the neuraxis. Only 
major subdivisions of the neuraxis and a 
simplified subset of crest derivatives arc 
shown. The results are based primarily on 
fate-mapping experiments in avian 
embryos (adapted from 64). 
However, from these experiments it is not evident whether the environment acts 
instructive, on a homogenous population of neural crest stem cells, or selective, all a 
collection of committed crest cells. To address this issue, lineage tracing experiments have 
been perfomled, for instance by labelling single cells ill vivo with a vital dye or with an 
heritable retroviral constmct 65,66. These studies demonstrate that most pre-migratory 
crest cells are multipotent, on the basis of the location of the daughter cells into various 
neural crest derivatives, such as sensory neurons and glia 67. However, precursors 
generating just a single unique neural crest derivative have also been observed, indicating 
that some neural crest cells are already committed while still being in the neural folds. 
These studies characterise accurately the prospective fates of the individual cells, but do 
not reveal the total range of their phenotypic repertoire. 
After clonal culture conditions were established of mouse and rat neural crest 
cells from various stages of development, it became possible to address this issue 68-70. 
These studies demonstrated that most premigratOlY neural crest cells are multipotent self-
renewing stem-like cells, which however vary in the types of derivatives they generate. For 
instance, in mouse it has been demonstrated that neurons, smooth muscle and Schwann 
cells can be produced from a single precursor in vitro 71, 
FurthemlOre, these clonal culture assays have led to the identification of factors 
that are potentially involved in the lineage determination of the neural crest. For instance, 
one of the products of the neuregulin gene, glial growth factor 2 (GGF-2) causes neural 
crest cells to differentiate into Schwann cells 72(Fig. II). On the other hand, neuronal 
development of neural crest stem cells is promoted in the presence of BMP2 or BMP-4, 
while smooth muscle cells are the major derivatives after treatment with TGF-p 7\Fig. 
11). These signalling molecules act in an instructive manner, rather than in a selective onc, 
since they promote development of one lineage at the expense of others. However, when 
these cells are treated with combinations of TGF-p, BMP-2 and GGF-2, the former two 
fhctors are dominant over GGF-2, indicating· that intrinsic biases in the stem cells can 
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affect the outcome of lineage decisions made in the presence of multiple competing 
instructive signals 74, 
Targeted deletion of the genes coding for these factors indicated that some of 
these factors might also exert these functions in vi~'o. For example, targeted mutation of the 
neuregulin gene, leads to a major reduction in the number of Schwann cells associated 
with peripheral nerves, while a TGF-~ knock out interferes with cardiac and vascular 
development 75-78. Mice homozygous for mutations in BMP-2 or BMP-4 die too early to 
evaluate a requirement for these factors in neuronal development 42,79, 
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Figure 11 :Individuailleural crest cells 
are Illullipotent and capable of 
undergoing symmetric self-renewing 
divisions. Several growth factors have 
been found to instruct cultures of 
mammalian multipolent neural crest 
cells to adopt different fales. Cultures 
treated with TGF-p fonn smooth 
muscle, while those treated with OGF-
2 form glia. Cultures treated with 
BMP-2/4 form autonomic neurons, 
and to a lesser extent smooth muscle. 
Adapted from 80. 
Multipotent progenitors can also be derived from postmigratOlY neural crest 
populations. These progenitors, however, are more restricted in the types of derivatives they 
can generate when clonal cultures of these cells are challenged with the same instmctive 
factors. For instance, progenitors derived from the developing gut are able to divide 
multiple times ill vitro, but exclusively give rise to neurons. This occurs even when they are 
challenged with GGF-2, an agent that suppresses neural differentiation in neural crest stem 
cell cultures in favour of SchWalm cells or smooth muscle cells 81. Furthermore, various 
l11ultipotent neural crest derived progenitors have been isolated from a rat sciatic nerve 
during development 82 In this study, different populations of multipotent self renewing 
stem cells were isolated by FACS &orting based on the presence or absence of the surface 
molecules protein zero (PO), the major peripheral myelin protein, and the low affinity 
neurotrophin receptor (P75). Progenitors expressing p75 in the presence or absence of PO 
behaved in an identical manner as the originally identified neural crest stem cells, when 
challenged with GGF-2, BMP-2/-4 or TGF-~. However, fate restrictions became apparent 
when these different clones were grown in standard culture conditions. While the majority 
of clones expressing p75 but not PO exhibit multiple fates producing colonies containing 
glia, neurons, and myofibroblasts, clones positive for both p75 and PO predominantly 
generate glia and myofibroblasts. A multipotent precursor population expressing p75, PO, 
and also the peripheral myelin protein 22 (PMP22), has been isolated from yet another 
neural crest derivedtissue, thedorsal root ganglion (DRG) 83. Strikingly, ineontrast to p75 
_ 28 
Chapter I 
and PO positive progenitors isolated from the sciatic nerve, these cells generate mainly glia 
and neurons when cultured in standard conditions. Furthermore it has been demonstrated 
that by a community effect groups of PO/PMP22 positive progenitors interpret instmctive 
signals differently than single POIPMP22 positive cells 84 When single cells were treated 
with TGF-p, they are fated to generate smooth-muscle-like cells, while communities of 
PO/PMP22 progenitors generate neurons or go into apoptosis. It is likely that this effect also 
occurs ill vivo in the DRGs, where the cellular association of these multipotent progenitors 
might suppress the generation of a non-neuronal fate. 
Earlier studies had demonstrated PO expression in late migratory neural crest cells. 
It was suggested that these PO expressing crest cells represent a sub population of cells 
predetermined to form glia 85,86. The data presented earlier in this section argue against 
this view. The fact that PO expressing neural erest progenitor eells are able to generate other 
cell types (such as neurons or myofibroblasts) next to glia, either in the presence or absence 
of instmctive signals, demonstrates that early PO expression is not restrictive for neural 
crest cells to generate glia at the east of other cell types ill vitro 82,84. Whether this is 
actually the case ill vivo still has to be determined by transplantation experiments. 
In summary, these different studies demonstrate that migrating crest cells are 
multipotent and that environmental eues drive them to differentiation into diverse cell 
types. Differentiating crest cells do not lose their multipotency. Other differentiation fates 
remain open. This situation is reminiscent of that in B-eell differentiation. In the absence of 
Pax-5, B220 positive B-cells abandon a B-cell fate and differentiate into osteoclasts when 
challenged with the appropriate growth factors 87,88. The general picture that emerges 
from these and other studies is that lineage determination and differentiation is not a route 
down a one way track, but instead is highly flexible with eells retaining multipotency very 
far down a differentiation pathway. It also calls for eaution in using so called differentiation 
markers to determine the fate of a cell. 
1.5.4 How to become a Schwann cell 
The first contact between early post-migratory neural crest cells and axons 
probably occurs when both start to migrate away from the neural tube through the rostral 
part of the somites along the rostro-caudal axis of the embryo 89. Both neural crest cells 
and axons do this independently of each other 90. This preference for the rostral site of the 
somite is mediated through interactions between repulsive forces in the caudal part, such as 
Ephrins and their receptors, F-spondin, Cytotactin-binding proteoglycan, T-cadherin, and 
Versican, and attractive cues, like Tcnascin, butyrylcholinesterase, and Thrombospondin in 
the rostral part of the somite 91-100. These cues direct the axons and the associated neural 
crest cells towards their target organs, resulting in segmentation of the peripheral nervous 
system. 
Based on morphological and cell biological properties, three transitional states can 
be distinguished within the Schwallll cell lineage. The intimate relationship between neural 
crest, its derivatives and axons by means of reciprocal signalling are a prerequisite for these 
transitions to occur. During the last decade' one component of this reciprocal signalling has 
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been identified and was shown to playa role in at least two of these transitions and to be 
essential for normal peripheral nerve development. A family of epidernuil growth factor 
(EGF)-like proteins produced by neurons, dubbed neuregulins (NRGs), are ligands for 
members of the EGF family of four receptor tyrosine kinases, telmed ErbBI (EGF-
receptor), ErbB2 (Neu), ErbB3, and ErbB4, of which several are expressed during Schwann 
cell development 101. GGF-2 is a member of this family. As discussed in the previous 
section this factor functions as an instmctive signal for neural crest stem cells to generate 
glia. Other members of this family are Neu differentiation factor (NDF), heregulin, sensory 
and motor neuron-derived factor (SMDF), and acetylcholine receptor inducing activity 
(ARIA). It has been demonstrated that all these factors are products of the same gene: the 
neuregulin-I gene. This family of growth factors compromises at least 12 members, which 
arise through alternative splicing of the 13 exons of the NRG-I gene. All these ligands 
consist of different combinations of several identifiable domains: an EGF-like motif (a or p 
variant), a signal peptide, an inmlUnoglobulin (Ig)-like domain, a cysteine-containing N-
terminal domain, a glycosylation domain and a transmembrane domain. The presence or 
absence of the transmembrane domain determines whether the precursor is made as a 
membrane bound or a secreted protein. NRGs are grouped into three different isotypes. 
Members of isotype NRG I (containing NDF and ARIA) includes variants with an Ig-like 
domain and a glycosylation domain, which are mainly expressed at the early embryonic 
stages and predominate in the endocardium. Members of the NRG II group (including 
GGF-2) have an Ig-like domain but no glycosylation domain and are expressed in 
embryonic skeletal muscle. The NRG III isotypes (containing SMDF) have the cysteine-
rich domain, whose main site of expressing is in the sympathetic and somatic motor and 
sensory neurons. As mentioned earlier, receptors for these ligands are the four members of 
an EGF family of receptor tyrosine kinases, ErbB I (EGF-receptor), ErbB2 (Neu), ErbB3, 
and ErbB4. These proteins consist of a large extracellular ligand-binding domain, a single 
transmembrane segment, and an intraceHular portion containing a carboxy terminal tail 
region and a tyrosine kinase subdomain. The latter domain of the ErbB3 receptor has 
diverged from the other three receptors and lacks tyrosine kinase activity. Notwithstanding 
this fact, together with ErbB4, ErbB3 is the actual receptor for all the NRG isoforms. 
ErbB2 has no affinity for NRGs, and there is no other ligand known for it. ErbB I binds at 
least six other known EGF-like molecules, such as EGF, heparin-binding EGF (HB-EGF) 
and TGFa 10 I. The lack of catalytic activity of the ErbB3 receptor, however, can be 
overcome by the process of ligand induced receptor dimerization, in which the three other 
ErbB members are recruited as coreceptors. This will lead to receptor phosphorylation and 
activation of downstream signalling. pathways. Thus, ErbB3 signalling depends not only on 
NRG binding, but also requires association with other ErbB proteins, which in Schwaml 
cells is most likely Erbb2. The other ErbB proteins share the ligand-induced fonnation of 
homo- and heterodimers, and all ten possible receptor combinations can exist. It has been 
demonstrated that different ligands prefer fonnation of specific heterodimers. Another 
mechanism leading to the observed multipotency of the NRGs, is the ability of the different 
residues in the cytosolic tail regions of these receptors to determine which intra cellular 
signalling proteins will be recmited to the activated receptor. Hence, heterodimerization 
and activation of different pairs of receptors could result in the triggering of different 
combinations of signalling pathways, which might also function synergistically. 
In summary, different receptor-heterodimer combinations can associate with 
different combinations of hitracelluiar signalling proteins, leading to diversity in the types 
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of pathways that are elicited by a single growth hoctOr. This might explain the observations 
that NRGs can elicit different responses such as Schwaml ceIl proliferation or survival, as 
will be discussed in the foIlowing sections. 
1.5.4.1 Neural crest - Schwann ceIl precursor transition 
The first transition occurs just after neural crest has invaded and populated the 
embryonic nerve bundles (Fig. 12). At this stage ceIls associated with these axons can be 
distinguished from neural crest cells on the basis of a number of properties, and are termed 
Schwallll ceIl precursors 102, I 03. 
First, they differ morphologicaIly from neural crest ceIls. Precursors have sheath 
like processes, which contact each other and encircle large groups ofaxons into large 
bundle (fig. 12). These bundles can be observed in a rat El4 sciatic nerve, and two days 
earlier in the mouse embryo 103,104. Second, fonnation of Schwann ceIl precursors from 
neural crest ceIls is characterised by the appearance of the differentiation markers F-
spondin and the membrane associated phosphoprotein growth associated protein-43 (GAP-
43) 105,106. 
However, the most cOllvincing fact demonstrating that precursors arc an 
intermediate stage between neural crest and mahlre SchWalm cells becomes apparent when 
precursors and Schwann cells are dissociated from the axons and placed in culture. In 
contrast to Schwann cells, which are very able to survive under deftned culture conditions 
when deprived of axonal contact, Schwann cell precursors die through apoptosis within 
several hours of culture 103 This indicates that the survival of Schwann ceIl precursors in 
developing nerves is probably supported by axon derived signals. In agreement with this 
Neural (;fest 
to 
precursor 
to 
immature 
to 
non elina!!n 
Figure 12: Three transitional stages can be identified within the SchwalUl cell lineage; from neural crest to 
Schwann cell precursor, from precursor to immature Schwann cell, and from Immature to (non) myelinating 
Schwann cells. 
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was the observation that whcn cultured in medium that was conditioned by DRG neurons, 
these precursors were able to survive and additionally differentiate into immature Schwanll 
cells in a similar time frame as ill vivo. The factor regulating survival and developmental 
progression ofSchwann cell precursors has been identified as NDF, a member of the NRG 
growth factor family 107. This study demonstrated that the signal in DRG conditioned 
medium could be blocked by addition of a soluble protein containing the extracellular 
domain of the ErbB-4 receptor, which is a high affinity receptor for NDF 107. Furthermore, 
addition of purified NDF to defined media could mimic the effects of DRG conditioned 
medium. 
It has also been demonstrated that NDF and its receptors are essential for precursor 
survival ill vivo. Targeted deletion of the NRG-l gene in mice resulted in an early 
embryonic lethal phenotype, caused by a heart defect 75. However, just before these 
embryos died, it could still be assessed that there was an almost complete loss of Schwann 
cell precursors in the emblyonic nerves. Targeted deletion of only the Ig-domain of the 
NRG gene leads to an isotype specific loss of type I and II, while NRG type III isoforms 
are normally expressed. Strikingly, mice homozygous for this mutation seem to have 
nom,.1 SchWalm cell precnrsor numbers along their axons, indicating that type III NRG (~ 
SMDF) is sufficient for precursor survival 108. 
Lack of SchWalm cell precursors was also observed after targeting of individual 
components of the NRG receptor. Animals lacking the ErbB3 receptor survive until birth, 
but their nerves were devoid of Schwann cells, as expected from the lack of precursors at 
earlier developmental stages 109. Mice homozygous for a targeted ErbB2 allele died of 
heart defects at an embryonic stage, which was too early to evaluate its effect on Schwann 
cell development 110. Recently, however, this heart defect has been rescued either by a 
transgene directing ErbB2 expression specifically to the heart via a cardiac-specific 0:-
myosin heavy chain promoter, or by knocking in the ErbB2 cDNA into the heart specific 
Nkx2.510cus via homologous recombination 111,112 In both cases rescued knock out mice 
survived until birth, and all peripheral nerves were essentially devoid of Schwann cells. 
This embryonic nerve phenotype is strikingly similar to the ErbB3 knockout phenotype. 
The ErbB4 gene has been targeted as well, but resulted in an embryonic lethal too early to 
investigate its role on Schwann cell precursor survival 113. However, the fact that ErbB4 is 
not expressed in Schwann cells suggests that this is very unlikely 114,115. Whether the 
lack of precursors is due to the fact that the neural crest is not instmcted to become 
precursors, or precursors arc formed but are not able to survive has not been demonstrated 
in these studies. 
Nevertheless, these results underscore the importance of axonal contact, and 
identifY the NRG-p and its receptors as essential components of this interaction. However, 
this dependence on axonal contact for survival will decline as precursors mature and 
become Schwann cells, which will be discllssed in the following section. 
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1.5.4.2 Precursor- immature SchwauIl cell transition 
This transition occurs quite rapidly, between El4 and El7 in the rat (E12/13-
E15/16 in mice), and is accompanied by several morphological changes ill vivo. In contrast 
to precursors which group axons into large bundles, immature SchwaHn cells start to invade 
this bundle and sort the axon population into smaller groups (Fig. 12). Depending on the 
size of the axons, immature Schwalm cells will associate with only onc large axon Of 
multiple small calibre axons, and adopt a pro-myelillatillg and pro-non-myelinating 
configuration, respectively (Fig. 12). In rodents, most immature Schwaml cells will have 
adopted this configuration just after birth. 
In addition to these changes ill vivo, interesting differences between these two 
populations become apparent, when these cells are put into culture. What is immediately 
apparent is the difference in morphology. Precursor cells are flattened cells with high 
motility and extensive cell-cell contacts, while immature Schwann cells have low motility 
and are bi- Of tri-polar cells. Furthermore, immature Schwann cells can be distinguished 
from precursors as the fonner start to express a set of molecular markers, such as the Ca2+ 
binding protein S100, Galactocerebroside (GalC), and the sulphatide lipid antigen 04 102 
However, the most striking difference between precursors and immature Schwann 
cells is that the latter have the ability to survive when cultured in high density under defined 
conditions, without the addition of NRG-p supplemented or DRG conditioned medium 
103,104. These results indicate that these immature Schwaml cells have acquired an 
autocrine survival loop. 
First, in vitro experiments have demonstrated that survival of these cells is dependent on 
the density of the cultures. Low-density cultures go into apoptosis, while high-density 
cultures survive. Second, low-density cultures can survive when grown in medium 
conditioned by high density immature Schwann cell cultures 107. 
Potential components of this autocrine survival signal were identified when low-
density cultures were grown in defined medium in the presence of various growth factors. 
Three factors, insulin-like growth factor I or 2 (IGF-1I-2), platelet derived growth factor 
BB (PDGF-BB), and neurotrophin-3 (NT-3) were able to individually and synergistically 
block immature Schwallll cell death under these conditions 116. In contrast to NRG-p, 
these factors are not mitogenic and do not promote survival of Schwann cell precursors. 
Mature (non-myelinating and myelinating) Schwann cells probably fully depend 
on the autocrine survival signal. This assumption is based on experiments that described the 
cxpression pattem of the factors that are mediating the NRG-p and autocrine survival 
routes. Although NRG-p is present in adult nerves, the ErbB-2 receptor is downregulated in 
Schwann cells of adult peripheral nerves 107,115,117. The lack of ErbB-2 disables the 
formation of a functional heterodimer ErbB receptor on the Schwann cell surface (See 
section 1.5.4) and hence prevents activation of the NRG-~ mediated survival route. 
In contrast, IGF-2, PDGF-BB, and NT-3 and their corresponding receptors are 
upregulated in Schwann cells during peripheral nerve development and regeneration, and 
are all present in mature Schwallll cells 116,118 This would suggest that in adult nerves, 
Schwann cells depend on autocrine signals for survival. 
This switch from axon dependent survival in precursors, to an axon-independent 
autocrine survival in mature Schwann cells occurs gradually during peripheral nerve 
development. This is demonstrated when axot'131 contact is lost after rierve trmisecfion at 
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perinatal stages. At that stage Schwalm cells go into apoptosis, which could be prevented 
by the application of exogenous NRG-~ 119. However, in nerves that were transected only 
two weeks later Schwaml cells were already able to survive with very little programmed 
cell death occurring 115,119,120. 
Two intracellular signal transduction pathways are involved in mediating both the 
NRG-~ and autocrine signals that lead to survival of Schwann cells. First, the mitogen 
activated protein (MAP) kinase pathway is involved in the regulation of both precursors 
and immature Schwann cell survival. In precursors, this pathway is activated by NRG-~ 
107, However, NRG-~ does not utilise this pathway in immature Schwann cells, since 
addition of agents that specifically block this pathway did not lead to a loss of NRG-~ 
mcdiatcd survival. Nevertheless, these MAP kinase pathway blocking agents, were able to 
interfere with the survival of cultures supplemented either with the IGF-I1-2, PDGF-BB 
and NT-3, or high-density culture conditioned medium 116. This indicates that NRG-~ 
mediates immature Schwann cell survival via another signalling pathway. 
The second intracellular signal transduction pathway that has been demonstrated 
to be involved in Schwann cell survival is the phosphoinositide-3-kinase (PI3K) pathway 
104. Recently, it has been shown that both precursors and immature Schwalm utilise this 
pathway in NRG-~ mediated survival 104. In this study, NRG-~ mediated survival could be 
prevented by addition of a specific PI3K pathway inhibitor in both precursor and low-
density immature Schwann cell cuihlres. 
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Figure 13:During peripheral nerve development, the Schwann cell gradually changes its survival potential from 
being completely dependent on axonal contact (NRG-P) in SchWailil cell precursors to being self-supporting in 
mature Schwann cells via an autocrine survival loop. This autocrine survival loop is acquired by immature 
Schwallll cells, which rely on both axonal and autocrine survival signals. The MAPK and PI3K intracellular 
signalling pathways are involved in mediating these signals. 
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In summary, during peripheral nerve development, Schwann cells gradually switch 
their survival potential from being completely dependent on axonal contact (NRG-p 
mediated survival) in Schwaml cell precursors, to self supporting in non-myelinating and 
myelinating Schwalm cells (the autocrine survival loop) (Fig. 13). These changes in 
survival potential during Schwann cell development can be very well reconciled with the ill 
vivo situation. The dependence of precursors on axonal contact is likely involved in the 
matching of precursor numbers to axon numbers, preventing survival of precursors not in 
contact with axons at abelTant locations 120,121, On the other hand, axon independent 
survival of Sclnvallll cells is a prerequisite for axoIlal regeneration to occur after nerve 
damage (See section 1.5.5) 122 
1.5.4.3 Immature to (non-) myelinating Schwaml cell transition 
At this final transitional stage in Schwalm cell ontogeny, which in rodents occurs 
perinatally, Schwann cells differentiate into a myelillating or non-myelinating phenotype 
(Fig. 12). The choice between cither of the two fates is determined by thc axon. The 
identity of the axonal signal is still not known although it does correlate with the axonal 
diameter. Axons above a certain diameter (> l~ll11) will be myelinated, while smaller axons 
will be accOllllnodated in shallow troughs along the surface of non-myelinating SchWalm 
cells (See section 1.4.1). If the latter option occurs, only few mOlphological and 
biochemical changcs can be detected. 
First, non-myelinaling Schwallll cells express several surface markers which 
distinguish them from myelinating Schwarm cells, such as p75, neural cell adhes,ion 
molecule (N-CAM), glial fibrillalY acidic protein (GFAP), and an itlllnunogiobulin-related 
adhesion molecule (L1). However, these are also already expressed by the pro-non-
myelinating Schwann cells. So far only the absencc or presence of thc glycolipids 
galactocercbroside (GalC) and galactosulfatide (sGalC) in the non-myelinating SchWalm 
'cell membrane distinguishes the immature stage from the mahlre stage, respectively. 
However, GalC is also prcscnt in the lipid bilaycr of myelinating Schwann cells. 
The scarcity of molecular changes during the pro-non-myelinating to non-
myelinating switch is directly correlated to the number of studies performed on non-
myelinating Schwaml cells. Only the role of LI in non-myelinating Schwarm cells bas been 
addressed thoroughly. Targeted deletion of the LI gene in mice leads to a reduced 
association of non-myelinating Schwann cells with axons 123. However, since neurons 
were also affected, it could not bc addrcssed whether this defect was Schwaml cell 
autonomous. Recently, it was observed that in unmyelinated sensory nerve fibres, both 
axons and Schwaml cells express the LI gene 124. In nerve fibres of unmyelinated 
sympathetic neurons, only Schwann cells express Ll. In Ll knockout mice, only non-
myelinating SchWalm cells of the sensory fibres were affected, while Schwann cells of the 
sympathetic fibres appeared normal 124. Furthermore, transplantation experiments between 
nerves of wildtype and L1-deficient mice demonstrated that L1-deficient Schwallll cells 
transplanted on wildtype axons generated apparently normal unmyelinated axons, while 
wild type Schwann cells brought into contact with L1-negative axons reproduced the L1-
deficient phenotype 124. These data establish that LI expression on axons but not on non-
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myelinatil1g Sc1nvann cells is essential for the formation of unmyelinated axons. Probably 
hetcrophilic interactions between LIon the axonal membrane and other components on the 
non-myelinating Schwalm cell membrane are required for the formation of functional n011-
myelinated nerve fibres. 
1.5.4.4 Myelogenesis 
In contrast to non-myelinating SchwaHn cells, an overwhelming number of studies 
have been performed on its myelinating counterpart. 
The myelin sheath is composed of two distinct domains, compact and nOll-
compact myelin, each of which is characterised by a unique set of proteins (Fig. 14). 
Compact myelin, forming the typical major dense and intraperiod lines as observed by 
electron microscopy (see section 1.4.2), contains the major myelin proteins PO, PMP-22 
and myelin basic protein (MBP). Non-compact myelin are regions where the intracellular 
surface of the membrane are separated by cytoplasm as in the Schmidt-Lantelman incisures 
and paranodal loops (see section 1.4.2). These regions contain proteins such as myelin-
associated glycoprotein (MAG), E-eadherin, a6~4 integrin, and cOimexin 32 (Fig. 14). 
GalC and sGalC are the dominant glyeolipids in the myelin membrane (Fig. 14). All these 
elements are highly upregulated as soon as the Schwann cell is instructed to myelinate, and 
concomitantly most immature Schwann cell markers arc downregulated. Thus a 
transcriptional programme must exist that initiates and modulates the myelination 
progranul1e in response to an axonal signal. The role of myelin proteins and glyeolipids in 
the fomlation of the myelin sheath has been investigated in various experimental settings. I 
will first discuss the proteins present in compact myelin. 
PO is by far the most abundant protein present in the peripheral myelin accounting 
for approximately 50% of the total amount of protein in the sheath. PO is a transmembrane 
protein belonging to the inmmnoglobulin class of proteins. Recently, a stmctural model 
based on X-ray diffraction data has been proposed. These data suggest that PO molecules 
form tetramers that are a!Tanged parallel to the Schwalln cell membrane 125,126. These 
tetramers form a functional unit that interacts with PO tetramers on the opposing membrane, 
forming a lattice that holds compact myelin together. The intracellular components of PO 
might also be involved in the adhesive property of the protein, by interacting with each 
other or acidic lipids or cytoskeleton proteins 127-129. 
PMP22 is a tetraspan transmembrane protein, predominantly expressed in compact 
myelin. Its extracellular domain has been implicated in intracellular recognition and 
adhesion, while on the other hand, it also structurally resembles an ion channel 130. The 
precise role of PMP22 in the compaction of myelin is not clear. 
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Figure 14: Location of Schwann cell membrane associated and axonal proteins in a myelinated nerve fibre. 
Abbreviations: Ax, axon; icJ, inner collar; ocl, outer collar; SLl, Schmidt-Lantcmlann incisures; PNL, paranodal 
loops; BL, basal lamina. 
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Third, MBP is present in the compact myelin regions of both oligodendrocytes in 
the CNS and Schwann cells. In contrast to PO and PMP22, which are transmembrane 
proteins, MBP is localised in the cytoplasm. The association of MBP with membranes is 
primarily ionic, by virtuc of its high positive charge. MBP probably mediates apposition of 
the myelinplasma membrane by reacting with acidic lipids, undergoing conformational 
changes, or with other proteins on the opposite site of the intracellular plasma membrane 
(reviewed in 131). 
I will now further elaborate on the proteins present in the non-compacted regions. 
Both MAG (a member of the Ig super gene family) and E-cadherin are transmembrane 
proteins present in the uncompacted myelin compartment. In contrast to MAG, E-cadherin 
can interact homophilically and probably serves to hold the layers of non-compact myelin 
together at adherens junctions, which join actin bundles of two opposing Schwann cell 
sheaths and are found in non-compact myelin 132. MAG has been suggested to stabilise the 
extracellular space between the inner mesaxon and the axon, which cOlTclates with the 
adaxonallocalisation of MAG during myelination 133,134 
The abaxonal side of the Schwann cell is where it contacts the basal lamina. 
Several Schwann cell membrane associated proteins have been identified which interact 
with the basal lamina. One of those factors is p4 integrin, which is expressed together with 
its heterodimeric partner 0:6 integrin on the abaxonal surface of the myelinating Schwann 
cell membrane. It probably functions as a receptor for laminins present in the Schwann cell 
basal lamina. Interactions between laminin and 0:6P4 integrin might potentially be linked to 
the ras-MAP kinase signal transduction pathway 135. Other factors that have been 
identified, which might playa role in the interaction between the outer membrane of the 
myelinating Schwann cell and the basal lamina, are dystroglycan and NRsyndecan. 
Connexin 32 is a member of the gap junction protein t:1mily, which is expressed in 
these non-compacted regions of the Schwann cell membrane, such as the Schmidt-
Lanterman incisures and paranodal loops 136. Gap junctions allow fast transport of low 
molecular weight proteins between adjacent non-compacted myelin regions, such as 
paranodalloops (see section 1.4.2). 
Summarising, the highly stmctured positioning of these molecules in the 
myelinating Schwann cell membrane suggests that they execute particular functions in the 
myelin sheath. That this is indeed the case can be concluded from the fact that mutations in, 
or altered levels of, most of these t:1ctors will results in the dysfimction of the myelin 
sheath, as discussed in the following section. 
1.5.4.5 Myelinopathics 
The importance of the stmctural Schwann cell proteins mentioned in the previous 
section is demonstrated by the peripheral nerve phenotype of many mice canying targeted 
deletions or naturally OCCUlTing mutants of these genes. Alterations in the stmcture or copy 
number of the homologous genes in humans result in several peripheral neuropathies (Fig. 
15). In this section I will discllss the consequences of these alterations on myelination in 
mice and humans. 
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Figure 15: The relationship bet\\'cen mutations in PMP~22, PO, connexin 32 and inherited demyelinating 
neuropathies. Abbreviations: HNPP, hereditary neuropathy with liability to pressure palsies; CMT. Charcot-Marie· 
Tooth disease; DSS, Dejerine-Sottas syndrome. (Adapted from 137) 
Targeted deletion of the PO gene in mice results in a severe loss of myelin in the 
PNS 138. Schwann cells do establish a one-to-one relation with the axon, but the 
subsequent process of forming compact myelin is greatly disturbed. Furthermore, young 
mice heterozygous for the PO deletion appear normal, but develop progressive 
demyelination with age 139 These observations suggest that myelin compaction can occur 
normally with only one PO allele, but that the accurate dosagc of functional PO is required 
for maintenance. 
Strikingly, the formation of the major dense line in PO knockout animals is still 
present, while the intracellular part of PO has been thought to be important for the formation 
of this stmctllre. This led to the conclusion that other factors present in the compact myelin 
region might contribute, in addition to PO, to the formation of the major dense line. This 
became evident when the mice doubly mutated for PO and MBP were generated. A natural 
occurring nuH-mutant of MBP, the shiverer mouse, was used for the generation of double 
mutant mice. The shiverer mouse has hypomyelination in the eNS, where major dense 
Jines are lacking. PNS myelin however does not show major abnormalities, which has been 
attributed to the presence of PO 140. The combination of PO-deficient knock outs and MBP-
deficient shiverer mice, generated thin myelin sheaths which lack major dense lines, 
indicating that both molecules contribute to the fusion of the cytoplasmic surfaces 141. 
Combinations of PO targeted mice crossed with knockout mice either deficient for PMP22, 
.MAG, or connexin32 only gave subtle additional phenotypes when compared to mice only 
homozygous for the PO deletion 142-144 The defect of the compact myelin regions in 
these double knockout mice were indistinguishable from single PO-deficient knockouts, 
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indicating that PO together with MBP are the major determinants of compact myelin 
struchlre. 
Phenotypes of mice with mutations in the PO gene are reminiscent to human 
neuropathies. This group of disorders includes Charcot-Marie-Tooth disease type 
18(CMTI B), Dejerine-Sottas syndrome (DSS) and hereditary peripheral neuropathy with 
liability to pressure palsies (HNPP) reviewed in 130(Fig. 15). It is assumed that mutations 
leading to reduced levels of functional PO protein cause relatively mild clinical phenotypes 
seen in CMTl B, whereas those mutations that perturb the multimeric assembly of PO are 
responsible for more severe neuropathies such as DSS 145. 
Secondly, PMP22 is linked to the most prevalent form of hereditaty peripheral 
neuropathy in humans, CMTlA, which has incidence of I in 4,000 new-borns. Also other 
peripheral neuropathies are linked to PMP22 with distinct clinical parameters. CMTlA is 
most frequently associated with a duplication of a 1.5Mb region of chromosome 17 
resulting in a triple gene dose of PMP22. Homozygosity of this 1.5Mb duplication, leading 
to a quadruple gene dose or other specific point mutations in the gene result in the more 
severe demyelinating neuropathy DSS. Deletion of the same 1.5Mb region, resulting in a 
monosamy, gives rise yet to another phenotype, which is HNPP. Therefore, clinically 
different syndromes are mostly associated with varying gene doses of the PMP22 gene. 
Changing the number of PMP22 gene copies in mice and rat generates similar 
phenotypes as compared to human PMP22 related syndromes having the same gene dosage. 
For instance, transgenic mice or rats having an extra copy of the gene develop a neuropathy 
which clearly resembles the CMTlA neuropathy related with a triple gene dose of PMP22 
in humans 146,147. Furthermore, mice heterozygous for targeted deletion of the PMP22 
gene (one gene dose) develop pathological features reminiscent of HNPP, which again is in 
agreement with the con-esponding gene dosage in humans 148. 
Mice homozygous for targeted deletion of the PMP22 gene develop a severe 
polyneuropathy caused by delayed myelin formation and focal hypermyelination 
(tomacula) 148. This phenotype resembles a CMTl-like demyelinating neuropathy, but 
human families lacking PMP22 have not been described yet. Originally, PMP22 was found 
to be mutated in the natural occuring mouse mutant Trembler 149. Trembler and Tremble/ 
mice, have mutations which correspond to mutations at the same positions of the PMP22 
gene in human CMTlA and DSS syndromes (reviewed in 137). 
Switching to proteins present in the non-compacted myelin, the X-linked gene 
connexin 32 has been associated with the second most common human neuropathy 
(occurrence I in 25,000), CMTlX 150. CMTX is best characterised as an X-linked 
dominant disease. Affected males are invariably affected with moderate to severe 
manifestations, whereas heterozygous females tend to be more mildly affected and may be 
asymptomatic. The variable manifestations in females may be due to variation in X 
inactivation, although this has not been proven. 
Mutation of connexin 32 in CMTX vary from point mutations to partial and 
complete deletions in the coding region, but also point mutations outside the coding regions 
have been identified. These mutations have been demonstrated to interfere with connexin 
32 function in several ways. First, cell culture experiments demonstrated that after 
transfection of mutated connexin 32 genes, mutant protein was localised to the plasma 
membrane but did not form functional channels 151. Strikingly cotransfection of mutated 
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and normal c0I111cxin 32 demonstrated that mutated connexin 32 has a dominant negative 
effect on the formation of channels by wildtype connexin in this system 151. 
Second, mutations in the gene have been demonstrated to interfere with the trafficking of 
the protein to the plasma membrane. Most mutations seem to result in accumulation of 
mutant protein in the Golgi apparatus 152. 
The effects of connexin 32 mutations and deletions have also been addressed in 
mouse models. Initial observations of mice with targeted disnlption of the connexin 32 
gene did not show any obvious signs of peripheral nerve pathology 153. However, 
subsequent studies demonstrated that these mice develop a late-onset demyelinating 
neuropathy, similar to that secn in CMTX patients 153-155. In female heterozygotes the 
loss of expression was segmental and cell autonomous, consistent with random X-
inactivation 155, Transgenic mice expressing mutant forms of connexin 32 present with a 
pathology that depends on the naturc of the mutation. In a missense mutation, dominant 
effects are seen in transgenic mice 156. These mice develop a late-onset demyelinating 
neuropathy despite the presence of endogenous connexin 32. Interestingly, normal and 
mutant connexin 32 are retained in the cytoplasm, indicating a dominant negative effect of 
mutant connexin 32 on the trafficking of the endogenous protein 156. This effect of mutant 
connexin 32 on the normal protein is unlikely to occur in CMTX patients carrying this 
mutation, where, by X-inactivation, only one allele is expressed. 
Although previous data suggested that MAG plays an important role in the 
formation of myelin, targeted deletion of MAG in mice demonstrated that MAG is not 
essential for myelination in rodents 133,134,157,158. However, subtle defects in the myelin 
sheath developed over time in MAG -/- animals 159. In older MAG -/- animals myelin 
degenerates and Schwann cells express genes that are typical for non-myelinating nerves 
160. These data indicate that MAG is important for maintenance of the myelin sheath. 
Natural occurring mouse mutants or human neuropathies linked to the MAG gene have not 
been identified. 
Two other factors present in non-compact myelin are a6~4 integrin and E-
cadherin. The function of the latter in Schwaml cells has not been addressed in a gene 
knockout or transgenie mouse paradigm. Mice homozygous for deletion of the ~4 gene 
have been generated, but die too early to asses its effect on myelination 161. However, few 
myelinated fibres are present in femoral nerves of newborn ~4 integrin deleted animals 
suggesting that ~4 is not essential for initiation of myelination. In addition, in vitro 
myelination studies using explants from ~4 -/- animal show that Schwaml cells are capable 
to myelinate in the absence of~4 integrin 162. 
Finally, during myelination Schwaml cells synthesise myelin-enriched lipids. TIle 
dominant lipids in the myelin bilayer are the glycolipids, which include GalC and sGalC 
(sulfatide). These glycolipids have the unusual property that their fluid/solid phase 
transition temperature is so high that they almost behave as crystals at body temperature 
(reviewed in 163). The identification and targeted deletion of the key enzyme in the 
synthesis of galactolipids, UDP-galactose-ceramide galactosyltransferase (egt) has provided 
insights into the pivotal function of these glycolipids in the normal myelin sheath. Mice 
lacking the cgt gene are completely devoid of GalC and sGalC 164,165. Instead these mice 
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incorporate glucocerebroside in their myelin membrane. Expression afPO, MBP, and MAG 
in these mice was normal, in agreement with the finding that myelination \vas unaffected in 
these mice. However, a striking phenotype developed from 10 days after birth, which 
included whole~body shivering, seizures, increasing loss of motor activity, reduced growth 
and death from 20 days onwards. Nerve conduction measurements demonstrated that, 
despite normal myelination, the nerve conduction velocity in homozygous cgt knockout 
mice was reduced from saltatory conduction of myelinated nerves to the much slower 
continuous conduction of unmyelinatcd nerves 164. These results suggest that GalC and 
sGalC maybe involved in the maintenance of an ion permeability barrier in the myelin 
sheath. More recently, defects in the paranodalloops of these mice havc been described. It 
is thought that these defects contribute to the phenotype 166. 
1.5.5 SchwaHn cells support neuronal survival 
NGF, BDNF, NT·3. GDNF, LlF, CNTF, IL-6 
~ 
Figure 16: Schwarm cells (Sc) support neuronal (N) survival during development and regeneration by the 
production of the neurotrophins NGF, BDNF. NT~3 and GDNF and the lleurokines LIF, CNTF and JL-6. For 
details sec text section 1.5.4. 
In the intimate axon-Schwann cell relationship, the axon seems to be the main 
driving force of peripheral nerve development, directing Schwallll cells towards their final 
differentiated state (myelinating or non-myelinating Schwallll cell). However, numerous 
studies have suggested that axon-Schwalm cell interactions are reciprocal. Over the last few 
years it has become clear that neurons do not only depend on target derived neurotrophic 
support, but also on support provided by the Schwann cells. In addition, much evidence has 
accumulated to support a role for Schwarm cells in all aspects of peripheral nerve 
development, including the formation of a fhnctional perineurial sheath (see sectionl.5.5) 
and positioning of the nodes of Ranvier (see section 1.5.6). In this section I will focus on 
the role of Schwalm cells in the control of neuronal survival during development and 
regeneration 
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The involvement of Schwann cells in the regulation of sensory and motor neuron 
survival became apparent after detailed examination of neuregulin, ErbB2, or ErbB3 
deficient mice. As mentioned earlier (see section 1.5.4.1), peripheral nerves in these mice 
are completely devoid of Schwann cells. Strikingly, mice homozygons for the ErbB3 
mutation lost 80% of their sensory neurons at El4 while at El2 this number was still 
comparable to wild type embryos. Furthermore, the number of knockout and wildtype 
motoneurons at EI6 were similar, but at E18 the number of motoneurons in knockout 
animals was only 20% of the number counted in wildtype embryos 109. 
Sensory neurons already died before most of them had reached their target tissue, 
indicating that cell death was not caused by the lack of contact between neurons and their 
targets, but seemed completely attributable to the lack of Schwann cells and their 
precursors. In contrast, survival of motoneurolls seems to depend on survival signals from 
both Schwann cells and target organs, since motoneurons die after they have reached their 
target. These data also demonstrate that motoneurons depend on signals derived from 
Schwalm cells but not from Schwaml cell precursors as most have already differentiated 
into Schwaml cells in mouse E 16 peripheral nerves 104 
The generation of chimeric mice by injecting ErbB3-/- ES cells into wildtype 
blastocysts demonstrated that these cells contribute to sensOlY and motoneuron lineages, 
but not to the Schwann cell lineage 109. This result established that ErbB3 function is 
SchwalUl cell autonomous. 
Schwann cell dependent neuronal survival was also observed in mice lacking the 
ErbB2 gene after rescuing the early embryonic lethal phenotype by restoring the ErbB2 
expression specifically in the developing heart 111,112. As in the ErbB3 knockout mice, 
SchWalm cells were completely absent in peripheral nerves of rescued ErbB2 lacking mice. 
Consequently, motoneuron apoptosis occurred in a comparable time frame and the same 
extend as in ErbB3 deficient mice. In addition, loss of scnsory neurons in ErbB2 knockout 
mice was also observed, but the time span and extend to which this cell death occurred was 
not reported. By and large these experiments demonstrate that both motoneurons and 
sellSOlY neurons depend on SchWalm cells for their survival. 
Several lines of evidence have demonstrated that Schwann cclIs promote sensory 
neuron and motoeuron survival by the production of neurotrophic factors 167. Thus, in the 
absence of SchWalm cells neurotrophic support is reduced and consequently neuronal cell 
death increascd. 
In addition to Schwaml cells, target organs also produce neurotrophic factors. 
During development of the nervous system excess numbers of neurons are produced. Only 
those making contact with their target organs will survive, suggesting that neurons compete 
for a limiting supply of these target-derived factors. 
The last few decades a large number of factors demonstrated to support neuronal 
survival have been identificd 168 They can be divided into several groups according to 
primary sequence similarity and to the type of receptors they bind to. Thus, a specific 
neurotrophic factor will only support survival of a subset of neurons expressing the 
cOlTesponding receptor. 
The first neurotrophin identified in 1952 was nerve growth factor (NGF) 
(reviewed in 169). NGF belongs to a family of factors, including brain-derived-
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), NT4/5 and NT-6. These factors bind 
with high affiliity to members of tyrosine recept6rkinase (trk) family. These receptors 
43 
Chaptcr I 
heterodimerize with the low-affinity receptor p75 to fOlm a functional receptor 170. Three 
receptors have been identified, each specific for a different neurotrophin. NGF binds to 
trkA, while trkB is specific for BDNF and NT-4/5, and NT-3 specifically interacts with 
trkC 170. All thrce receptors are distributed to discrete but partially overlapping 
subpopulations of primary sensory neurons, while trkB and trkC are present on spinal 
motoneurons. Consistently, the target tissue innervated by these neurons express the 
relevant neurotrophins. 
However, some sensory neurons do not express trk receptors. This population has 
bccn found to express a receptor complex for another neurotrophin termed glial-derived-
neurotrophic factor (GDNF) 171 This receptor complex consists of the Ret receptor, 
combined with GFRa-1 or GFRa-2. In addition to its trophic effect on this trk deficient 
sensory neuron population, GDNF also supports survival of motoneurons and autonomic 
neurons 172,173. 
Other factors that have been demonstrated to promote neuronal survival, are the 
neurokines. They differ from the neurotrophins by their interaction with multicomponent 
receptors, which are different from the neurotrophin receptor tyrosine kinases. Members of 
the neurokine family are ciliary-neurotrophic-factor (CNTF), leukaemia inhibitory factor 
(LIF), and interleukin-6 (lL-6). LIF and lL-6 are able to mediate survival when the receptor 
is composed of two components, which are LIF receptor P (LIFRP) and gp 130. CNTF 
rcquircs an additional component, CNTF receptor a (CNTFRa), to be functional 174. 
The dependence of subsets of neurons to interact with specific llcurotrophins and 
neurokines to survive underscores the complex interactions that are involved in setting up a 
functional network betwcen the nervous system and the tissues it innervates. The 
observation that neurotrophin dependence of specific subsets of neurons varies during 
development sets yet another level of regulation on thc formation of this network 175. For 
instance, sensory neurons in the trigeminal ganglion are dependent on BDNF and NT-3 for 
their survival, while growing towards their targets. However, after reaching these targets, 
they lose their dependency on BDNF and NT-3 and now require NGF for their survival 
176. This became apparent after targeted deletion of members of the neurotrophin family 
and their receptors. A large number of trigeminal ganglion neurons die before reaching 
their targets in mice lacking NT-3 or the BDNF receptor trkB, while the same neurons die 
later during development in mice lacking the NGF receptor trkA (reviewed in 177). 
As in the ErbB3 and ErbB2 deficient mice, death of these neurons before they 
reach their targets, indicates that cells along the trajectory of the developing nerve are 
required for trophic support. It is likely that Schwaml cells are the cells producing these 
factors. Indeed, most of the neurotrophins and neurokines mentioned above are expressed 
in Schwann cells during different stages of development (Fig 16). For instance, BDNF 
secreted from Schwann cells has been demonstrated to play a role in the survival of 
motoneurons during embryonic development 178. It complements the motoeuron survival 
promoting effect of CNTF, which is only expressed in mature myelinaling Schwann cells 
from two weeks after birth onwards 179. 
NT-3 has been demonstrated to be produced by Schwann cell precurors and 
mature Schwallll cells 116. Although NT-3 seems to be a component of an autoregulatory 
survival loop for mature Schwaml cells, it does not support survival of Schwaml cell 
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precursors. This would indicate that Schwann cell precursors do not produce NT-3 to 
support their own survival but that of the neurons they are associated with. This could 
explain the death of neurons before they have reached their targets in NT-3 knockout mice 
180, Neurons in turn produce NRG, which is essential for Schwalm cell precursor survival 
75,107. This reciprocal survival signalling between neurons and non-neuronal cells has also 
been demonstrated bet\veen sensory neurons and satellite cells in sympathetic ganglia 181. 
The neurotrophin GDNF is also produced by Schwann cells and their precursors. 
Lack of GDNF in knockout mice results in 20% reduction of the number of motoneurons at 
birth 172,182 
Since the number of neurons that die in mice which are completely devoid of 
Schwann cells (like in ErbB3 knockout mice) is higher than in mice that lack only a single 
neurotrophin or neurokine, indicates that concert action of several of these factors is 
required for neuronal survival during development. For instance, Schwann cell derived 
GDNF and muscle derived cardiotrophin-I (CT-I), in culture synergistically regulate 
motoneuron survival in vitro 183. Moreover, as mentioned before, mice lacking CNTF 
loose a number ofmotoneurons during postnatal development 179. Although, mice lacking 
LIF have no significant motoneuron loss, double knockout mice ofLIF and CNTF produces 
an earlier and morc severe motoneuron apoptosis, than in single CNTF targeted mice 184. 
(a) 
~ ""-J .................................................. , ...•.......... Schwann (b) neuron cell 
Figure 17: Changes in peripheral 
nerve during WaiJerian 
regeneration. (a) An uninjured 
myelinated axon. The 
myelinating Schwann cells are 
surrounded by a basal lamina. 
The pair of scissors marks the 
site of injury (which in this case 
leaves the basal lamina intact). 
(b) A few days after injury, the 
axon and its myelin sheath 
degenerate distal to the site of 
injury. Macrophages invade the 
distal nerve stump, penetrate the 
basal lamina, and phagocytose 
degenerating myelin. SchwarHl 
cells proliferate. Proximal to the 
injury, a gro\\1h cone has fomled 
and begins to regenerate down 
the bands of BOngner. (c) A few 
weeks after iruury, the axon has 
regenerated further down the 
band of Biingner, and ils morc 
proximal portion has been rc-
ensheathed and subsequently 
remyelinated by Sehwann cells. 
(Adapted from 185). 
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Signalling from Schwann cells to neurons is also important to allow re-growth of 
axolls following nerve damage. The first thorough description of nerve regeneration dates 
from the 18th cenhlry 186, Ever since this report, the process of regeneration has been the 
subject of intense research. This has led to a precise temporal description of the 
morphological and molecular changes acetln'i.ng in neurons and Schwann cells during 
peripheral nerve regeneration (Fig. 17). 
When axonal integrity is interrupted by, for instance by crush or axotomy, 
degeneration will occur distal to the site of the insult in a process called Wallerian 
degeneration, named after its discoverer 187(reviewed in 188). Immediately after damage, 
the proximal and distal nerve shunps retract, axoplasm leaks out and damaged membranes 
collapse. Macrophages are recruited to the site of the lesion during the first week after 
injury, which contribute to the lysis and phagocytosis of myelin (reviewed in 122 
Dedifferentiation of Schwarm cells is accompanied by downregulation of expression of the 
major myelin genes (PO, PMP22, MBP) and reestablishment of many immature and non-
myelinaling Schwaml cell markers. At this stage Schwaml cells are proliferating within the 
distal stump and line up in their basal lamina, forming the so-called endoneurial tubes or 
bands of BUngner. Because these Schwalm cells have obtained an autocrine survival loop 
(see section 1.5.4.2), they are able to survive in the absence of axonal contact. These 
proliferating Schwann ceHs fann a conduit which guides regenerating axons to their target 
189. Proximal to the injury site, axons give rise to one or more sprouts, each of which 
contains a growth cone. These growth cones have to reach the distal part for regeneration to 
be successful. \Vhile both nerve crush and axotomy induce Wallerian degeneration, 
regeneration in the latter occurs less efficient. After a nerve crush, the continuous basal 
lamina provides guidance for regenerating axons, while after axotomy separation of the 
proximal and distal stumps can impede reinnervation. Ifregeneration does occur~ it happens 
with high accuracy, in the sense that axons are able to find the targets they innervated 
before the injury. Upon reestablishment of axonal contact, Schwarm cells stop proliferating, 
downregulate the immature/nonwmyelinating genes, and start to remyelinate the nerve 
sprouts. The process of remyelination is very similar to the process of myelination during 
normal development 25 
Schwalm cells are vital during regeneration, and one of their functions is to 
produce neurotrophic factors to create an environment that is supportive for axonal 
regrowth. Following axonal injury, Schwann cells of the distal stump immediately 
upregulate the synthesis of NGF, and LIF, and after several days BDNF, NT-4/5, but not 
NT-3 (reviewed by 190). In contrast, CNTF requires intact axon-Schwaml cell contact and 
is reduced during Wallerian de~eneration 191. Schwann cells also upregulate the 
expression of IGF-I and -II, which has also been demonstrated to have neurotrophic 
capacities 192,193. Furthermore, after sciatic nerve cmsh, there's a rapid upregulation of 
GDNF in the distal part of the nerve 194. 
Sunllllarising, the striking loss of sensory neurons and motoneurons before target 
innervation in ErbB-2 and ErbB-3 knockout mice, and the ability of neurons to regenerate 
after nerve damage in the absence of target derived neurotrophic factors, point to Schwann 
cells and their precursors as an important source of these factors. Correctly timed and 
combined expression of these factors by SchWalm cells are essential to obtain optimal 
development and regeneration of sensory neurons and/or motoneurons. 
46 
Chapter I 
1.5.6 Schwam) cells and the formation of the nerve sheath 
The formation of the perineurium (see section 1.3.2.2) starts during embryonal 
development and it arises from mesodermally derived mesenchymal cells surrounding the 
embryonic axons and Schwalm cell precursors 19, The recruitment of these cells occurs late 
during embryonic development, from about E15 onwards in the mouse sciatic nelve. Cells 
assemble concentrically around the developing nerve, and around birth a recognisable 
perineuriulll is present. At this stage the perineurium is still leaky, but becomes 
impermeable a few weeks after birth. 
Recently a Schwann cell derived signalling molecule has been demonstrated to be 
essential in the formation of the perinenrial sheath 195. Examination of peripheral nerves of 
homozygous desert hedgehog (Dhh) mutant animals suggested that Dhh signalling is 
required for the development and function of the perineurial nerve sheath 195. 
Dhh is one of the three members of the Hedgehog family of intercellular signalling 
molecules that play key roles in embryo patteming 196 DWI is expressed in testis and 
SchWalm cells during development 197. Mice homozygous for targeted deletion of the Dbb 
gene failed to develop mature spermatozoa, indicating a role for Dhh in spermatogenesis 
198, Strikingly, in peripheral llcrves of these mice, all three layers of connective tissue were 
severely affected (Fig. 18). However, myelinating and non-myelinating fibres appeared 
morphologically normal. Not surprisingly, nerve conduction velocities in these mice were 
normal 195. 
Expression of patched (Ptc), the cognate receptor of DWl, was demonstrated in the 
presumptive perineurial cells during development in normal nerves from El5 onwards. 
However, Ptc expression was severely down regulated in Dhh lacking mice, indicating that 
Dhh regulates the expression of its own receptor. This has also been demonstrated for the 
other hedgehog gene homily members (reviewed in 199). 
The remaining perineurial sheath consisted of only a few layers and extends 
abnormally within the endoneurium, fonning mini-fascicles. Ultrashuctural studies 
revealed that tight junctions of Dhh knockout perineurial cells were abnomlal despite the 
fact the expression of several tight-junction associated proteins appeared unaffected. 
However, Dhh deficient perineurial cells were lacking expression of gap-junction protein 
connexin 43. Dismption of gap- and tight-junctions in the perineurium, suggested that the 
barrier function of this layer might be compromised. Indeed, marker proteins that are 
normally excluded penetrated the nerve of Dhh -/- animals. In addition, neutrophils moved 
freely into the nerve, following a focal infection outside the nerve. 
The fact that still a thin layer of perineurial cells is formed in Dhh knockout mice, 
indicates that Dhh is not essential for the early formation of a loose perineurial sheath in 
embryonic nerves. The factor involved in this initial recruitment of mesenchymal cells 
around axon-Schwann cell units is unknown. However, the observation that a perineurial-
like sheath is formed in the absence of SchWalm cells in the genetically rescued ErbB2 
knockout mice, suggests that the initial signal might be axon derived 112 However, lack of 
markers for presumptive perineurium at these early stages makes it difficult to prove that 
this layer is indeed presumptive perineurium. 
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In summary, the data described in this section clearly indicate that in addition to 
supporting neuronal survival, Schwaun cells are also involved in the development of a 
functional protective connective tissue layer surrounding the nerve. 
E15 
Adult 
?: Dhh 
';: Patched 
).: Collagen 
Wildtype 
perineurium 
epineurium 
Dhh -/-
Figure 18: Schematic representation of trans\'crse sections through peripheral nerves of wildlype and Dhh 
homozygous knockout animals at E15 and in adult stages of development. Nerves in both animals are 
morphological indistinguishable at E15. However at adult stages, the nerves of Dhh knockout mice have a very 
poor developed endo-, peri·, and epineurium and form minifascicles when compared to adult wildtype animals. 
For a more detailed description see text section 1.5.6. 
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1.5.7 Schwann cells and the formation of the node of Ranvier 
The node of Ranvier (node) is a complex stmcture consisting of several specific 
domains that play distinct essential roles in impulse propagation and myelin stability. In the 
PNS, the nodes are fonned by a small stretch of axonal membrane (1-2 /lm), which is 
exposed directly to the extracellular environment and flanked on both sides by 
uncompacted pat'anodal regions of myelinating Schwann cells. This regularly spaced 
stmcture along the axon allows the rapid so-called saltatory conduction of action potentials 
from node to node. In concordance with its function in nerve impulse propagation, the node 
contains high concentrations of Na+-channels and Na+1K +-pumps. These channels are 
probably linked to the nodal region of the axon by interacting with a nodal specific ankyrin 
protein, 311kyrino 4801270 lcD, which "anchors" the channels and also other transmembrane 
proteins to the nodal cytoskeleton 200. 
Recent discoveries have demonstrated that Schwann cells play an important role in 
positioning of nodes along the axon. Na+-channels are located on the axonal membrane in 
the middle of the node (Fig. 14). Strikingly, it has been demonstrated that the distance 
between Na +-channel clusters increases as the Schwann cells elongates longitudinally along 
the axon during regeneration after nerve damage and during development 201-203. 
Furthennore, addition of Schwaml cell or oligodendrocyte (The myelin fomling glia cell in 
the CNS) conditioned inedium to glia depleted neuronal cultures, resulted in the formation 
of Na+-channel clusters, which in the latter case were even regularly spaced 204,205 _ This 
would suggest that a soluble factor produced by Schwaml cells and oligodendrocytes is able 
to induce Na + -channel clustering along the axon. This might also explain why in dystrophic 
mice, which in addition to myelinated and non-myelinated axons contains amyelinated 
axons (lacking Schwann cells) that still have clusters of Na+-channels along the naked 
axons 206. 
In addition to the involvement of this putative soluble factor in inducing the Na +-
chatmel clusters, a more physical interaction between Schwann cells and axon might be 
involved in the eventual positioning of the clusters. Although no direct interactions between 
Schwann cell and axonal proteins have been demonstrated, electron microscopic 
observation of longitudinal sections through a node show electron dense structures that 
connect the paranodalloops to the axon 207. These stmctures have been termed septate-like 
junctions, because they resemble invertebrate septate junctions (reviewed in 208) (Fig. 14). 
These junctions prevent diffusion of small molecules and ions. However the septate-like 
junctions do not form an impermeable batTier, since it has been demonstrated that 
molecules below a certain size can still pass this obstmction (reviewed in 209). They might 
also physically demarcate the boundaries of the node by limiting the lateral diffusion of 
Na' -channels, and thereby confining them to the node. 
Recently, an axonal component of these septate-like junctions has been identified 
as paranodin/Contactin associated protein (Casprl) 210,211 (Fig. 14). Interestingly, the 
homologue of Caspr I in Drosophila is the septate junction protein Neurexin IV, which has 
been demonstrated to be essential for axonal insulation in Drosophila emblYos and larvae 
212. The Caspr interacting protein on the Schwann cell paranodal membrane has not been 
identified yet. It has been suggested that the Casprl interacting factor is a neuroligin related 
moleclllc, as neuroligin interacts with Neurexiil IV in Drosophila 208. 
49 
Chapter I 
Involvement of Caspr I in the positioning of Na +-channels has not been addressed 
yet by generation of knockout mice. Several domains in the cytoplasmic region of Caspr I 
suggest that it might be connected to the nodal cytoskeleton and to several intracellular 
signalling pathways. The link of Casprl to the axonal cytoskeleton might occur via a 
member of the band-4.1 family of proteins, which links transmembrane proteins to the 
cytoskeleton 213 Strikingly, in Neurexin IV mutant flies, the band-4.1 member Coracle is 
no longer restricted to the septate junctions, strongly supporting a direct interaction 
between Neurexin IV and Coracle 212. Furthermore, direct interaction between band-4.1 
protein and Casprl has been demonstrated ill vitro 210. 
The link of Casprl to intracellular signalling cascades, was suggested by the 
presence of a canonical SH3 domain binding region in the protein, which has been 
demonstrated to interact with several SH3 containing signalling proteins, such as fyn, src, 
and PI3K 214 
The ability of Casprl to interact with several signalling pathways at the node 
suggests that Schwann cells could regulate axonal stmcture at the node via the septate-like 
junctions through an unknown SchWalm cell factor that interacts with Casprl at the node. 
Together, These results underscore the role of myelinating SchWalm cells in 
positioning of the nodcs and the regulation of axonal cytoskeleton architecture. 
In summary, the data presented here demonstrate that Schwaml cells are involved in the 
regulation of many aspects of peripheral nerve limction in addition to deposition of an 
insulating myelin. For instance the involvement of Schwann cel1s in the survival of 
neurons, in the regulation of perineurial sheath formation, and in the formation of the nodes 
of Ranvier stress the pivotal role of Schwann cells during peripheral nerve fonnalion. All 
these processes have to be carefully controlled during peripheral nerve development and 
regeneration. A major point of control occurs through transcriptional regulation genes 
involved in these different processes. Over the last few years, a number of transcription 
factors have been shown to playa role at different stages of Schwaml cell development. In 
the next section a number of these factors will be discussed 
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1.6 Transcriptional control in Schwann cell differentiation 
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Figure 19: Transcription factor expression profile in myelinating Schwann cells and their precursors. See text for 
details. 
1.6.1 Pax-3 
One of the first detectable transcription factors, which playa role in Schwalm cell 
development, is the paired box gene Pax-3. The gene is a member of the murine paired box 
gene family, which in vertebrates contains nine members (reviewed in 215). These 
transcription factors contain a DNA-binding domain, which is homologous to the pair rule 
gene paired, in Drosophila. Several members of the t:1mily, also Pax-3, contain besides this 
paired domain a homeobox DNA-binding domain, which is homologous to a domain in the 
homeotic genes, such asAlltellllapedia, of Drosophila. The combination of these two DNA-
binding domains allows the factor to bind to a bi-partite DNA-binding motif, which greatly 
increases the specificity of the interaction with the DNA target sequence, compared to 
members containing just the paired box. The paired domain binds a GTPyAlCPy motif 
while the homeodomain interacts with the TAAT sequence. The spacing between these two 
sequences detennines the binding affmity of these factors 216. 
In the mouse embryo, Pax-3 expression begins on E8.5 in the dorsal 
neuroepithelium from which the neural crest will arise along the antero-posterior axis 217. 
A day later the expression extends to the developing dennamyotome, somitic mesodenn, 
aild neural crest. 
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In the Schwarm cell lineage Pax-3 is expressed in a strictly regulated pattern (Fig. 
19). Based on RT-PCR data, Pax-3 is expressed in the embryonic sciatic nerve from El2 
onwards at a low level, which peaks at El7 218 Subsequently Pax-3 levels gradually drop 
to a lower level at 3 days postnatal. Another report, demonstrated that Pax-3 is expressed in 
immature Schwarm cells or precursors at E 14.5 and strictly in non-myelinating Schwaun 
cells in sciatic nerves 5 days after birth and in adult animals 219 These data indicate that 
Pax-3 is associated with neural crest and the non-myelinating Schwann cell types during 
development. 
This suggestion is further supported by the observation that Pax-3 is never 
coexpressed with the myelin gene MBP. F1ll1hermore, microinjection of Pax-3 expression 
vector into cultured Schwarm cells which had been induced by cAMP elevation to express 
myelin genes, led to downregulation of these markers, and upregulation of non-myelinating 
Schwann cell markers 219. Cotransfection experiments have shown that Pax-3 is able to 
function as a general repressor of the myelin gene MBP 219. It has also been shown by 
nerve cmsh and transection experiments that Pax-3 expression is dependent on axonal 
contact. In those cases, again Pax-3 is only expressed in non-myelinating Schwann cells. 
These results suggest that Pax-3 might be involved in determining the fate of inUl1ature 
Schwann cells into the non-myelinating pathway. 
Mice homozygous for the natural occurring mutants of the Pax-3 gene, temled 
splotch (sp) and splotch delayed (Spd) are embryonic lethal. Homozygosity for mutations in 
the Pax-3 gene in humans results in the Waardenburg syndrome (reviewed in 220). All 
tissues in which Pax-3 is expressed are affected in these mutants. Strikingly, sp mutants die 
at EI3.5, and their nerves are virtually lacking Schwann cells. In contrast, mice 
homozygous for the spd mutation survive until E18.5 221. These mice still had a small 
number of Sehwann cells at EI3.5, but already at E15.5 Schwarm cells could no longer be 
detected 222 There are several possibilities that could explain the absence of these cells. It 
could either be that neural crest delamination is affected, or that the generation of Schwann 
cell precursors is affected or that Schwann cell precursors die in Pax-3 knockout mice. 
The potential role of Pax-3 in the specification of the non-myelinating Schwann 
cells can not be addressed in these mutants, because they die too early. It would require a 
stage and tissue specific targeting of the Pax-3 gene in mice, to elucidate this issue. 
1.6.2 SoxlO 
Another transcription fhetor playing a role during SChWall11 cell development, 
which is expressed in the neural crest is the high-mobility group (HMG) domain-containing 
factor SoxlO. SoxlO is a member of a subclass of the superfamily of HMG domain 
containing DNA-binding proteins, which are highly conserved in evolution. The members 
of the Sox family of proteins have a high amino acid similarity with the HMG domain of 
the testis-determining factor Sry 223,224. This domain termed the Sry box gave the Sox 
proteins their name. Members of this family bind to the consensus sequence 
(A/T)(AlT)CAA(A/T)G (reviewed in 225). In contrast to many other transcription factors, 
Sox proteins have the ability to bind to the minor groove of the DNA and are abIe to 
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strongly bend the DNA (70° - 85°) they interact with. It is therefore hypothesised that Sox 
proteins might perform part of their function as architectural proteins by organising local 
chromatin st11lcture and assembling other DNA-bound transcription factors into 
biologically active, sterically defined multiprotein complexes 226. 
Sox-IO transcripts can be first detected in the developing mouse embryo from E8.5 
onwards in the dorsal neural tube and region of the neural plate which both correspond to 
the presumptive neural crest region 227. Subsequently, expression in the CNS is confined 
to the oligodendrocyte precursors, which will become the myelin forming cells in the CNS. 
Sox-lO expression increases during emblyollal development until birth, and remains high in 
oligodendrocytes of adult animals. 
In the PNS Sox-IO can be clearly detected in the migrating neural crest after E8.5, 
mainly in those crest cells participating in PNS formation 227. This restriction became 
clearer later during embryonal development, where SoxlO expression is detectable in 
enteric ganglia, glial cells of the sensory and sympathetic ganglia, and in SchWalm cell 
precursors from EIO.5 onwards. Expression of SoxlO remained at high levels in glial and 
Schwam1 cells during all subsequent stages of emblyonal and postnatal development (Fig. 
19). 
The occurrence of natural mouse and human mutants of the gene underscore the 
importance of Sox 10 in neural crest development. A Sox-lO mutation in mouse termed 
Dominant megacolon (Dam), is a valuable model system for the human mutation which 
results in a form ofHirschprung disease called the Shah-Waardenburg syndrome 228-230. 
The Dam mutation leads to variable defects in all neural crest derived tissues, such as 
enteric agallglionosis and spotted pigmentation. Depending on the genetic background, 
mice homozygous for the mutation die between E 13 or just after birth. Effects of the 
mutation on the Schwann cell lineage were not reported in these studies. 
Nevertheless, the potential importance of Sox lOin Schwann cell development, 
became evident by its ability to specifically interact with the transcription factors Pax-3, the 
POD-domain factor Oct-6 and the zinc-finger protein Krox-20, and modify their 
transcriptional regulatory activity 227. The latter two factors play an important role in the 
. switch from immature-to-myelinating Schwann cell transition, as will be discussed in the 
following sections (1.6.3 and 1.6.4). Since SoxlO lacks a transcription activation domain, it 
requires interaction with these fhctors to regulate transcription. Cotransfection experiments 
demonstrated that SoxlO interacted synergistically with Pax-3 and Oct-6 to activate 
transcription of a reporter gene, containing a promoter with DNA binding sites for each of 
these £1ctors, at levels several fold higher than when each factor was added to the culture 
individually 227. Strikingly, in the same experimental set up, interaction of Sox 10 with 
Krox-20 repressed the trancriptional activity of Krox-20. 
The synergy between SoxlO and Oct-6 depended not on their DNA binding 
domain, but on their amino terminal region, and Sox 1 0 was not able to synergise with other 
POD-domain containing proteins, such as Brn-l or Bm-2, which closely resemble Oct-6 
231. However, the latter two were able to synergise with another member of the Sox 
family, Soxll, which is not able to synergise with Oct-6 231. A similar interaction has also 
been demonstrated for yet another Sox and POD-domain protein, Sox2 and Oct-4, which 
synergise to activate the FGF4 promoter 232. 
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These obsclvations argue for the existence of a specific partner code between 
members of the POU and SOX families of transcription factors. Furthermore, The 
synergistic effect of SoxlO on the activities of Pax-3, Oct-6 and Krox-20 suggest that 
Sox 1 0 might playa pivotal role during Schwann cell development. 
1.6.3 Krox-20 and Krox-24 
The zinc finger transcription factors Krox-20 (Egr-2) and Krox-24 (Egr-l/NOFI-
Alzif-268) belong to the family of ~arly growth response (Egr) factors. This family also 
includes Egr-3 and Egr-4 (NOFI-C). The family is based on the homology within the 
conserved DNA-binding domain composed of three zinc-finger motifs, of which each 
finger binds to 3 nucleotides of a nine base pair OC-rich DNA element 233. Both Krox-20 
and Krox-24 contain, in addition to a DNA-binding domain, also an activation domain, and 
a domain that is able to interact with two co-repressor proteins NAB 1 and NAB2 (NOFI-A-
llinding protein)234,235. Interaction ofKrox-20 and Krox-24 with these co-repressors leads 
to repression of transcription from several promoters. 
Within the Schwann cell lineage, Krox-20 and Krox-24 are expressed in reciprocal 
fashion 236 Both genes are activated around EIO.5 in the peripheral nerve in non-
overlapping patterns (Fig. 19). Only Krox-24 is expressed in Schwam! cell precursors, 
while both genes are expressed in the dorsal and ventral roots close to the neural tube, 
where it is thought that the transition from precursor to immature Schwann cell seems to 
occur sooner than in the peripheral nerves 237, This situation remains until around E15, 
when Krox-20 is activated in the peripheral nerve, which coincides with the down 
regulation of Krox-24. It was suggested that this transition coincides with the switch from 
Schwam! cell precursor to immature SchWalm cell, based on study performed in the rat 103. 
However, recent data demonstrated that this switch in mice already occurs between El2 
and E14, with almost all SchWalm cells (>90%) in the peripheral nerve being at the 
immature Schwalm cell stage at EI4 104. It is therefore more likely that the transition fi'om 
Krox-24 to Krox-20 expression in Schwaml cells coincides with the acquisition of a one-to-
one relationship between Schwann cell and the axon. 
Krox-24 expression in SchwalUl cells is strongly reactivated around birth. As myelination 
proceeds, Krox-24 is down regulated in myelinating Schwann cells, while it is maintained 
in non-myelinatillg SchWalm cells 236, In contrast, Krox-20 expression is maintained in the 
myelinating Schwam! cells until adulthood. 
This differential regulation of Krox-20 and Krox-24 becomes also apparent after 
nerve damage. During Wallerian degeneration, as Schwaml cells lose their myelin sheath 
and dedifferentiate into an immature Schwann cell phenotype, Krox-24 is rapidly 
upregulated, while Krox-20 is turned off 7,236. These complex patterns of expression 
coincide precisely with distinct steps of SchWalm cell development and suggest 
antagonistic roles for both factors. 
Although the Krox-24 knockout has been generated, a Schwann cell phenotype 
has not been reported in these mice 238,239. On the other hand, targeted deletion of the 
Krox-20 did reveal its role during Schwann cell development 24(). In addition to the 
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development of a Schwalm cell defect, which will be discussed below, Krox-20 knockout 
mice die soon after birth. Furthermore, Krox-20 -/- animals show defects in hindbrain 
segmentation and bone fonnation 240-244 
All Schwann cells in the peripheral nerves of Krox-20 deficient animals seem to 
be arrested at the promyelination stage of development 240. They have aquired a one-to-
one relation with the axon, but do not form a compact myelin sheath. This is exemplified by 
the strong reduction of major myelin gene expression, such as PO, MBP, and PMP22 when 
compared to wildtype Iittemlates. A recent study demonstrated that Krox-20 might directly 
regulate PO expression, since it is able to activate transcription of a reporter gene ill vitro 
via the PO promoter 121 
Both SchWalm cell survival and apoptosis are markedly increased in the peripheral 
nerves of the few animals that survive after birth as compared to normal Iittemlates 
121,240. This might be explained by the fact that promyelinating stage, Schwann cells are 
still proliferating 7. This will result in an excessive amount of Schwann cells, of which the 
surplus will die as a result of competition for the limited amount of Schwann cell survival 
factors produced by the nerve. This balance between higher proliferation and apoptosis 
results in a more or less stable number ofSchwann cells in the nerves 121. 
The importance of Krox-20 in the differentiation of myelinating Schwann cells is 
further substantiated by the identification of Krox-20 gene in CMTl, DSS and congenital 
hypomyelinating neuropathy (CHN) patients 245,246 Of the 4 reported mutations, 3 are 
dominant. The other mutation is recessive, and locates in the RI domain of Krox-20. This 
mutation prevents interaction with the NAB COw repressors and thereby increases 
transcriptional activity 246. This deregulation of Krox-20 causes CHN through a gene 
dosage mechanism. The recessive nature of this mutation may reflect a threshold effect in 
which a certain increased protein level of the down stream Krox-20 target genes must be 
achieved for manifestation of a phenotype. 
The other three mutations, which occur within the zinc-finger domain, affect DNA 
binding and thereby potentially influence the transcriptional activity of genes important for 
myelination. The variation in severity (CMTl <DSS<CHN) seen with the zinc finger 
mutation appears to correlate with the level of residual DNA binding 246. The most severe 
phenotype (CHN) is associated with the mutant, which confers the greatest level of DNA 
binding and transcriptional activation, while the least severe phenotype (CMTl) is observed 
in the mutant which shows no binding. The dominant nature of these human mutations is 
interesting given that heterozygous Krox-20 knockout mice appeared phenotypically 
normal 241. This suggests that rather than acting as loss-of-function alleles, the zinc finger 
mutations may instead be acting as dominant negative or gainwof-function alleles. 
Elucidation of this issue would require introduction of these zinc finger mutants via 
transgenesis specifically into the SchWalm cell lineage of Krox-20 null mice. If this would 
generate a (partial) rescue of the phenotype, then the mutation would be a gain of fhnction 
allele. If there would be no rescue, it would be a dominant negative allele. 
SUllunarising, these results suggest a role for Krox-24 in Schwann cell precursors 
and non-myelinating Schwann cells, while Krox-20 is essential in SchWalm cells to 
progress from a promyelinating to a myelinating phenotype. 
Nerve crush experiments have demonstrated that regulation of both genes is 
dependent· on interaction between. Schwann cells.,and. the axon. Evidence of an ·axonal 
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derived signal regulating Krox-20 expression, came from a study in which Krox-20 
induction in Krox-20 heterozygous knockout Schwalm cells was tested in vitro undcr 
several culture conditions 237. These experiments reveal that Krox-20 expression is lost 
upon dissociation from the axon. Furthermore, Krox-20 expression could be restored when 
these Schwann cells wcre grown in contact with sensory dorsal root ganglia (DRG). 
However, this restoration of expression depended on the developmental age of the Schwaml 
cclls rather than that of the neurons. Only Schwallll cells of EI5 and older were able to 
induce Krox-20 expression when brought into contact with DRGs of any developmental 
timepoint. Thus, the stage at which Schwallll cells are able to activate Krox-20 expression 
ill vitro corresponds perfectly with the stage at which Krox-20 is induced ill vivo. This 
indicates that Krox-20 induction in Schwalm cells requires a modification in the Schwalm 
cells, which allows them to respond to a pre-existing axonal signal. In the same Shldy it was 
determined that the signal is brought about by a diffusible factor. This signal could be 
mimicked by growing pure Schwalm cells in medium conditioned with Neuregulin or a 
combination ofCNTF and bFGF. Furthermore, the activity of the diffusible factor could be 
blocked by addition of a soluble protein containing the extracellular domain of the ErbB-4 
receptor, which is a high affinity receptor for neuregulin 107 These results strongly 
implicate a role of the neuregulill pathway in Krox-20 activation, and hence in the 
generation of the promyelinating Schwann stage. 
1.6.4 Oct-6 
The last factor to be discussed here is the POU domain transcription factor Oct-6. 
As this factor is the main subject of this thesis, only those studies that relate to its role in 
Schwarm cell differentiation will be thoroughly discussed. Oct-6 (POU3fl/SClPfTst-l) 
belongs to class ill of the POU (fit-I, Qct-1I2, !!nc-86) domain transcriptional regulator 
family 9,247-249 The POU DNA-binding domain consists of two conserved regions, 
which are connected by a less conserved linker region. The aminoterminal POU-specific 
(POU,p) domain of - 75 amino acids and the carboxy terminal POU-homeodomain (POUhd) 
of - 60 amino acids, which show high homology with other homeodomain proteins 
250,251 The two domains constitute a bipartite DNA binding domain, which recognises 
the classical octameric sequence A TTTGCAT. The POUhd interacts mainly with A TTT 
sequence, while the POUsp domain interacts with the GCAT sequence and derivatives 
thereof 252. 
Genetic experiments have demonstrated that different members of all the six 
classes of the POU domain transcription factor family play important roles during 
proliferation and/or differentiation of various cell types during embryonic and postnatal 
development 253,254. 
The Oct-6 gene is a single exon gene located on chromosome 4 in the mouse and 
chromosome I in humans 255-257. Based on sequence homology of the linker region, Oct-
6 belongs to class III of the POU domain family, together with the as well intronless POU 
genes Bm-I, Brn-2, and Bm-4 253. Although all members are expressed in an overlapping 
pattern atvarious stages of GNS development, they are not genetically linked, in contrast to 
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for example the Hox genes and p-globin locus, and hence do not share transcriptional 
regulatory sequences 249,258,259 
During the early embryonic stages of development Oct-6 displays a highly 
dynamic and complex expression pattern in ectodermally derived tissues 258,259_ Later in 
development, this pattem becomes more restricted when Oct-6 starts to be expressed in 
suprabasal cells of the epidermis, proliferating oligodendrocyte precursors, and various 
neurons in the central nervous system (CNS) 258,260 261,262 
In the Schwallll cell lineage, Oct-6 expression can be first detected at E12, at the 
precursor stage and is not detectable in neural crest cells (Fig. 19). Oct-6 expression is 
induced around EI5, when inullahlre Schwann cells start to acquire a one-ta-one relation 
ship with' large calibre axons. As myelination proceeds, Oct-6 expression is down 
regulated, although low levels of expression can still be seen in non-myelinating Schwann 
cells or some myelinating Schwann cells 6,8,218. 
Oct-6 is expressed earlier than Krox-20, and their expression patterns hardly 
overlap, indicating that Oct-6 is upstream of Krox-20 in the genetic cascade during 
Schwalm cell development 7. However, recently it was shown that in Krox-20 knockout 
animals Oct-6 expression is not downregulated, indicating that Krox-20 might be involved 
in the down regulation ofOct-6 expression 121. 
As Krox-20, Oct-6 expression is dependent on axonal contact, which was 
demonstrated by nerve cmsh and transsection experiments. After nerve damage, Oct-6 is 
induced in regenerating nerves at the stage when contact between the ingrowing axons and 
Schwarm cells is restored (in mice between four and seven days after crush), comparable to 
promyelinating Schwann cells during normal development. Strikingly, in contrast to normal 
peripheral nerve development, complete down regulation of Oct-6 afier nerve damage 
requires two months as compared to two weeks after Oct-6 induction during normal 
development. This implies that these two phases of Schwann cell morphology are not fully 
comparable. In transected nerves, where axonal contact is completely lost, Oct-6 expression 
is extinguished 6-8. 
The dependence of Oct-6 expression on axonal contact can be mimicked ill vitro· 
by the addition of cAMP elevating reagents to cultured Schwann cells. When Schwann cell 
are cultured under standard conditions, they do not express Oct-6. Addition of cAMP 
elevating factors led to the induction of Oct-6, preceding a rise in the expression level of 
late myelin genes, suggesting an involvement of the adenelyl cyclase-PKA signalling 
pathway in the onset of myelination 9. These results led to the assumption that Oct-6 might 
be directly activating the endstage myelin genes. However, cotransfection experiments in 
cultured SchwaIlll cells showed that Oct-6 is a potent repressor of genes, like PO, MBP, and 
nerve growth factor receptor (NGFR)263. Furthermore, in other cell types Oct-6 has also 
been shown to act as an activator of transcription, suggesting that Oct-6 interacts with co-
factors that can modulate Oct-6 activity in given cell type 264,265 227,231. 
To investigate the role of Oct-6 during Schwann cell development ill vivo 
transgenic mice were generated, which specifically express a dominant negative form of 
Oct-6 in the Schwann cell lineage 266. This was achieved expressing an Oct-6 protein that 
lacks the first 141 amino acids under the control of the PO promoter. 11lis experiment was 
based upon the observation that Oct-6 specifically represses the PO promoter in co-
ttansfection experithents, as nlt~lltioned before. "Tliis""repressidil"cotild be" prevented by co-
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expression of the Oct-6 POU-domain, which by itself was not able to modulate the 
expression via the PO promoter 263,266. Therefore it was stated that Oct-6 POU expression 
together with nonnalOct-6 would interfere with the nOlmal, repressing, fimction of the 
latter. Transgenic mice generated with this construct, named P06SCIP, are viable, but 
demonstrated premature myelination and hypernlYelination of nerve fibres with a reduced 
diameter. In line with this observation the major myelin gene PO was overexpressed in 
these mice when compared to normal littermates. Furthennore, P06SCIP transgenic mice 
had an increased nerve conduction velocity compared to nonllal littemlates in axons with 
the same diameter 267 Strikingly, P06SCIP mice also displayed increased nerve 
regeneration after nerve crush 268 These transgenic data is supported by the in vitro co-
transfection data, and implicates that normal Oct-6 function is to repress the major myelin 
genes. 
Summarising, based on the Oct-6 expression pattern, the gene seems to be 
involved in the transition from the promyelinating to myelinating stage of Schwann cell 
development. In vitro and transgenic data suggest that Oct-6 functions as a negative 
transcriptional regulator and as a repressor of myelin genes in proliferating Schwann cells. 
Hence, one would predict that in the absence of Oct-6, Schwarm cells would differentiate 
(myelinate) prematurely and that their numbers will be reduced. In addition, induction of 
Oct-6 expression in vivo depends on axonal signals, which can be mimicked by addition of 
cAMP elevating factors to cultured Schwann cells. This suggests axonal signal(s) activate 
Schwann cell intracellular signalling cascades that are able to induce Oct-6 expression 
mediated by cAMP inducible transcription factors. These hypotheses on Oct-6 fimction and 
regulation will be addressed in the following chapters. 
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The POD Factor Oct-6 and Schwann Cell differentiation 
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The PQU transcription factor Ocl-6, also known as SCIP or TsI·1, has been implicated 
as a major transcriptional regulator in Schwann cell differentiation. Microscopic and 
Immunochemlcal analysis of sclaUc nerves of Oct-6-/~ mica at different slages of 
poslnatal development reveals a delay in Schwann cell differentiation, with a transient 
arrest at the promyelinalion stage. Thus, Oct·6 appears to be required for the transition 
of promyelin cells to myelinating cells. Once these cells progress past thIs point, Oct-6 
Is no longer required, and myelination occurs normally. 
Schwaml. ceUs are lm'olved in the trophic 
support and insulation ofaxons and are the 
only glial cell type in peripheral nerve 
trunks. The two types of Schv?ann cells, 
m,elinating Schwann cells associated with 
axons greater than I ].lm in diameter and 
nonmyeHnating cells associated with multi-
ple lower caliber axoru, both differentiate 
from neural crest-derived &::hwann cell 
precursors. Mrelination initiation correlates 
I.'MeaI Ger!eticsCenter, DepartmeniolCell8io1ogyand 
Galetics. Erasmus lJni',~ty. Post Offce Box 1738. 
3OC.Q DR Rotterdam. t.~. 
with axon diameter and is gm'emed by 
axonal signals that are as yet not under-
stood (I). 
A number of transcription factors have 
been proposed to be involved in &::hwann 
cell differentiation and myelination (2). 
Prominent among those is the POU domain 
transcription factor Oct-6 (also kno .... -n as 
SCIP or Tst-l) (3). The Oct-6 protein is 
expres.sed in [he &:hwann cells of the sci-
atic nerve and the sympathetic tfUnk from 
embryonic day 16 (E16) onward (4). During 
postnatal nerve de\'eiopmenr, the expres-
sion of Oct-6 mRNA is gradually down-
regulated and extinguished, with only spo-
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radie eXprc55ion in Schwann cells of the 
adult nerve (5). In vitro and transgenic 
mouse experiments have ~uggeHed that 
Oct-6 acts as a negative transcriptional reg-
ulator and as a general reprcs>Of of myelin 
genes in prolifer.3ting &hwann cells (6). By 
inference, 0:1-6 was rostu1ated to be in-
volved in embryonic &hwann cell prolifer-
ation and to regulate the correct number of 
Schwann cells in the peripheral nerves. In 
the absence of CkI-6 gene function, one 
prediction of this mood is that Schwann 
cells will differentiate prernature!~' and their 
numbers will be reduced. 
To eluddate the role of the OCI-6 gene in 
Schwarm cell differentiation, we interrupted 
the DNA bindirrg domain of the mouse 
Oct-6 [o;;us through homologous recombina-
tion in embryonic stem (ES) cells, with a 
p-galactosida5c-noomycin fusion gene (7) 
(Fig. I). Two different Oct~6+1- ES cell 
lines produced chimeric animals and had 
B FIg. 1. Targeted disruption of the A 
Oct-6 gene. (A) Targ€tiog stra~egy. 
Schematic representation of the :"9 "'. C EIDll_ 
mouse Oct·6 gene (rnidd'-e). The s\ / -.~ .~ ~ :;"~~"'o:'iho~:.~: :~;~ ~".. : . "'i-~l 
Y.1lich is encoded b}'a s'ng'eexon. • Cd. .. ""_ ... 
The open box represc-nts the open 
read·ng frame, and the hatched box ... ~ '""" C I.¥.t • ..., 
represents the POU doma·n. A :;;:' 
o.~ fragment conta:ning a Il·ga· 
... , 
lactosidase-noom,'dn fusion gene precOOed b}' an internal nbosome ffltry site ~RES) (7) {gray and 
striped boXeS) was inserted into the Xho t site of the Oct·6 gene. thereb}' ctsrupting the o.~ I>oong 
domain of the Oct·6 protein (top). A schematic represffltation is a'so silO\'.fl of the mutant a"eTe, 
irxfCilting the position of the probes that .... 'ere used to idffl~fj homdogoos recomb:nant ES ce~ ~nes 
(bottom). \B) Southam blot of Eco Rl-restricted DNA. sho'l/.ng a 4 .6-kb mvtant a"e'e band and a 6.8·kb 
wM·type a'ree band detected b}' probe 2, The mutant a1&'e expresses a 6.9·kb bicistronic mANA under 
control of the endogenous Oct·6 promoter and its regulatory sequences. No fuil-length Oct·6 protein 
can be produced from tho's mRNA.. 
Fig. 2. Immunohistochemical analysiS of y,11d-
type versus Oct·6-1- mutant SCiatic f!eI\'es. Sci-
aticnervesof 18dayspostc6tum embryos(Aand 
8) and PB (Cand 0) and P14 pups(E and F) Viere 
ana!yzed for the ex.press:On of the Oct·6 protein 
(9'000 ~\JOfexenl s.'gna!) and the myeLn protein 
Po (red fiuorescents;gna~(9). WJd-typeand Oct· 
6-1- rl€!ves express basal\€r .. \tsofthe Po protein 
at Et8 (A and B). A lew cens e1press a!rea<r/ high 
\€r,'e:s of Po (A, y,tite arrows). At P8 and at P14, 
h;gh le'.'€1s of Po expression ate soon in w;rd-type 
f!eI\'€l (C and E), Ivhereas in mutant 00fY9, only" a 
smaij number of Schwam cells express high lev-
els Of the Po protein (0 and F, v.tJite arrO'm),Im-
rnur.oh;stochem~ analysis 01 paraff", sections 
was as descnbed (8). The bar represents 50 filll. 
FIg, 3. Expresslon Of ear1}' and Jate A. ,"~,.~,...£!.'...,~ 
mj'el:n markers in the SCiatic r"!elves _!- + _!- -I_ _!- + <1- + 'I ~ 
of Oct·6-1- and Oct-6H - anima!s. 
(A) Protein immoooblot analysis of 
protein extracts from mutant and 
heterozygote sciatic f!eI\'BS at PI, 
PB,Pll,andPI4. The blots were ,'f$ "."'i .'1i.:n 
prObed'hithanlbo::festoPo:CNP, _ ,_ _>1 
MBP, and NF-M. The amount of ..... : - - ... -" 
protein Is norma'"lZed for the NF.M ~ 1 .., I 
signal. The r~tr.'e mo'eruar mass is incf.cated b}' M,. (8) Sem.iquanMa· 
We PCRanal'jSisof expression le'.'e!sofMAG, PMP-22, and MBP in P14 
Oct-6+I - and OcI·6-1- SCiatic nerves. For each gene, ~f!Cation of 
~~-:----'-
--.~~ 
-
-"'''': 
~ .. ~. 
"" ,.,. 
hypoxanthine phosphoribosyl·transferase (HPRT) eDNA was used as an internal control in every second 
panel. Samp1es W€f(I takffl atcycles 20 (lane 1 and 5), 22 (lane 2 and 6), 24 (lana 3 and 7), and 26(lane 
4 and 8). 
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high (requencies of germline tl1lrumL<sion. 
Identical rewlts were obtained from both 
lines. Hetero!ygote animaL; were healthy 
and had no readilr applrent abnormalities. 
Analrsis of f3.galactosida..<e activity in the..<e 
animals confinned the previously described 
Oct-6 expre.<sion pattern (3, 4, 8). 
Mice homozrgOL15 (or the mutated Oct-6 
allele were produced at normal Mendelian 
ratios and dc\'e!oped to term and showed no 
gr055 anatomical abnormalities. Most Oct-
6-1- pups died soon after birth, but 2 to 4% 
suI"h-ed for a longer period. From pJstnatal 
da)' 5 (P5) onward, mutant animals could be 
identified by their ~maller site and occasion-
al tremors in the second postnatal week. 
To determine whether Schwann cells 
were affected in the Oct-6-1- mice, immu-
nohistochemical analr;;is was perfOffiled (8). 
NorrnalJr, mrelinating Schwann cells coor_ 
dinately express mrelin genes such as those 
encoding protein lero (Po)' retipheral mre-
lin protein (PMP-l2). mrelin basic protein 
(MEP), and mrelin-as..<ocialed gl)'coprotein 
P1 
P4 
P8 
P16 
P90 
Ffg. 4. Microscopic cross sections of sciatic 
nerves of Oct..fj+!- and Oct-6-1- animals at d'i-
ferfflt stages of postnatal development. The left 
panels were derived from Oct-6+!- rina.!s, and 
the right panels were darNed from Oct·6-f- ani-
mals. Semithin sections (111m) of Epon-errbed-
dad material y,-ere stained mth methyleoo boo. 
Theageofthean;ma1 isioct:-catedonthe right. The 
bar in each panel represents 2S Ilffl. 
(MAG). Ex,llllination ofElS n.erves shuwN 
that Pc, expression !cH'!S were norma!, and 
no al:>nonn,llities in either the numh-r of 
Schwann cells or the ,h~re of their nuclei 
werearrJrent (Fig. 2, AanJ B, and Fig. 4, A 
and 8). Howe\"er, P8 and PI4 sciatic nerves 
of -/- animal> arreareJ to h- Jefecti\'c in 
myelination. The nerves ren.'alcd reduced 
!en~!s of P" expression rebti\'e to the highly 
P,,-posith-e nerves of +1+ IineIT!\ates (Fig. 
2), Some Oa.6-1- &hwilnn cells exrress 
normill, high levels ofP" (Fig. 2D), but most 
express little Po- At P14, the number of 
Schwann cells that express high lewis of Pc, 
had increased (Fig. 2F). 
Protein immunoblotting and semiquan-
titati\"e reycrse tnlrl.Scriprrue-roiymer.l>c 
chain reaction (RT-PCR) were used to ex-
amine the expression levels of a numl-er of 
early and bte myelin markers in the sciatic 
nerve at different ~tagc; of postnatal devel-
opment (9). Le.>S than nor1llal Po and MBP 
levels wefe found in the mutant nerve (Fig. 
3A). Early expre50ion of Z',3'-cyclic nude-
otide y.phosphc-Jiesterase (CNP) rrotein 
at PI was not affected (Fig. 3A), but the 
ro.>tnat'll increase was le50. \Ve also exam-
ineJ the rnRNA levels of the genes encod-
ing myelination markers PMP-22, MAO, 
and MBP (Fig. 3B) and found them to l-e 
Fig. 5. Uitrastructure of sciatic 
('!elves at 6fferent stages of postna· 
tal development. Shown is the lilra· 
structural appearance of an Oct· 
6+1- (A) and Oct·S- I - (B) nerve at 
Pt. EnsheaUing and prorn..'ef.n ce~s 
arev.$;b'e til ixlth rl(!(\'es. The daiker 
eel til the upper right part of (A) has 
made the fiSt \~Tap arolJfld its axon. 
(C)Oct-6"· IWveatPt6.(DandE"j 
Represen!atr.-e sectiOns of an Oct-
6+ 08IVe at P16. Panet (OJ i'!us· 
tra~es the normal but irnmature ap-
pearance of an Oct·S·· I - 11€f\'iI at 
P16, and (E) f'ustrates the sporoo.c 
abnormal,ties observed til mutant 
ner.-es. The open arrON io6-cates 
m,-e!;natioo til the absence 01 an 
axon. The asterisks inO<:ate large 
axons aSSOCiated I',jth a m,.ernating 
SchWaM ce1. (f) Mutant SchWaM 
001 that has produced a normal ITrj-
e~n sheath. The sold Mcr.'l$ ifld<· 
cata an uncompacted per;axor;a) 
membrane. The I'.n!e arlOw po;nts 
at an apparently normal basement 
I11€mbrane. />Jso shov,n are repre· 
sentatr.-e soctons of adu'l heterozy· 
gous (O) and mutant (HJ ner.-es. 
reduced. TIle""" expre~i<ll) d,lIa ~ugge;t that 
in CXt-6-1- animals, nefye myelinatiun is 
del,lred rut not completely blockeJ. Alter-
narin:ir, it is po50ible that a numl-ef of 
Schw,lnn cells ,1ifferenti,lIe normally, where-
as the re,t are blockeJ at an eMir stage uf 
differenti,ltion. 
To distingui~h l-etween these ru~ibili. 
ties, we examined the micro;;coric Hructure 
of ~ciatic nerves at different ~tages of pt)stna· 
t,ll development (10). Normally, only a few 
myelinating Schw<'Inn cells were ob,erv",,1 ,1I 
hitth, with cxtensiw myelination visible at 
Pi and PS (Fig. 4, A, C, ,md E). At P16, 
myelination was 11"..11 aJI',1Occd, with many 
fully myelinated ,lxons (Fig. 4, ° ;md I). 
However, in the On.6-1- nerve, no c\"i-
denee of myelination \\\15 reen until the ~ec­
ond week of po;;tnal;lJ[ development (Fig, 4, 
B, D, F, and H). In adult Oct·6-1- ner.·es, 
myelination arremeJ complete (Fig. 4J). 
Electron microscopic analy,is of SO-nm 
~e((ioll5 of sciatic nerves fwm -/- and 
+/- mice rel'e,lleJ no differences at PI. 
SchwJnn cells were actively ensheathing 
axollS, and rromyelin figure. were ohserved 
in which Sch\I'Jnn cells had ;lCljuireJ a I; I 
rebtion with an axon. There was a normal 
derusitillll of coHagen fibrilb, ,lnti Oct· 
6-1- and Oct-6+1- Schwann cells proJuccd 
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a lw'ement membr,lIle (Fig. 5, A, B, and F). 
In wild-tH'" P16 nerves, most brge-(alibcr 
axons were myelinated, whereas Oct·6-1-
PI6 nerves showed an imm,lIure phenotyrc 
with prom\'e!in figures with only the larger 
axoru mre!inateJ. Schw,lnn cells that had 
myelinated a single, large calil-er axon ap-
peared normal, with an uncomra(:ted peri-
axonal membrane and tightly racke.] mye-
lin membranes (Fig. 5F). Vcr.,. sporadically, 
abnormal myelin figures were ub,erved that 
showed sel'er,l! brge axons associated with 
a myelinating Schwann cell (Fig. 5E). 
TIlese SchwJnn cells showed sC\'en~I}' dis-
rupted myelination, as el'idenc",,) hy their 
f,lilure to wwp myelin ar,lund the axun, 
re,ulting in disorganized myelin sheath,. 
Such Schwalm cells stalted myelination~. 
fore a 1: 1 relation with an axon WJ5 estab-
li,hed. Sometimes myelination was ob· 
served in the absence of an axon (Fig. 5E), 
In adult Oct-6-1- animals, nerve myelina. 
tion was complete (Fig. 5, G and H), 
These data demonstrate that in Oct-
6-1- mice there is a delay in the- onset of 
myelination and not a block in the differ-
entiation of Schwann cells. This delay is 
characterized by a transient arrest of 
Sdl\l\lnn cells at the promyelin stage. Once 
cells progress rast this stage, m\'elinatinn 
occurs normall\", which indicates that Oct·6 
is not invol\"eJ in the execlllion of the-
terminal differentiation progrJm. These reo 
suits are in contra,t with transgenic stuJies 
in which a dominant negati\'e forlll of 
Oct·6 under transcriptional control of the 
P" promoter results in an early omet of 
myelinatiun and hypermyelination, This 
discrepancy may sURl;est separate {unctions 
for Oct·6 pwtein in early and late Schwann 
cell de\'e!opment, as discmsed by \Veinstein 
<'I al. (6, I I). Our results suggest that Oct·6 
exerts its function in Schwilnn cell devel-
orment through the regulation of genes 
that are in\"ol\"eJ in emhry<'nic Schwann 
cell a.xon interactions that g,wem the tr,lll-
5ition fWIll il pwmyelin cell Tn a ffi\"elinat-
ing Schwann cell. Exactly which genes are 
regulated hI' Ckt-6 and how this rrocess 
mediates the rrogression of Sch\\'Jnn (:ell 
differentiatinn require further stud),. 
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Abstract 
To examine the role of the Oct-6 gene in Schwann cell differentiation we have cloned and characterized the chicken and zebrafish 
homologues orlhe mouse Ocl-6 gene. While highly homologous in the Pitl-CktJI2-Unc86 (pOll) domain, sequence similarities are limited 
outside this domain. Both genes are inlron!ess and both proteins lack the amino add re~ats that are a characteristic feature of the 
mammalian Oct-6 proteins_ However as in mammals, the aminoterminal parts of the chicken and zebrafish Oct-6 proteins are essential 
for transactivation of octamer containing promoters. By immunohistochemistry we have found that the chicken Oct-6 protein is expressed 
in late embryonic ensheathing Schwann cells of the sciatic nerve and is rapidly downregulated when myelination proceeds. This expression 
profile in glial cells is identical to that in the mouse and rat. Furthermore the zebrafish Oct·6 homolog is expressed in the posterior lateral 
nerve at a time when it contains actively myelinating Schwann cells. Thus despite extensive primary sequence di\'Crgence among the 
vertebrate Oct-6 proteins, the expression of the chicken and zebrafish Oct-6 proteins is consistent with the notion that Oct-6 functions as a 
'com~lence factor' in promyelin cells 10 execute the myelination program. © 1998 Elsevier Science Ireland Ltd. All rights reserved 
Kepl'ords: OCI-6 gene; Schwann ceil differentiation; Zebrafish; Chicken; Mouse; POU genes 
1. Introduction 
The embryonic development of multicellular animals is a 
highly organized process of cellular proliferation and differ-
entiation. Extra- and intra-cellular signals ultimately lead to 
the expression of specific genes that define and maintain the 
differentiated state of individual cells in the organism. Tis-
sue specific transcription factors playa pivotal role in these 
processes. These factors are encoded by gene families 
defined by distinct structural characteristics of their DNA-
binding domain. The POU domain genes constitutes such a 
family of transcription factors (for review see Ryan and 
Rosenfeld, 1997). The POU proteins are characterized by 
a 150-160 amino acid domain which can be subdivided in a 
• Corresponding autoor. Tel.: +)1 10 4038250; fa.~: +)1 10 4360225; 
e·mail: mdj~r@gen.fgg.eur.nl 
I Pres~nt address: Centre de Re,her,he en Neuroscience~, McGill Uni. 
versity, The Montreal General Hospit.ll Research Institute, 1650 CedJf 
Avenue, Montreal, PQ 113G 1M, Canada. 
carboxytemlinal portion (the POU homeodomain) related to 
the homeodomain DNA binding proteins and a aminotenn-
inal portion consisting of a variant helix-turn-helix motif 
thai is a defining characteristic of this family of proteins 
(the POU-specific domain). More than I3 mammalian 
POU genes have been characterized and POU genes have 
been cloned from the genomes of worms, amphibians, birds 
and flies. Based on sequence homology and gene structure 
the POU genes can be subdivided into six classes (Wegner 
et ai., 1993). 
The vertebrate class III POU genes are intronless and 
expressed predominantly in the developing and adult ner-
vous system where they show considerable overlap. The 
Ocl-6 (accession number chicken Oct-6 gene AF064608) 
(SClPffst-l) gene is one of the most intensely studied 
class III genes (He et aI., 1989; Monuki et a\., 1989; Meijer 
et al., 1990; Suzuki el al., 1990) and its expression pattern is 
highly dynamic, complex and overlapping with other mem-
bers of the class III POU gene family. Ocl-6 is first 
expressed in the primitive ectoderm of the egg·cylinder 
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stage mouse embryo. During gastrulation and subsequent 
neurulation expression is progressively restricted to the 
anterior primitive brain. There is a second wave of Oct-6 
induction in the neurepithelium of the entire brain in the latc 
headfold stage embryo. This expression becomes restricted 
to mid- and forebrain structures. At later stages Ocl·6 is 
observed in specific subset of motor- and commissural neu-
rons in the spinal cord and hindbrain, different mid- and 
forebrain structures, the skin and the neural crest derived 
Schwann cells of the peripheral nervous system (He et aI., 
1989; l-.'Ionuki et al., 1989; Suzuki ct al., 1990; Zwart ct aL, 
1996). Genetic studies in mice have shown that the Oct-6 
gene plays an important role in the differentiation of per-
ipheral glial cells. In the absence of Oct-6 Schwann cells fail 
to mature on schedule leading to a transient arrest at the 
promyelin stage and a 1-2 week delay in the onset ofmye-
lination, while eNS myelination is not affected (Berming-
ham et al., 1996; Jaegle et aI., 1996; Jaegle and Meijer, 
1998). 
Thus it is interesting to study the conservation offunction 
ofOct·6 throughout evolution and take advantage of other 
non·mammalian vertebrate models for further analysis of 
this gene. The zebra fish and chicken offer several advan· 
tages among which arc the accessibility of embryonic mate· 
rial for grafting and tracing studies and the possibility 10 
study gene function through o\'crexpression and ectopic 
expression of genes in embryos. Furthermore, comparison 
of cis-acting regulatory sequences that driVe celltype·speci-
fie expression of the Ocl-6 gene in these vertebrate species 
will allow the identification of evolutionary conserved DNA 
binding sites and the nuclear factors that bind to them. 
Recently a zebra fish POU gene, called zp-50, was cloned 
that shows highest homology to the mouse Oct·6 gene 
(Hauptmann and Gerster, 1996). Based on differences in 
embryonic expression patterns between this gene and the 
mouse Ocl-6 gene Hauptman and Gerster suggested that 
the zp-50 gene might not be the functional homologue of 
the mammalian Oc/-6 gene. However, since genetic data 
obtained in the mouse suggest a critical role for Ocl-6 in 
the Schwann cell lineage, it is important to study the expres-
sion of putative Ocl-6 homologues in the differentiation of 
peripheral glia cells. 
In this paper we report the cloning of the chicken and 
zebrafish Oct-6 homologues and examine their transactiva-
tion potential and expression in peripheral glial cells. 
Within the POU domain the chicken and zebrafish are 
highly homologous to the mammalian Oct-6 proteins, 
while sequence similarities outside this domain are limited 
to short stretches. We show that the chicken and zebrafish 
Oct·6 proteins both contain a functional aminoterminal 
Iransactivation domain lacking the simple amino acid 
repeats which afe a characteristic feature of the mammalian 
Oct·6 proteins. Despite sequence divergence outside the 
POU domain both the zebrafish and chicken Oct-6 proteins 
are expressed in developing peripheral nerves of both spe-
cies, strongly suggesting that they indeed represent the 
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structural and functional homologues of the mammalian 
Ocl-6 gene. 
2. Results 
2.1. Isolation ofOcl-6 gene homologllesfrom zebrajisll and 
chickell gellomes 
Using a mouse Oct-6 POU domain DNA probe, hybridi-
zation conditions were established at which one relatively 
strong hybridizing band was observed on Southern blots 
containing zebrafish and chicken DNA (data not shown). 
The probe was used under these conditions to screen gena· 
mic phage libraries of zebrafish and chicken DNA. Several 
phage clones were recovered from both libraries. Restric-
tion enzyme analysis and Southern blotting revealed three 
independent zebrafish clones. The most strongly hybridiz-
ing clone was mapped, subcloned and partially sequenced. 
This zebrafish Oct-6 homolog is identical to the zp-50 clone 
described by Hauptman and Gerster (1996). The remaining 
phage clones were not further analyzed. Two different 
phage clones were isolated from the chicken library and 
were found to contain partially overlapping inserts. Ocl-6 
hybridizing bands were mapped, subcloned and sequenced. 
The restriction enzyme map of the zebrafish and chicken 
Ocl-6 homologues genes are depicted in Fig. I A. Both frag-
ments contain an open reading frame not interrupted by 
introns. Thus, like all other vertcbrate class III genes the 
fish and chicken Oct-6 homologues arc encoded by one 
exon genes. 
The open reading frame (ORF) of the chicken and zebra-
fish (and Xenopus) (Agarwal and Sato. 1991) Oct-6 genes 
predict that the homologous proteins are considerably smal-
ler than the mouse Oct-6 protein (calculated molecular mass 
is 39 and 41 kDa, respectively versus 45 kDa for the mouse 
Oct·6 protein; Fig. lD). This difference is due to the pre-
sence of blocks of long simple sequence repeats in the 
mammalian Oct-6 protein directly flanking the POU 
domain. The proline-rich repeat carboxytemlinal of the 
POU domain of the mouse Oct-6 protein is encoded by an 
inverted repeat with a lO·bp stem. It is conceivable that this 
sequence was lost in all other vertebrates except mammals 
following a replication error over this secondary structure. 
Shorter simple sequence expansions in the mammalian Oct-
6 protein are found in the aminoterminal half of the protein 
(the rat and human Oct·6 protein sequence is virtually iden-
tical to that of the mouse (110nuki el al., 1989: Faus et ai., 
1994) and interrupt blocks of considerable amino acid con-
servation (Fig, I B). Within the POU-specific domain the 
proteins show 100% homology while the POU homeodo-
main is 99% conserved (Fig. IB). Furthermore. all four Oct-
6 proteins have a threonine residue at position 74 in the 
carboxytemlinal helix of the POU-specific domain and a 
histidine residue in position 29 in helix 2 of the POU home-
odomain while all other known class III proteins have an 
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Fig. 1. (A) Schematic representation of the genomic maps of the chicken and ubrafish OcI·6 homoJogollS genes. The open reading frame which is not 
interrupted by introns is indicated as a box. The POU-spe-cific and POU homeodomains are indicated \\ith black and slri~ boxes, reslXcliwiy. (B) 
Alignment oflhe amino add sequence of the mouse, chicken, ubrafilh and frog protein sequence using the clustalW program. Identical amino adds and 
conservative amino add 5IlbSlitulions are boxed. Dashes irnlicate gaps in the sequence that w~re introdu,ed to optimize the alignment. The POU.specific and 
the POU homrodoffi3in are indkatoo. The starting "",itions orthe IrunNted proteins used in the Ir3IlS.l"j\"3Iion assa.y are indkated by their amino acid 
numbu and an arrow. (C) GC conlent5 (%) of the vertebrate 0(1·6 genes at first, second and third base of codons. (D) Phy!ogen~tic tree sho\\ing the 
evoluticmal)' relationship ""I,wen the knO\\TI vertebrate class III POU genes. This tree was constructed using the neighbor.joining method (DNAMan 
software package). Abbreviations; GO, Gflllus galfus; /lim, Mus m.uw/w, XI, Xenapuf lflf?!u; Dr, Dallio rerio. 
alanine residue and a glutamine residue, respecti\'ely, in 
those positions. Based on these specific and overall 
sequence homologies (see Fig. ID) we conclude that the 
chicken and zebrafish proteins are the homologues of Oct-
6 as found in mouse, rat and human. 
A remarkable feature of the vertebrate Oct-6 genes is that 
they are encoded by DNA with very different guanine and 
cytosine (GC) content. The mammalian and chicken Oct-6 
genes arc both encoded by very GC-rich DNA sequences 
(72%) while the zebrafish and Xenopus genes have a much 
lower GC content (55%). Analysis of the organizational 
principles of genomes has shown that the genomes of 
waml-blooded vertebrates are composed of mosaics of 
very long DNA segments, called isoehores. Isochores are 
compositionally homogenous and belong to a small number 
of families which cover a very extended GC range (Ber-
nardi, 1993, 1995). The base composition of genes located 
within isochores reflect their GC content and the composi-
tional constraints operating on these isochores result in a 
bias at the third codon position. In contrast, the genomes 
of cold-blooded vertebrates arc compositionally unifonn. 
Although it is not known what the GC content is of the 
isochore in which the Oct-6 gene resides it is of interest to 
compare the GC content in the first, second and third codon 
positions of the POU domain and the whole open reading 
frame of the known vertebrate Oct-6 genes (Fig. IC). Indeed 
the GC content at the third codon position is considerably 
higher than the average GC content in mouse, chicken zeb-
rafish and frog suggesting a tendency towards higher GC 
contents in both cold-blooded and wann-blooded verte-
brates. Howe\'er, within the conserved POU domain there 
is a extreme preference for GC nucleotides at the third 
codon position in only the warm-blooded animals (mouse 
and chicken). The cold-blooded animals have a GC content 
that is even slightly lower than that observed at the third 
codon position in the entire coding region (frog and zebra-
fish). 
2.2. Mapping the transcriptional actil'ation domain of the 
chicken and zebra fish Oct-6 proteins 
Simple amino acid repeats are a characteristic feature of 
many transcription factors. Previously. we and others have 
detemlined the transcriptional activation domain of the 
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mouse Oct-6 protein and found it to be located in the ami-
notenninal third of the protein. The contribution of the 
amino acid repeats to this transactivation function is not 
clear although Monuki ct a!. (1993) have shown that the 
polymorphic alanine stretch can be deleted without aftee!-
iog the transcriptional activation potential of the protein. 
Since the zebrafish and the chicken Oct-6 homologues 
lack the amino acid repeats of mammalian Oct·6, these 
proteins provide an opportunity to assess their role in trans-
activation, 
To this end we performed co-fransfection experiments 
in HeLa cells with cytomegalovirus (eMV) promoter dri-
ven zebrafish and chicken POU protein expression vectors 
and a rabbit p-g1obin reporter construct that contains an 
octamer sequence just upstream of the rabbit p·globin 
TATA box (Westin et aI., 1987; Muller et a!.. 1988; Mat-
thias et a!.. 1989). Binding of the chicken and zebrafish 
Oct-6 proteins and the various aminotenninal truncation 
mutants to the octamer sequence (A TITGCAT) was 
examined by a bandshift assay using whole cell extracts 
of transfecled cells, As shown in Fig. 2A, full length (N I) 
and aminoterminal truncated (N47 and N133) zebrafish 
and (N77 and N150) chicken Ocl·6 proteins arc produced 
in the transfected HeLa cells and bind the octamer 
sequence with high affinity_ This is as expected since 
they all contain an intact POU domain, To assess trans-
activation of transcription by these proteins, RNA from 
CO-Iransfected cells was isolated and transcription from 
the reporter and reference plasmid was measured using 
A 
.<i' / 
z~~z~~ 
B 
z~~z 
PrcOO .......... 
1 2 3 4 5 6 1 6 \I 10 11 12 
zfOcl·6 ch(){)I·6 
Fig. 2. Transactivation ofan oclamer co~taini~g promoter by ubraRsh and 
chicken (k1·6 proteins. (A) The full length and trunc.1ted protems are 
expressed at high levels in transfecled cells. Bandshift experiment using 
a IIp·!abele-d. octamer prob¢ \\ilh whole tell utracts [rom cells expressing 
the various effector plasmids. (B) Acth'a!ion of the reponer tonstroct 
OCTA was monitored by RNase protection. 'Rer indicates the position 
of the reference signal th.lt is derived from transcripts torrectly iniliated 
from the plasmid OVEC reference plasmid. The reponer plasmid and 
reference plasmid is described in detail in (Westin et .11., 1987). 'Tes!' 
indicate, the position of the rorrectly initiated RNA trans,ripts from the 
reporter plasmid. Lanes maiked by minus signs indicate tonlrols \\ithout 
Ir.lnsactivator plasmid. N1, N47, NtB, N71, NISO refers to the amino add 
position (s<'e Fig. IB) at \\hich the truncated protein is fusN in frame to 
the shonlead~r sequence of th~ pEVRF ve.:tor, (Matthias et aI., [989). 
0.:13 indicat~s the oct3m~r containing reporter plasmid and (kta(6) indio 
cates the reponer plasmid in which the oxtamer seqwrn:e is mutated. Lane 
II shows the s'lgrul when the prob¢ was h)'bridize-d. 10 tRNA. 
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a RNase protection assay (Fig, 28), Both the zebrafish 
and chicken proteins activate a simple promoter in a ocla-
mer dependent way (Octa; lanes I and 6). However, upon 
mutation of the octamer sequence transactivation of the 
reporter construct (Ocla(.6); lanes 4 and 10) is abolished. 
In addition, the transaclivation potential of the chicken 
and zebrafish Oct-6 proteins is dependent upon an intact 
aminoterminal domain. As shown in Fig. 2B progressive 
deletions first slightly reduce (N47 and N77) and than 
abolish (N133 and N150) octamer dependent transactiva-
tion. Deletion of the first 47 amino acids in the zebrafish 
protein removes the largest block of homology in the 
aminoterminal region between the different vertebrate 
Oct-6 proteins, yet this does not significantly affect 
trans-activation, Only removal of the aminotemlinal 
third of the protein results in a severe reduction of trans· 
activation by both zebrafish and chicken Oct-6 proteins. 
Thus, like the mouse and ral Oct·6 proteins the chicken 
and zebrafish Ocl-6 proteins have an aminoterminal trans-
activation domain, Despite the fact that the zebrafish and 
chicken proteins lack the characteristic short homopoly-
meric amino acid stretches present in the mammalian Oct· 
6 protein, they are capable of transactivating a minimal 
promoter in an octamer dependent way. 
2.3. Expression oJtlle chicken alld zebrajish Oct-6 prolei1lS 
ill peripheralnen:e del,e/opmellt 
Comparison of the primary amino acid sequence of the 
zebrafish and chicken proteins (Fig, I) and the ability of 
Ihese proteins to transactivate transcription through the 
octamer consensus sequence clearly identifies them as the 
homologue of the mammalian Oct·6 gene, However do 
these proteins actually have the same function? It is antici-
pated that homologous proteins perform the same crucial 
function in different vertebrates and therefore would be 
expressed in the same tissues or cell lineages in which 
their function is critically required. Genetic studies in 
mice ha\'e shown thai Oct-6 plays an importanl role in per-
ipheral glia differentiation. Thus. functionally homologous 
chieken and zebrafish Oct·6 proteins should be expressed in 
differentiating peripheral gHa in these species. To examine 
this question we raised antibodies in rabbits against bacte-
rially overexpressed chicken and zebrafish Oct-6 protein 
(aminoterminal region) and used these antisera to study 
the developmental expression pattern of the protein in 
chicken sciatic nerves and in the posterior lateral nerve of 
zebrafish embryos, 
The specificity of the chicken and zebrafish Oct-6 anti-
serum used for expression analysis was verified in se\'eral 
ways. First, the chicken Oct-6 antiserum detects only one 
band of44 kDa in Western blots of protein extracts of COS 
cells transfected with a veclor expressing chicken Oct-6 
(Fig. 3A, lane Oct·6). A protein with the same electrophore-
tic mobility is detected in extracts of embryonic day 17 
chick sciatic nerves (Fig, 3A, lane El7), Both bands are 
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Fig. 3. The chicken Ckt·6 ;~tibody detects a 44·kDa protein in embryonic 
nerves. (Al Wntern blot. Cell extracts were preparw from COS ails 
expres.sing chOct-6 (I) and from EI1 embryonic nerW5. Proteins were 
separated on a 10% SOS JXllyawylamide gel and transferred to nitrocellu-
lose. The chicken (kt·6 antibody detects one protein of 44 kDa in embryo-
nic neryes and OcI·6 expressing COS cells. (8) The chicken 0.:1·6 
antibody spcdfkally supcfShifts the chCkt·6 complex. Ele.::trophoretic 
mobility shift as!.3y using freeze/lhaw exlracts of chicken E\7 embl}'onic 
~Iye and a radiolabeled octamer probe. The CkI·6 and OCI·[ complexes 
are indic.ated. The immune serum (lane I) spcdfically supcrshifts (5lip;;) the 
0.::(·6 complex bul docs not affect the 0.:1·1 complex or the unidentilkd 
o;omple_'( that migratesjllSt above <k1-6. -, no serum added to the bandshif\ 
reaction:, I, I pi cho.:t-6 anti·serum added; P, J pi pre-immune serum 
added. The free probe .. vas mn out of the gel. (C) The zebrafish 0.:1·6 
antibody sp.!dficaHy supershifts the zilKt·6 complex. Elttlrophoretic 
mobility shift assay using a radiolabeled octamer probe and nuclear 
exlracts of COS cells transfttted \\ith expression (Oll5truct ern:oding the 
full length zebrafish 0.:1-6 protein (lanes I and 2), an aminoterminal trun· 
tilted form ofzilKt-6 (N133zilKt-6; lanes 3 and 4), mouse Dm-2 (lane 5J, 
mouse Dm-I (lane 6) and mouse 0.:1-6 (lane 1). Addition of Ipl ofzilKt-
6 antiserum tomplete!y supershifts the zilKt-6ioctamer complex (sup in 
lane 2) but does nol affect the mobility of the Nl33zfo.:t·6'octamer com-
plex (lane 4), nor does it affed the mobility of the mouse Bm-2, Bm-! and 
O.:Hi complexes (lanes 5--7). . 
effectively competed with bacterially expressed and purified 
chicken Oct-6 protein (data not shown). Second, in electro· 
phoretic mobility shift assays (EMSA) using an octamer 
probe and El7 embryonic nerve extracts, the antiserum 
selectively supershifts a protein/DNA complex that has 
the same electrophoretic mobility as a complex observed 
, with ehOcl-6 overexpressing COS cell-extracts (Fig. 3B 
and data not shown). The antibody does not reacl with the 
chicken Oct-l protein or with the protein in the unrelated 
complex that runs just above Oct-6. The pre-immune serum 
does not affeClthe mobility of any of the octamercomplexes 
observed (Fig. 3B, lane P). Thus, an octamer-binding pro-
tein of 44 kDa is selectively detected in embryonic nerves 
with the antiserum raised againstlhe aminotenninal domain 
of the chicken Oct-6 protein. The specificity of the zebrafish 
Oct-6 antiserum was tested in EMSAs using nuclear extracts 
of COS cells Iransfecled with a full length zfOct-6 expres-
sion vector and the aminoterminal truncated fonn ofzfOct-6 
(N130zfOct-6). The antiserum completely supershifls the 
zfOct-6 complex (lanes I and 2 in Fig. 3C) but does not 
affect the mobility ofthe Nl30zfOct-6 complex {lanes 3 and 
4 in Fig. 3C} indicating that the antiserum selectively recog-
nizes the aminoterminal part of the zfOct·6 protein and does 
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not recognize epilopes in the conserved POU domain of the 
zfOct-6 protein. Furthermore, the zfOct-6 antiserum docs 
not cross react with the mouse poum proteins Bm-2 
(lane 5), Bm-l (lane 6) or Oct-6 (lane 7). 
Using the chicken Ocl-6 specific antiserum and a sec-
ondary fluorescent labeled antibody, Oct-6 expression in 
the developing sciatic nerves of chick embryos was exam-
ined by light-microscopy and was found to be high in 
Schwann cells (Fig. 4, lane LM). Both the level and the 
number of cells stably expressing Ocl·6 increase dramati-
cally from EI4 to E20, while only sporadically Oct-6 
expressing cells are observed in fully myelinated nerves 
(P21). To correlate the regulation of the Oct-6 gene with 
the differentiation stage of the Schwann cells we exam-
ined the nerves using electron-microscopy (Fig. 4, lane 
EM). At EI4 Schwann cells are ensheathing large bundles 
of immature axon fibers. The celJs have typical cytoplas-
mic processes (sp in Fig. 4) invading the nerve fiber bun-
dles and there is no evidence yet of a basal lamina. By 
E 17 many cells have adopted a one to one relation with 
axon fibers and some cells have initiated myelination 
(arrowheads). A basal lamina is now visible. At E20 
most myelinating Schwann cells have initiated myelina-
lion and some compact myelin is clearly visible. By P20 
myelination is complete. Thus, the strong upregulation of 
Oct-6 expression coincides with the stage in which 
Schwann cells have adopted a one to one relation with 
the nerve fibers and initiate myelination. Like in the 
mouse, Oct-6 expression is extinguished in actiYe1y mye-
linating Schwann cells. 
We examined the expression of the zebrafish Ocl-6 
protein in the lateral line nerve of the developing zebra fish 
at 72 h post fertilization (hpt) using zebrafish specific Oct-
6 antiserum and a fluorescent labeled secondary antibody 
(Fig. 5C). At this stage of development Schwann cells 
have wrapped seyeral rounds of uncompacted myelin 
around large caliber axons, while lower caliber axons 
are grouped in families (Fig. 5B). Some compaction of 
the myelin sheath is apparent in the most advanced stage 
of differentiation seen in Fig. 5B (arrowheads). All nuclei 
in this field are Schwann cells apart from one endoneural 
fibroblast-like cell indicated with a star. It is anticipated 
from the chicken and mouse data that Oct-6 will be highly 
expressed in the peripheral nerve at this stage. We 
focused on the lateral line nerve system of the zcbrafish 
which we visualized on whole mount embryos at 12 hpf 
using an antibody directed against acetylated a-tubulin 
(Fig. SA). The position of the section in Fig. 5B,C is 
indicated with a dOlled line. Oct-6 positive nuclei (green 
fluorescent signal) are found associated with axonal tubu· 
lin stained nerve fibers of the lateral nerve, strongly sug-
gesting Schwann cell specific expression. 
Thus, the expression of the zebra fish and chicken Ocl-6 
genes in the peripheral glia lineage of these species further 
corroborates our conclusion that these genes are the true 
homologues of the mouse Ocl-6 gene. 
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Fig. 4. o.:t-6 npression during peripheral nerve deve!opmenl Chicken 
sdatic nerve'S of embryonic day 14 (EI4), E17, E20 and post-hatching 
day 21 (PII) were analyzed for 0.:1-6 npressioo. Paraffin emlx"d<kd sec-
tions of sciatic ner.,.es wert incubated \lith chicken (kt.{i sjX'dfic animo.. 
dies. E .. pressing ctlls were \lsualized using a flIe roupJoo second.!rY 
antibody and pho!(lgraphed using a scanning electron mkroscopc (LM, 
light microscopY). The ultra structure of the contra lateral sciatic nerve 
was examined using transmission electron mkroscopy. Electron micro-
graphs of representative fields are sholln at Ihe stages indicated. The 
I;oasal lamina is ck<lrly visible at E20 and is indicated .",ith an arrow. 
The &h\\'aM cell pro!;esse; in\<lding the ner.,.e fibers are labeled 'sp' 
(EI4~ The fOfT]1.1tion of the first uncompacted myelin sheaths in panel 
El7 are indicate.:! by arrQ\\heads. 
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3. Discussion 
3.1. Seqllence conservation of the Oct-6 POU domain 
protein in emllltioll 
High stringency screening of genomic libraries of zebra-
fish and chicken with a mouse Oct-6 POU domain probe 
resulted in the cloning and characterization of the zebmfish 
and chicken orthologous genes. Not unexpectedly, both the 
chicken and zebmfish Oct-6 genes, like the mammalian 
genes, do not contain introns in their open reading frame. 
Class III POU genes have been found in worms, insects and 
all vertebrates examined. It has been suggested that the class 
III POU genes arose through reverse transcription of a POU 
domain messenger RNA molecule and integration of the 
cDNA in germ line genomic DNA in the pre- or early-Cam-
brian period. While even flatworms have class III POU 
genes that do not contain introns {at least not in the POU 
domain for which sequence information is available (Orii et 
aI., 1993; Stuart et aI., 1995), the one class III gene present 
in the roundworm C. e/egans, Ceh-6, has four introns (NCBI 
accession number z75711). Thus it is possible that the Ceh-
6 gene represents the direct descendant of Ine primordial 
class HI POU gene or, alternatively, the Ceh-6 gene has 
acquired introns since the gene arose. 
Duplication of the ancestral class III POU gene, or multi-
ple random integrations of its reverse transcribed mRNA, 
and recruitment of gene regulatory sequences in the vicinity 
of the integration or recombination site resulted in the four 
functional class III genes found in mammals (Kuhn et aI., 
1991; Bara et aI., 1992; Avraham et aI., 1993; Xia et aI., 
1993). The mammalian OCI·6, Bm-l and Bm·2 proteins are 
encoded by GC rich genes and they contain, outside their 
POU domains, multiple homopolymeric stretches of pro-
line, alanine, histidine, glycine and glutamine residues. 
The Xenopus and zebrafish Oct-6, Bm-) and Bm-2 proteins 
lack these blocks of simple amino acid repeats and are 
encoded by GC-poor genes. The correlation between the 
presence of protein domains that consist mainly of simple 
homopolymeric repeats and a high GC content led 
Sumiyama et al. (1996) to suggest that the appearance of 
these new protein domains during evolution in the mamma-
lian Oct-6, Bm-1 and Brn-2 gene has been facilitated by 
compositional constraints (GC pressure). Since the class 
III POU genes are predominantly expressed in the central 
nervous system of vertebrates they speculate that these 
newly evolved protein domains have contributed to the 
diversification of gene regulatory mechanisms in the central 
nervous system of mammals and by extension to the evolu-
tion of recent brain structures like the neocortex. Although 
our analysis of the transactivalion potential of the chicken. 
zebrafish and mouse Oct-6 proteins fail to provide support 
for this hypothesis it is possible that the simple protein 
domains present in the mouse Oet-6 are important in some 
aspects of the regulation of complex promoters in a tissue-
specific fashion. This hypothesis can now be critically tested 
in an experiment in which the chicken or zebrafish Oct·6 
gene are used to rescue the phenotype of the Ocl-6 knock 
out animals. 
Fig. 5. 0:1-6 expression in the lateral peripherainer-ie of ubrafish. (Al 
Whole-mount immunolocaHzation of acetylated tubulin positive MOns. 
Alkaline phosphatase staining visualiu, the acetylated tubulin positive 
a.'I[ons of the latera! line nerve tract (arrows) of a 72-bpf zebra fish. The 
plane of s~tioning in (S,C) is indicated. SC, spinal cord. (8) H«tron-
micrograph ortile posterior lateral line nerye ofa 12-hpfzebrafish. Trans-
verse se.;tion through the latera! line nerve lract of a ll-hpfzebrafish. The 
nucleus of an epineural cell is indicated v.ith a star, Arro\\heads point at 
closely apposed myelin membrane-;:. (C) immuno\oca\iz.ation of 0.:1--6 
expressing cells. Transvuse 50:<;11011 at the anterior-posterior !e\'d indi-
cated in (B) through a 3-day-eJd ubrafish. o.::t-6 e:o;pressing nuclei 
(green fluorescent signal) are seen closely associated \\ith acetylated tubu-
lin po;;itive a'wns (red fluorescent signJI) of the lateral line ner ... e tract 
(arrows). o.:t·6 positive (ells are also seen in the neural tube and epider-
mis. NO, notochord; NT, neural tube. 
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Does GC pressure actually facilitate the expansion of 
amino acid sequences during evolution? The cloning of 
the zebrafish and chicken Oct-6 genes allowed us to test 
this hypothesis. We compared the amino acid sequences 
of the zebra fish, Xenopus, chicken and mouse Oct-6 pro-
teins and the GC content at the first, second and third codon 
position of the POU domain and the entire coding region 
(Fig. IC). The zebrafish Oct-6 (zp-50) gene is, like the 
Xenopus .. Ipolt] (OCI-6), GC-poor and the predicted zebra-
fish Oct-6 protein lacks long simple amino acid repeats. In 
contrast, the chicken Oct-6 gene is very GC-rich, like the 
mammalian Oct-6 genes, but the predicted chicken Oct-6 
protein lacks extensive amino acid repeats. Thus, the corre-
lation between a high GC content in the gene and the pre-
sence of amino acid repeats in the protein sequence breaks 
down when the chicken gene is included in this analysis. 
Therefore, GC pressure alone does not seem to be sufficient 
to allow or to facilitate the evolution of amino acid repeats 
suggesting a second requirement which is met in mammals 
but not in birds. 
3.2. FunctiOllal cOllsen'ation of the Ocl-6 POU domain 
proteills in emIl/lion 
Although the primary amino acid sequence comparison 
of the zebrafish, chicken and mouse Oct-6 proteins identify 
them as the structural homologues of the mammalian Oct·6 
proteins it is not evident from such a comparison that they 
also represent the functional homologues. In this context it 
is of note that the frog and zebrafish Oct·6 proteins are more 
homologous to each other (85%) than the mouse and 
chicken proteins are (73%). This is rather surprising as the 
fossil record suggests that the birds and mammals have a 
longer shared evolutionary history than the fish and amphi-
bians (Colbert, 1969) and is corroborated by the phyloge-
netic relationship of many conserved regulatory genes such 
as sonic hedgehog (shh) andgoosecoid (gsc). The avian and 
mammalian shh and gsc proteins show higher homology 
than the amphibian and zebrafish proteins (data not shown 
and De Robertis et ai., 1994; Fietz et al.. 1994). Thus, the 
relationship of the vertebrate Oct-6 proteins as illustrated in 
Fig. 1 D could suggest functional divergence of the Oct-6 
genes in the fish and amphibians which could have retained 
or acquired certain functions that are lost or taken over by 
other closely related class III POU proteins in mammals and 
birds or their common reptilian ancestor. Consistent with 
this possibility is the observation that the embryonic expres-
sion patterns of the frog, fish and mouse genes are diverged. 
For example the zp-50 (zfOct-6) gene is expressed in hind· 
brain in a rhombomere 3· and 5-specific fashion while the 
mouse Oct-6 gene is expressed initially throughout the hind-
brain, is then progressively restricted to the posterior part 
and is later expressed in certain nuclei such as the facial 
nuclei. However, there is also substantial overlap in expres-
sion in these two vertebrates: Oct-6 is highly expressed in 
the rostral diencaphalon in 9.5 and 10.5 dpc mouse embryos 
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and zebrafish at equivalent stages, bOlh overlapping with 
shh expression (Hauptmann and Gerster, 1996; Zwart et 
a!., 1996). Also, in frogs and mice, the xlpoul and Ocl-6 
genes are both expressed in skin (Agarwal and Salo, 1991). 
Thus, both the structural and the expression data are con-
sistent with the possibility thaI the Oct-6 homologues serve 
conserved and diverged functions in vertebrate develop-
ment. Indeed, extensive overlap in expression patterns of 
the closely related class III POU genes does provide a fair 
degree of redundancy allowing for the diversification of 
expression patterns and function of the individual class III 
genes in different vertebrate species. For example, while 
both the frog and mouse, but not zebrafish, Oct·6 gene is 
highly expressed in skin, genetic evidence in mice suggest 
that Ocl·6 function in skin is redundant (Andersen et aI., 
1997). Therefore, when considering whether the chicken 
and zebmfish Ocl-6 genes represent functional homologs 
of the mammalian Oct·6 gene it is relevant to examine 
and compare the expression of these genes in those cell 
lineages in which the gene plays a pivotal role. We therefore 
examined the expression of the chicken and zebrafish Ocl·6 
proteins in peripheral nerve development. 
In all higher vertebrates, Schwann cells originate from the 
multipotent neural crest and proliferate and differentiate in 
intimate contact with the outgrowing axon (Jessen and 
Mirsky, 1992). The generation and survival of Schwann 
cells relies on axonally derived neuregulins and their recep-
tors expressed on the Schwann cell membrane (Shah et a!., 
1994; Riethmacher et a!., 1997). Schwann cell precursors 
differentiate through a series of well defined stages to give 
rise to the two mature phenotypes observed in the adult 
nerye; myelinating Schwann cells associated with one 
large caliber axon and non-myelinating cells esheathing 
multiple lower caliber axons (Mirsky and Jessen, 1996). 
Oct·6 is not expressed in the neural crcst but is induced in 
the Schwann cell precursors, is upregulated in premyelinat-
ing cells reaching maximum levels when Schwann cells 
cease to proliferate and establish a I: I myelinaling relation-
ship (promyelin stage) with large caliber axons or ensheath 
mul!iple small axons. Oct·6 expression is subsequently 
extinguished in the tenninally differentiating Schwann 
cell (Scherer et aI., 1994; Blanchard et a!., 1996; Jaegle 
and Meijer, 1998). Mice carrying a null mutation for the 
Ocl-6 gene show a marked delay in peripheral nerve matura-
tion with Schwann cells transiently arrested at the promye-
lin stage suggesting that Oct-6 is a positive regulator of 
genes important for the transition from promyelin into 
actively myelinating cells (Benningham et a!., 1996; Jaegle 
et al., 1996). Thus like other vertebrate POU genes Oct-6 is 
involved in lineage progression but not in lineage determi· 
nation. The chicken Oc/-6 gene is similarly regulated as the 
mouse gene; the gene is induced in Schwann cell precursors, 
upregulated in premyelinating cells and extinguished in 
myelinating cells, strongly suggesting conservation of 
gene function and of the mechanism by which the gene is 
regulated. Also, the zebrafish OCI·6 gene is highly expressed 
in Schwann cells of the developing peripheral nerve at a 
time that these cells start myelination, analogous to what 
is observed in mouse and chick. By what mechanism Ocl-6 
expression is regulated in the Schwann cell (ineage is at 
present unknown although in vitro experiments have sug-
gested that the cAMP-PKA pathway is important for the 
upregulation ofOct-6 in immature cells but in vivo evidence 
for a role of cAl\-lP is lacking (Monuki et aI., 1989). 
Recently we have identified a region in the mouse Ocl·6 
locus that direct Schwann cell-specific expression in trans-
genic mice (W. Mandemakers and D. Meijer, unpublished 
data). The isolation of the functionally equivalent region 
from the chicken Ocl-6 locus and DNA sequence compar-
ison will allow the identification of potentially important 
nuclear factors involved in the activation and regulation 
of the gene and will be helpful in further functional dissec-
tion of this DNA region. This type ofphylogenelic approach 
to dissect gene regulatory mechanisms has been highly sue· 
cessful, for example, in the elucidation of the mechanism by 
which Hoxb-l expression in rhombomere 4 is regulated 
(Popper! et al., 1995). 
On the basis of the comparative data presented here we 
conclude that the chicken and zebra fish Ocl-6 genes repre-
sent the homologs of the mammalian Oct-6 gene. This work 
provides the basis and the tools for a further comparison in 
expression pattern in these different vertebrates, in particu-
lar in the brain, identification of conserved regulatory 
mechanisms and functional studies across largc cvolution· 
ary distances. 
4. Materials and Methods 
4.1. Cloning of zebrajish alld chicken Ocl-6 genes 
Genomic phage libraries of chicken (Clontech CLlOI2J) 
and zebrafish (a kind gift from Barbara Jones and Martin 
Petkovich) were screened with a mouse Oc/-6 fragment 
encompassing the POU domain. DNA from strongly posi-
tive clones was used as a template in a polymerase chain 
reaction (PCR) with fully degenerate primers. These pri· 
mers correspond with the FAKQFK and the WFCNRR pep· 
tide sequences within the aminoterminal POU domain and 
the carboxytenninal homeodomain, respectively_ Amplified 
fragments were doned and sequenced. Clones that showed 
the highest homology to the mouse Oct·6 POU domain were 
further characterized by restriction fragment analysis and 
sequencing. 
4.2. Tran5aclimtfon assay 
HeLa cells were transfected with 15}-tg reporter plasmid, 
2}-tg reference plasmid and 3 JIg of the POU factor expres-
sion plasmid using the DEAE-Dextran procedur-c of Holter 
et al. (1989). The reporter, reference and CMV based 
expression vectors were all obtained from the Schaffner 
lab (Muller et al., 1988). The reporter plasmid consists ofa 
consensus oefamer site directly upstream of the rabbit {3-
globin gene (OCTA(2) (Muller et al., 1988» and an SV40 
enhancer downstream. A plasmid in which the octamer site 
was mutated was used as a control for oclamer dependent 
transaclivation (Octa{A». Cells were harvested 30 h after 
transfeelion. RNA was extracted with the lithium/urea 
method of Auffray and Rougeon (Auffray and Rougeon, 
1980). Aller the removal of any residual plasmid DNA 
with Dnasei, 10 p.g RNA was hybridized to a 32P-1abeled 
SP6 RNA polymerase generated RNA probe that spans posi· 
lion -37 to + 179. Hybridization products were digested with 
5 units Rnasel (Promega) at 37°C for 30 min and separated 
on a 6% polyacrylamide/8 M urea gel. 
Expression vectors encoding full length or aminotenninal 
truncations of zebrafish and chicken Oct·6 protein werc 
generated by cloning different restriction enzyme fragments 
in frame in the appropriate pEVRF plasmid (Matthias et aI., 
1989). Overexprcssion of the proteins in COS cells and 
bandshift experiments were done as described previously 
(Meijer et ai., 1992). 
4.3. Generatioll of antibodies againsl chicken alld zebra fish 
Ocl-6 
A 670-bp NcoI-Asp7IS genomic fragment encoding the 
aminotenninal part of the chicken Oct-6 protein was cloned 
in frame in the IPTG inducible bacterial expression plasmid 
pQE9 (QIAGEN). This creates a fusion Oct-6 protein with 6 
Histidine residues at its aminoterminus. O\'Crexpression in 
E. coli MIS and purification of the protein was done as 
described (QIAGEN), Purified protein was resuspended in 
Freund's incomplete adjuvants and injected into New Zeal-
and white rabbits. Serum was collected after the fourth 
immunization. The same protocol was followed to raise an 
antiserum against the zebra fish Oct-6 aminotemlinal 
domain (AA 1-134). 
I 
4.4. Immunohistochemistry and eleclrolllllicroscopy 
Chicken sciatic ne[\les were dissected from chick 
embryos and young chicks at different slages of develop-
ment and fixed in 60% methanoIl3.7% para-fomlaldehyde 
(PFA). Zebrafish embryos were allowed to develop at 
2S.5°C and were staged according to Kimmel et al. 
(1995). Embryos were fixed in 4% PFA. After dehydration 
and paraffin embedding 6-Jlm sections were cut and 
mounted on gelatin coated microscope slides. Antibody 
incubations were perfonned in PBS/O.05% Tween·20/5% 
fetal calf serum. The primary antibody was used at a dilution 
1:200 (anti-chicken Oct-6 and zebrafish Oct-6) and incu-
bated overnight at room temperature. After extensive wash-
ing the sections were incubated for 2 h at room temperature 
with an fluorescein isothiocyanate (FITC) coupled goat-
anti-rabbit secondary antibody (Nordic). The anti-acetylated 
tubulin monoclonal antibody was obtained from Sigma. 
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Sections were viewed and photographed using a Zeiss con-
focal laser microscope or a Leica fluorescence microscope. 
Sciatic nerves to be processed for electronmicroscopy 
were immersion fixed in 1% gluteraldehyde, 3% parafor-
maldehyde in 100 mM sodium cacodylate buffer pH 7.2. 
After washing the nerves were incubated in a 1% osmium 
tetroxide solution, dehydrated and embedded in Epon. 
Ultra-thin sections were stained with uranyl-acetate and 
lead citrate. Zebrafish embryos were immersed in 2% par-
afonnaldehydell% gluteraldehyde in 100 mM cacodylate 
buffer pH 7.2. Sections were viewed and photographed 
using a Philips CMlOO transmission electron microscope. 
4.5. Western b/olling 
Protein extracts of COS cells expressing chicken Ocl-6 
and embryonic day 17 sciatic nerves were separated on a 
10% SDS-PAGE. Proteins were transferred onto nitrocellu-
lose by electroblotting. The blot was incubated in blocking 
solution (1.5% BSAfI.5% milk powder in Iris-buffered sal-
ine) for I h at room temperature. The first antibody incuba-
tion (anti-chicken Oct-6 serum No. 1907 1:500) was carried 
out o\'Cmighl in blocking buffer plus 0.3% honidet·40 
(NP40). After washing the blot extensively with blocking 
solution, the blot was incubated with peroxidase-conjugated 
swine-anti-rabbit IgGs in blocking buffer for 2 h at room 
temperature. The staining reaction was carried out using 
DAB (Aldrich). 
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Summary 
Genetic evidence suggests that the POU transcription factor Oct-6 plays a pivotal 
role as an intracellular regulator of SchwatUl cell differentiation. In the absence of Oct-6 
function Schwalm cells are generated in appropriate numbers and these cells differentiate 
normally up to the promyelin stage at which they transiently arrest. During peripheral nerve 
development Oct-6 expression is initiated in Schwann cell precursors and is strongly 
upregulated in promyelin cells. Oct-6 expression is subsequently extinguished in tenninally 
differentiating Schwaml cells. Thus, identification and characterisation of the DNA 
elements involved in this stage specific regulation may lead us to the signalling cascade and 
the axon-derived signals that drive Schwann cell differentiation and initiate myelination. 
Here we present experiments that aim at identifying such regulatory sequences. 
Introduction 
Continued reciprocal signalling between axons and associated glial cells govems 
the proper development, maintenance and regeneration of peripheral nerves. In the 
Schwaml cell this signalling results in modulation of transcriptional programs that direct 
processes like proliferation and myeliuation. Recently a number of transcription factors, 
such as Krox-20, Pax3 and Oct-6, have been implicated as important intracellular regulators 
of Schw31m cell differentiation (Bermingham et a!., 1996; Blanchard et a!., 1996; Jaegle et 
a!., 1996; Jaegle and Meijer, 1998; Kioussi et a!., 1995; Topilko et a!., 1994). Chief among 
those is the Oct-6 transcription factor. 
The Oct-6 transcription factor belongs to the POU-homeodomain family of 
transcriptional regulators. POU proteins are characterised by a 150-160 amino acid domain 
which can be subdivided in a carboxy terminal portion (the POU homeodomain) related to 
the homeodomain DNA binding proteins and an aminoterminal portion consisting of a 
variant helix-tum-helix motif that is a defining characteristic of this family of proteins (the 
POU-specific domain; Herr et a!., 1988). More than 13 mammalian POU genes have been 
characterised. Based on sequence similarities within the POU domain, POU genes can be 
subdivided into six subgroups or classes (Wegner et a!., 1993). Genetic experiments have 
suggested important roles for the different members of this class of transcription factors in 
the proliferation and differentiation of distinct cell types during development (Ryan and 
Rosenfeld, 1997). 
In early mouse development the Oct-6 gene is expressed in a highly dynamic, 
complex patten!, overlapping with other members of the class III POU gene family 
(Alvarez-Bolado et a!., 1995; Zwart et a!., 1996). At later, foetal stages of development 
Oct-6 expression is observed in specific subsets of motor and commissural Ileurons and 
oligodendrocytes in the spinal cord and hindbrain, different mid- and forebrain stmctures, 
skin and neural crest derived Schwaml cells (Blanchard et a!., 1996; Zorick et a!., 1996; 
Zwart, 1996). Genetic studies in mice have shown that the Oct-6 gene has an important role 
in the differentiation of Schwallll cells. In the absence of Oct-6 gene function Schwann cells 
fail to mature on schedule leading to a transient arrest at the promyelin stage and a 1-2 
\Veekdelayin theoiisetof myelitlation, while CNSmyelination is not affected 
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(Bermingham et ai., 1996; Jaegle et ai., 1996; Jaegle and Meijer, 1998; Weinstein et ai., 
1995). Oct-6 expression in the Schwann cell lineage is initiated in the Schwalm cell 
precursor, is lIpregulated in prcmyelinating cells reaching maximum levels when Schwann 
cells cease to proliferate and establish a I: I myelinating relationship with large calibre 
axons or ensheath multiple small aXOllS, Oct-6 expression is subsequently extinguished in 
the terminally differcntiating Schwann cells (Blanchard et ai., 1996; Levavasseur et ai., 
1998; Scherer et ai., 1994). A prominent role for the adenelyl cyclase-PKA signalling 
pathway in the onset of terminal Schwann cell differentiation has been suggested. Oct-6 
gene expression is rapidly induced in cultured Schwann cells following administration of 
agents that increase intracellular cAMP concentrations (Monuki et ai., 1989). This 
indnction is shortly followed by that of a number of major myelin genes such as MBP and. 
PO. Furthermore, Oct-6 expression in oligodendroglia cell lines can be modulated by 
estradiol and anti-estrogens suggesting that Oct-6 is a key component in the estrogen 
regulation of myelination in vivo (Renner et ai., 1996). 
Thus, it is anticipated that the highly dynamic and diverse expression paltem of 
the Oct-6 gene is mediated through a mosaic of cis-regulatory elements within the Oct-6 
locus that alone, and in combination, respond to different intra-cellular signalling pathways 
and drive or repress expression in specific cell types. In this paper we describe experiments 
aimed at identifying of the minimal sequence requirements for Schwann cell specific 
expression of the Oct-6 gene. 
Results 
The promoter region of the Oct-6 gene is in a DNAseI hypersensitive chromatin 
configuration. 
The chromatin structure of promoter and enhancer regions of actively transcribed 
genes is often hypersensitive for nucleases, \vhile the entire transcribed region and beyond 
shows an increased generalised sensitivity when compared with non transcribed genes 
(Gross and Garrard, 1988; Svaren and Chalkley, 1990). This DNAse! hypersensitiyity 
reflects the accessibility of the DNA in vivo for nucleases and other molecules like 
transcription factors. ThusJ the presence of hypersensitive sites within a region of interest is 
taken as a first indication of the presence of important cis-acting regulatory sequences. 
The mouse Oct-6 gene is a single exon gene located on the distal arm of 
clll'omosome 4 (Hara et aI., 1992; Kuhn et aI., 1991). The entire transcription unit is 
contained within a 7kb EcoRl restriction fragment. This fragment contains 1.5 kb of 
upstream and 2.5 kb of downstream sequences. We probed for the presence of DNAse! 
hypersensitive sites within this 7 kb EcoRl fragment in chromatin of Oct-6 expressing cells 
versus non-expressing cells. For our analysis we choose embryonic stem (ES) cells and 
Tr6B (a mouse Schwannoma cell line) for Oct-6 expressing cells and MES cells (a 
mesoderm-like cell line ) for non-expressing cells. Nuclei of these cells were incubated with 
increasing amount of DNAse!. DNA was extracted from the nuclei, digested with 
re.slriClion.enzymes and separaled . on.agarose gels. South em .. blots. !lfthese. gels. were 
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hybridised with two distinct probes for identifying hypersensitive sites upstream and 
downstream of Oct-6 coding sequences (Figure 1). Probe a detects an EcoRIlXhoI DNA 
fragment of 2.9 kb that disappears with increasing DNAse! concentration. One major band 
of 1.5kb and two minor shorter bands appear and disappear again with increasing DNAse! 
concentration. Thus, a major DNAseI hypersensitive site maps around 150bp upstream of 
the transcriptional start site. This hypersensitive site was also detected in the mouse 
SchwamlOma cell line Tr6B (data not shown). Probe b detects a 4.1 kb EcoRIlXho! 
restriction fragment that gradually disappears with increasing DNAse! concentration. No 
shorter fragments appear indicating that there are no additional hypersensitive sites in the 
3"part of the Oct-6 gene up to the EcoRi site. The presence of the promoter associated 
DNAse! hypersensitive site detected with probe a correlates with the active state of the 
gene in ES and TR6B cells as it is not detected in the non-expressing cell line MES (Figure 
1). No other hypersensitive sites were detected in this 7 kb restriction fragment. 
A 
B 
Mouse Oct-6 gene 
~~ ~~. ~ '" ~ is ft J:f c;. c;. J? :f 
" " II I ! .. 
a b 
ES Cells ~ 
ik ~ "1.5kb 
EcoRllXhol 
probe a 
EcoRl/Xhol 
probe b 
1 kb 
"'~ &:0-l;ff ~·s JJ? ",<, 
II I I 
EcoRl/Hindlll 
probe a 
Figure 1. Mapping DNAsel hypersensitive sites within the Illouse Oct-6 gene. Panel A shows the genomic 
organisation of the Oct-6 gene and the position of the probes used (a and b). The DNAseI hypersensitive site is 
indicated with a vertical arrow. Panel B DNAsel fade-outs. Southcm blots of restriction enzyme digested DNA 
isolated from DNAseI treated ES cell nuclei were probed with the probes indicated in panel A. MES cell DNA 
was digested with EeoRI and HindIII. 
The Oct-6 promoter is not cell-type specific. 
The DNA sequence of the mouse Oct-6 gene promoter region was determined 
(Figure 2) and was found to be highly homologous to the rat Oct-6/SCIP gene promoter 
(Kuhn et a!.. 1991). The position of the transcription initiation site is indicated with an 
arrow. The sequence of the Oct-6promoteris extremely rich in the dinucleotide epG,as is 
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the entire 5' region of the Oct-6 gene. Thus the gene is located in a CpO island of 
approximately Ikb. Indeed this region is undermethylated in expressing and non-expressing 
cells (data not shown). The Oct-6 promoter has all the hallmarks of a strong basal promoter 
(Muller et aI., 1988). Around -30bp with respect to the transcription initiation site there is a 
TATA-Iike sequence and at -90bp there is a canonical CCAAT box. A computer search 
identified a number of additional putative transcription factor binding sites. Not 
unexpectedly there are at least eight consensus binding sites for the Spl, and Krox-20 
family members. In addition there are two consensus AP-2 binding sites. No cAMP 
response elements are present in the promoter region. However it has been reported that 
cAMP induction of gene expression can be mediated through AP-2 (Imagawa et aI., 1987). 
The presence of two AP-2 sites could therefore contribute to the cAMP inducibility of the 
Oct-6 gene in Schwann cells following administration ofForskolin. 
To test whether the Oct-6 promoter region contains all the information for cell-type specific 
expression of the Oct-6 gene we tested several promoter deletion constmcts by transient 
transfection of ES and MES cell lines. The promoter deletion constmcts, driving a CAT 
reporter gene are depicted in Figure 2. The activity of the various promoter constructs was 
measured in a CAT assay using cell extracts of transiently transfected cells (Figure 2B). 
The longest promoter constmct (6) tested contains all of the DNAsel hypersensitive sites 
and is active in ES cells. Activity is retained in mutants 4 and 5 but drops shaIply (5 fold) 
when the promoter is Ihrther deleted to mutant 3 and is completely lost in construct I and 2. 
Thus, the region between -90 and -160 contribute significantly to the activity of the Oct-6 
promoter. This region also contains the strong DNAseI hypersensitive site. However, these 
promoter constructs have a similarly high activity in MES cells, which do not express the 
endogenous Oct-6 gene. Also, these constructs do not show increased activity following 
Forskolin administration to the medium suggesting that the AP-2 site is not involved in 
cAMP induction of the Oct-6 gene (data not shown). Thus, the Oct-6 promoter constmcts 
do not show tissue specificity suggesting that important (negative?) regulatory elements are 
missing or that transient assays are not suitable for analysing the Oct-6 promoter. 
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Figure 2. Functional dissection of the Oct·6 
promoter. Panel A. Schematic depiction of 
the Oct-6 promoter CAT gene constnlcls. 
The positions of putative transcription factor 
binding sites are indicated. The various 5' 
tnlllcations of the promoter are indicated 
with arrows and their numbers correspond 
with those in panel 8. Panel B. CAT assays. 
RSV is Ihe Rous sarcoma vims promoter 
and 6Wtk is the minimal HSV TK gene 
promoter as present in pBLCA T2 with a 
multimcrized IgH enhancer upstream. The 
6Wtk promoter is strongly expressed in 
unditlerentiatcd ES cells but is less active in 
the MES cell line (Scholer et aI., 1989). The 
reverse is true for the RSV nromoter. 
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Regulatory sequences important for Schwann cell specific expression of the Oct-6 
gene are located at considerable distance from the Cap site of the gene. 
In order to further characterise the regulatory sequences of the Oct~6 gene we 
generated transgenic mice carrying constmcts with different sequences of the Oct-6 locus 
(see Figure 3). To conveniently analyse tissue-specific expression of the transgcnc, we 
inserted a bacterial LacZ gene in-frame in the Oct-6 coding sequence. This allowed us to 
examine transgene expression using a simple enzymatic staining reaction. We limited our 
analysis here to the Schwam! cell lineage. Two different DNA constructs were generated 
covering up to 32 kb of the Oct-6 gene locus. We either generated transgenic lines or 
analysed transgenic founder embryos at embryonic day 18. The first construct we analysed 
was the 7kb EcoRI fragment. Two transgenic lines and two founders were analysed. 
Although the transgene was expressed in all four transgenic animals, no expression was 
detected in the Schwam! cell lineage. Expression was found mainly in the brain, in a pattern 
that was not consistent among the different transgenic lines. Most likely these expression 
patterns are a consequence of the transgene integration site in the different mouse lines. 
Thus, this 7 kb trans gene does not contain enough sequence information to direct Schwann 
cell expression. 
We next generated transgenic mice with a construct that contains IS kb of 5' upstream 
sequences and 15 kb downstream of the gene transcription initiation site (Figure 3). Three 
transgenic lines were generated with this particular construct. All three lines expressed the 
transgene with varying expression patterns during embryonic development. Expression was 
mainly observed in the brain and overlapped in the midbrain area with the endogenous Oct-
6 protein. However, the transgene was consistently expressed in all three lines in the 
Schwam! cells of neonatal animals. Expression was observed in E 18 embryonic sciatic 
nerves (Figure 3, bottom panel) but not in EI6 nerves indicating that expression (as assayed 
here) is induced in Schwann cells between EI6 and E18. Also, heterozygote Oct_6+IL"z 
embryos show LacZ expression from Bl6 onwards, indicating that the transgene is 
expressed slightly later than the endogenous locus as assayed with X-gal staining (data not 
shown). 
§?;::. ~ 9:",.. ~ t/;f~ 4./ 4 
-------'-----'----"t!S: II 
LacZ 
7kb 
Schwann cell 
expression 
32kb--____________ _ 
0/5 
3/3 
Figure 3, Schwann cell specific 
regulatory sequences of the mouse 
Oct-6 10cus.The genomic 
organisation of the mouse Oct-6 
gene and the transgenic cons.tructs 
used here are schematically shown. 
The bacterial LacZ gene was fused 
in frame with aa 20 of the Oct-6 
ORF. The LacZ portion does not 
carry any transcriptional 
temlination sequences so that 
transcriptional temlinalion takes 
place at the normal Oct-6 
sequences. The photograph is a 
reprcscntative picture of hindlimb 
ner.'es of a EI8 transgenic embryo 
stained with X-gal. 
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Discussion 
In this report we have shown that the Oct-6 gene promoter is in a DNAsel 
hypersensitive chromatin configuration only in cells that express the Oct-6 gene. However, 
the Oct-6 gene promoter is equally active in expressing and non-expressing cells in 
transient transfection assays. This may not be surprising since the promoter is build up as a 
classical strong basal promoter with a TATA box, several CCAAT boxes and multiple GC 
boxes (Muller ct aI., 1988). These resuits indicate that this promoter is strongly repressed in 
non-expressing tissues as has been suggested previously (Zwart et aI., 1996). Our DNAsel 
mapping data suggest that repression is achieved by sequestering the promoter region in a 
non-accessible chromatin configuration. Thus, a mechanism could be envisaged in which 
the Oct-6 promoter, in itself non-tissue specific, is made available for interaction with 
ubiquitous factors resulting in transcriptional activation. How the chromatin configuration 
of the Oct-6 locus is regulated is unknown. A number of genetic loci have been described 
whose transcriptional output is under control of a 'locus control region' (LCR; Fraser and 
Grosveld, 1998). The best studied of these locus control regions is the LCR of the ~-globin 
domain. This LCR consists of a series of 5 DNAsel hypersensitive sites in a IOkb region 
upstream of the embryonic globin gene and is required for erythroid lineage-specific 
expression of individual genes within the locus. Strong evidence suggests that the LCR 
nlllctions as halo-complex directly interacting with the individual gene promoters to direct 
stage-specific expression of the genes (Dillon et aI., 1997). If a similar mode of regulation 
operates in the Oct-6 locus it is expected that additional DNAsel hypersensitive sites be 
present in the Oct-6 locus that are required for gene activity (see below). 
To begin to delineate the sequences required for Sc1l\vann cell-specific expression 
of the Oct-6 gene we generated a number of transgenic lines. The analysis of these mice 
indicates that the cis-regulatory sequences important for Schwallll cell-specific expression 
are located outside the 7 kb EcoR! fragment that contains the entire gene, but are included 
in the 32 kb cosmid clones. In preliminary experiments, we have mapped additional 
DNAsel hypersensitive sites within the 32kb genomic region. One of these sites 
corresponds to the previously described estradiol responsive enhancer located 5 kb 
upstream of the Oct-6 transcription initiation site. This enhancer was shown to mediate 
estradiol enhancement of the Oct-6 promoter driven transcription in cotransfection 
experiments with the estradiol receptor in oligodendroglia cell lines (Renner et aI., 1996). 
This observation is particularly interesting since estrogens influence myelination in vivo. 
Therefore, the estradiol mediated enhancement of Oct-6 transcription could be a key event 
in estrogen regulation of myelination. Whether this element is also important for initial glia 
cell-specific expression of the Oct-6 gene remains to be elucidated. Further deletion 
analysis of the 32kb genomic fragment will answer this question and will undoubtedly lead 
to the identification of the cis-acting element(s) involved in Oct-6 gene activation in the 
Schwann cell lineage. 
Expression of the 32kb transgene is correctly activated and extinguished in the 
Schwarm cell lineage. In addition, we have previously shown that down regulation of the 
Oct-6 locus in terminally differentiating Schwann cells is dependent, directly or indirectly, 
on Oct-6 itself (Jaegle and Meijer, 1998). This suggests two things: First, down regulation 
of Oct-6 in terminally differentiating cells is mediated through repression of the gene and 
not through the gradual disappearance of an activator. Second, down regulation requires 
Oct-6 itself. Whether activation and down regulation are .med.iated through the .same cis-
acting elenlc·nts remaills to ·be deterulitled. Such a mechanism has been shown to operate in 
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the Pit-I locus, a Class I POU gene. Separate enhancer sequences are responsible for initial 
Pit-l gene activation and for subsequent autoregulation (DiMattia et aI., 1997). The 
autoregulatory negative feedback loop in Oct-6 regulation sets au upper limit to the levels 
of the Oct-6 protein in Schwann cells but does not explain how the expression of the gene 
is completely extiuguished. One possible explanation is that Oct-6 activates expression of a 
factor that mediates repression through a remote silencer in the Oct-6 locus or through the 
Octw 6 promoter. In such a model of repression, Oct-6 gene expression is indirectly 
dependent on Oct-6. As repressiou of Oct-6 gene transcription is maintained in the adult 
nerve one has to assume that this repressor has either a very long half-life Of, alternatively, 
that maintained expression of this repressor is not dependent on the Oct-6 gene product. 
This latter possibility seems more attractive as Oct-6 gene expression is quickly resumed in 
denervated Schwann cells following nerve damage. Reactivation of Oct-6 gene expression 
in such reactive Schwalll1 cells could be accomplished through silencing of this 
hypothetical repressor. Such a mechanism could also explain the observation that Oct-6 
expression is not down regulated for at least two months following nerve damage. Taken 
together, our data are compatible with a mechanism by which Oct-6 down regulates its own 
expression in an indirect ,,,ay, through activation of a gene encoding a repressor that binds 
to an element in the 32 kb fragment. Critical testing of this hypothesis will require the 
identification of the silencing and cloning of the repressor that binds to it. 
Materials and Methods 
Mapping of DNAse I hypersensitive sites. 
Cultured cells (MES and CCE ES cells) were harvested and washed twice with 
ice-cold PBS. Cells were resuspended in 3 ml of ice-cold HS-buffer (l5mM Tris-HCI pH 
7.4, 60 mM KCl, 15 mM NaCI, 0.2 mM EDTA, 0.2 mM EGTA and 5% glycerol, 
'supplemented with I mM DTT, 0.15 mM spermine and 0.5 mM spermidine, just before 
use). The cells were disrupted by passing 5 to 10 times through a 25G needle. Examining a 
drop of the suspension under the phase-contrast microscope monitored the disruption 
process. Nuclei were collected by a brief centrifugation step at 2500 rpm and resuspended 
to a final concentration of approximately 5 x 10' nuclei per millilitre of HS buffer (the 
nuclei do not pack tightly after this centrifugation step. Limited DNAseI digestion of 
chromatin was carried out in a final volume of 500 III of HS buffer containing 5 x 10' 
nuclei, 5 mM MgCl, and DNAseI (Boehringer) varying in concentration from 0 to 400 
units. The reaction was incubated for 15 to 30 minutes on ice, stopped by adding an equal 
volume of20 mM EDTA, I % SDS and 
100 Ilglml Proteinase K solution and the mixture was filrther incubated overnight at 45 'c. 
After phenol/chloroform extraction the DNA was precipitated with an equal volume of 
isopropanol. The DNA was dissolved in 200 III of TE buffer and restricted with different 
restriction enzymes. Restriction fragments were resolved on 0.8% agarose gels and blotted 
onto a nylon membrane. The blots were hybridised to the probes indicated in Figure I. 
All other methods are described in Sambrook et al. (1989). 
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LacZ transgenic constructs 
The LacZ reporter gene was isolated as a 3.4 kb BamHI fragment from plasmid 
p6IOZA in which the Dral site 60 bp downstream of the LacZ stop codon had been 
converted into a BamHI site. This fragment was ligated into the unique Nsil site of a 
subelone of the Oct-6 gene. The Nsil site was modified first by blunting and addition of 
BamHI linkers. This procedure resulted in the creation of a fusion gene encoding the first 
22 amino acids of Oct-6 followed by a threonine, introduced by the cloning procedure, and 
the LacZ open reading frame. The fusion gene fragment was subsequently e10ned into the 7 
kb EcoR! genomic fragment. This clone was extended at the 5' and 3' end with genomic 
fragments resulting in cosmid 2CosOct-6. The 7 kb EcoRI fragment was isolated by 
electroelution from agarose gels foIlowed by purification on an elutip mini column 
(Schleicher and Schull). The 32kb Sail fragment from cosmid 2CosOct-6 was isolated and 
purified on a NaCI gradient. Transgenic mice were generated using established methods. 
Tissues derived from these transgenic were processed for p-galactosidase staining 
according to (Popper! et ai., 1995) 
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Summary 
The POU domain transcription factor Oct-6 is transiently expressed in the 
Schwallll cell lineage and is a major regulator required for the timely progression of 
Schwaun cells through the promyelin stage. During nerve development and regeneration, 
expression of Ocl-6 is under control of Schwann cell-extrinsic axonal signals. Identification 
of the cis-acting elements necessaty for Oct-6 gene regulation is an important step in 
deciphering the complex signaling between Schwalm cells and axons govcl1ling 
myelination. Here we show that a fragment distal to the OCI-6 gene, containing two 
DNAseI hypersensitive sites, acts as the Ocl-6 Schwal1ll cell specific enhancer (SCE). We 
show that the SCE is sufficient to drive spatially and temporally correct expression, both 
during normal peripheral nerve development as well as during nerve regeneration. We 
further demonstrate that a trans gene carrying a tagged version of Ocl-6, driven by the SCE, 
rescues the peripheral nerve phenotype of Ocl-6 deficient mice. Thus, our isolation and 
characterization of the Ocl-6 SCE provides the first description of a cis-acting genetic 
element that responds to converging signaling pathways to drive myelination in the 
peripheral nervous system. 
Illtl'od uctioll 
The development and proper function of peripheral nerves in vertebrates depends 
on the intimate interactions and continued signaling between Schwalm cells and associated 
nerve fibre(s). The ontogenic origin of Schwallll cells, and other glial cell types in the 
peripheral nervous system (PNS), sllch as the satellite cells, the teloglia and enteric glia, is 
the neural crest, a transient migratory population of llluitipotent cells emanating from the 
dorsal aspect of the neural tube (Anderson, 1997; Le Douarin et aI., 1991). During 
embryonic development neural crest cells associate with and migrate along the outgrowing 
axonal bundles, acquiring Schwann cell characteristics. These SchWalm cell precursors 
proliferate, invade, bundle and sort the fibres of the embryonic nerve and this process 
continues until the SchWalm cells ensheath individual fibres and groups of fibres.Schwarul 
cells then cease to proliferate and commence to myelinate the larger axons, while non-
myelin forming cells further ensheath multiple lower calibre axons resulting in the mature 
Schwann cell phenotypes observed in the nerves of adult animals (Webster, 1993). 
In recent years, much progress has been made in identifYing components of the 
cell-cell interactions necessary in early stages of peripheral nerve development (Jessen and 
Mirsky, 1999). In contrast, very little is known about the extracellular signals and the intra-
cellular signalling pathways that initiate myelination, beyond the fact that axonal contact is 
a cOllditio sille qua 11011. Earlier pioneering work by Aguayo and colleagues (Aguayo et aI., 
1976; Aguayo et at, 1976), involving nerve transplantation and cross anastomosis 
experiments, have indicated that the myelination program of Schwann cells is under control 
of the associated axon and correlates with axonal diameter (Voyvodic, 1989). Although the 
formation of the basa I lamina by the Schwarul cell is required for myelination, the nature of 
the axonal signal that drives myelination by the Schwaml cell remains unclear (Bunge et a!., 
1990; Eldridge et aI., 1989). This signal must ultimately be relayed to the nucleus where 
transcription factors mediate this signaling by modulating of expression of distinct sets of 
genes, such as periaxin, myelin associated glycoprotein (MAG), P-zero (Po) and cOllllexin 
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32. Expression of these genes both characterises and drives the myelination process by the 
Schwann cell. 
Of particular interest are the transcription factors Krox-20 and Oct-6 which are 
pivotal in the regulation of the transcriptional program that drives myelination 
(Bermingham et a!., 1996; Jaegle et a!., 1996; Topilko et a!., 1994). Neither of the two 
genes is expressed in the neural crest. However, within the sciatic nerve of the mouse 
Schwaml cells begin to express appreciable levels of Ocl-6 from embryonic day 16 onwards 
(Blanchard et a!., 1996, and tlus paper). Expression levels peak around birth, after which 
expression is gradually extiuguished. Fully differentiated cells do not express the gene 
(Levavasseur et a!., 1998; Scherer et a!., 1994; Zorick et a!., 1996). This down regulation of 
Ocl-6 gene expression is dependent on the OCI-6 gene product itself and on myelination per 
se (Jaegle and Meijer, 1998). Krox-20 expression is induced shortly after the first 
appearance of Oct-6 and becomes restricted to the myelinating lineage in which expression 
is maintained into adulthood (Topilko et a!., 1997; Zorick et a!., 1996). Expression of both 
genes is regulated by axonal contact. Following nerve crush and Wallerian degeneration, 
whcn axonal contact is disrupted, reactive Schwann cells extinguish Krox-20 expression in 
denervated nerves. During nerve regeneration, axonal contact with Schwarm cells is 
restored and Ocl-6 expression is rapidly re-induced, and subsequently followed by Krox-20 
induction (Scherer et a!., 1994; Zorick et a!., 1996). In fully regenerated nerves OCI-6 
expression is dowmegulated while Krox-20 expression remains high. Thus, both in 
development and regeneration SchWalm cell differentiation from early- to late 
promyelinating to myelinating stages corresponds with the phenotypic progression from 
Oct-6+/Krox-20-, to Oct-6+/Krox-20+ to Oct-6-/Krox-20+. 
Analysis of postnatal sciatic nerve development in Krox-20 and Ocl-6 null mice 
indicates that both genes are required for normal progression of Schwann cell 
differentiation through the promyelin stage and initiation of the myelination program. In 
both genetic mutants Schwann cells appear morphologically arrested at the promyelin stage 
(Bermingham et a!., 1996; Jaegle et a!., 1996; Topilko et a!., 1994). Ocl-6 null SchWalm 
cells eventually overcome this block and myelinate their associated axon normally, while 
Krox-20 null Schwann cells are permanently blocked at the promyelin stage. Induction of 
Ocl-6 expression in Schwann cells does not require Krox-20 gene activity as Oct-6 is highly 
expressed in Krox-20 null SchWalm cells (Zorick et a!., 1999). Ocl-6 and Krox-20 gene 
activity represent two subsequent steps in a genetic hierarchy that regulates progression of 
Schwann cell differentiation through the promyelin stage. Ocl-6 is the first transcription 
factor in this cascade responding to axonal signaling. Hence, it is of importance to 
understand how this regulator itself is regulated. 
As a first step in the systematic dissection of the regulation of Ocl-6 gene 
expression during Schwal1l1 cell development, we set out to define the cis-acting genetic 
elements in the Ocl-6 locus involved in the temporal and Schwann cell specific expression 
of the gene. Through DNAseI hypersensitive site mapping and deletional analysis in 
transgenic mice we identifY a fragment, located approximately 12 kb downstream of the 
Ocl-6 stmctural gene, that is sufficient to activate temporally COlTect expression in the 
Schwann cells of transgenic mice. Thus, Schwann cell specificity resides solely within this 
DNA fragment which we named SCE for Ocl-6 Schwallll cell-specific enhancer. 
Furthennore, we show that the SCEIOcl-6 promoter driven transgene is downregulated in 
myelinating cells and re-induced in reactive SchWalm cells of regenerating nerves following 
nerve crush. In addition, we are able to rescue the temporal delay in SchWalm cell 
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differentiation in Ocl-6 null mice by a hemaglutinin (HA)-tagged Ocl-6 gene expressed 
under control of the SCE. 
Results 
A chromatin region spanning 45 kb of the Oc/-6 locus contains 8 DNAseI 
hypersensitive sites. 
The mouse Oc/-6 gene is a single exon gene located on the distal arm of 
chromosome 4. The entire 3kb long transcription unit is contained within a 7 kb EcoRl 
DNA fragment and the promoter and 5' part of the gene is located in a CpG island. 
Previously, we have shown that the Ocl-6 gene promoter is highly active in transient 
transfection assays irrespective whether the transfected cell expresses endogenous Oc/-6 or 
not (Mandemakers et aI., 1999). In addition, this promoter does not drive specific 
expression of a reporter gene in transgenic mice. These preliminary experiments suggested 
that important regulatory elements are located outside the promoter region. 
To begin a systematic dissection of the regulatory sequences within the Ocl-6 
locus we first cloned and mapped an extensive region flanking the mouse Oc/-6 gene 
(figure 1A). Single copy DNA probes were isolated from this region and used to detect 
DNAsel hypersensitive sites (HSSs) within chromatin of Ocl-6 expressing versus non-
expressing cells and tissues. HSSs are often found in the vicinity of promoter and enhancer 
regions of transcriptionally active genes and represent nucleosome free sites in chromatin 
that are readily accessible to regulatory proteins (Felsenfeld et aI., 1996; Gross and Garrard, 
1988; Svaren and Chalkley, 1990). Thus, mapping HSSs within chromatin of the Ocl-6 
locus will reveal the position of DNA elements potentially involved in regulated OCI-6 gene 
expression. 
We analysed Ocl-6 expressing embryonic stem (ES) cells, MES-68 (an adenovirus El 
region transform P19 embryonic carcinoma cell derivative), TR6B (a mouse Schwannoma 
cell line; Fields et aI., 1975) and adult mouse brain and non-expressing mouse liver and the 
MES-1 (a P19 derivative) cell line. Nuclei from mouse cells were prepared and treated with 
DNAseI. The presence of HSSs in chromatin is revealed by the appearance of discrete 
hybridizing bands on Southern blots with increasing DNAseI concentration (Figure lB-E). 
For example, HSS-8 is detected with probe #9 in chromatin ofMES-68, ES cells and brain, 
all of which express Ocl-6, but not in liver and MES-l cells, which do not express Ocl-6. 
The absence of HSS-8 in chromatin of liver cells indeed cOlTelates with the expression 
status of the OCI-6 gene in these cells and is not simply due to limited DNAseI digestion as 
the albumin enhancer associated HSS is readily detected in the same liver DNA samples 
(Figure C). 
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Figure 1 DNAseI hypersensitive site 
mapping in the mouse Oct-6 locus. (A) 
Map of the mouse Oct-6 locus. Several 
diagnostic restriction enzyme recognition 
sites used to dctcnnine the positions of the 
DNAseJ hypersensitive sites are indicated. 
Black arrows and numbers above the locus 
indicate the positions of the corresponding 
HSS. The small bars below the map (#15 
and #9) show the probes that were used for 
the HSS mappings presented in panels B, 
0, and E. (B) Mapping of HSS-8 in various 
cell lines and tissues. DNAseI treated 
samples were digested with Slur, separated 
by agarose gel electrophoresis, blotted and 
hybridiscd with probe #9. The band 
demonstrating the presence of HSS-8 is 
indicated with a black arrow. This band is 
absent in untreated samples (0), but 
emerges with increasing intensity in 
samples treated with increasing amounts of 
DNasel (indicated by the triangle above the 
panels). The position of the HSS in the 
Oct-6 locus was deduced from the size of 
the emerging fragment and the position of 
the probe. All positions were verified with 
different digests or different probes. HSS-8 
could only be detected in Oct-6 expressing 
cells. (C) The same samples for ES cells, 
brain and liver and the same procedure as 
described for panel B were uscd to verify 
whether any HSS could be detected in the 
Iivcr series. Southern blots with EcoRI 
digested DNA were hybridized with a 
probe derived from exoll I of the mouse 
a/bumill gene, to resolve the prcviously 
identified HSS coinciding with the gene 
promoter region (Liu ct aI., 1988). The 
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baud coinciding with this HSS was indeed only detected in the liver samples (black arrowhead). (0, E) These 
panels describe the mapping ofHSS-6, HSS-7, and HSS-8 in ES-cells and TR6B cells, respectively. Samples were 
digested with Hpa! and hybridised with probe #15. These panels show that in ES-cells HSS-6 and HSS-8 are the 
most prominent ones, while in TR6B cells HSS-7 and HSS-8 seem to be more sensitive than HSS-6. 
In total we mapped 8 HSS within. the Ocl-6 locus (Figure IA). The degree of DNAse! 
sensitivity of these sites differs from cell line to cell line. For example, in ES cells HSS-6 
is more pronounced than HSS-7, while in TR6B cells HSS-6 is less pronounced (also 
compare HSS-8 sensitivity in ES cells and MES-68 cells in Figure IB). The relative degree 
of sensitivity of the sites in different cell types is summarized in Figure I F. The relatively 
low sensitivity of certain sites in brain most likely reflects the great diversity of cell types in 
this tissue with only a small subset of cells expressing the Ocl-6 gene. 
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A Schwann cell specific enbancer resides in a DNA fragment containing two HSSs. 
The relevance of these HSSs for Ocl-6 gene regulation was tested in transgenic 
mice. The bacterial {3-galaclosidase gene was inserted in frame in the OCI-6 coding region 
of a 32 kb genomic DNA constmct containing all 8 mapped HSSs (constmct I: Figure 2). 
Three transgenic mouse lines were generated with this constluct. Mice from all three lines 
expressed the {3-galaclosidase gene in the Schwann cells of their peripheral nerves. In 
addition, expression of LacZ was observed in many other tissues where OCI-6 is nomlally 
expressed, such as brain and skin and in particular the hair follicles. Next we generated 
transgenic mice with a smaller consollct, lacking all HSSs except site I (constmct II). 
These mice do not express the trans gene in Schwann cclls, although variable ectopic 
expression is seen in other tissues. These results indicate that the element necessary for 
Schwann cell specific expression resides within the 32 kb region but outside the 7 kb EeoR! 
fragment containing the Ocl-6 stmctural gene. 
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Figure 2 Deletion analysis. A. Schematic representation oflhe mouse Oct*6locus as described in Fig.IA, \vith the 
deletion constructs drawn to scale below. The E.co/i ~galactosidase reporter gene (lacZ) was cloned in frame into 
the Oct-6 CDR in every construct, as indicated for construct I and described in Materials and Methods. The 
number of transgenic animals displaying X-gal staining in the peripheral nerves out of the total number of 
transgenics obtained is shown to the right of each construct. The dashed lines in constructs VI, VII, and VIII 
indicate the deleted region between the construct II and the downstream fragments that have been linked to it. B. 
Schematic representation of the mouse SeE hsp68-LacZ construct (IX) and the human SCE-LacZ construct (X). C. 
X-gal staining of peripheral nerves. Strong blue staining (dark grey in this picture) is observed in peripheral nerves 
(SN = sciatic nerve; leN = intercostal nerve) of huSCE-LacZ (X) transgenic animals, as shown here, and construct 
I. Ill, VI and IX transgenic animals (not shown). 
109 
Chapter 5 
Schwaun cell specific expression was now tested in founder animals, containing 
the other deletion constructs shown in Figure 2, at 18 days post coitum (dpc), a time at 
which Oct-6 is highly expressed in Schwann cells of the sciatic nerve. Construct III is 8 kb 
shorter than construct I at the 5' end of the gene and lacks HSS-4. This site was present in 
ES and MES-68 cells but absent in the Schwannoma TR6B, brain and liver. All three 
transgenic founders obtained with construct III express LacZ in the Schwmm cells of the 
sciatic nerve, indicating that HSS-4 is dispensable for Schwalm cell specific expression. In 
addition, these three transgenics expressed LacZ in the hair follicles. Injections of constl1lct 
IV, which contains only HSS-2 and HSS-I, yielded seven founder animals. None of these 
animals expressed the trallsgene in SchwaHll cells but five showed variable expression in 
the brain and no expression in the hair follicles. Two transgenic lines and one founder,. 
containing construct V, in which HSS-6, HSS-7 and HSS-8 are missing, express LacZ in 
the hair follicles. However, none of the construct V animals expressed the transgene in 
Schwarm cells. These results pointed to the 3' region encompassing HSS-6, HSS-7 and 
HSS-8, as the region containing the DNA elements necessary for Schwaml cell specific 
expression. From this region we isolated a 4.3 kb restriction fragment containing HSS-6 
and HSS-7 and cloned it downstream of the Oc/-6 structural gene in the Schwann cell non-
expressing construct n. We generated five founders and two lines with constmct VI. Four 
of the five founders and one of the two lines showed expression of the transgelle in the 
sciatic nerve. Two of these. founders expressed only in the nerves while the two other 
founders and the line also showed brain and neural tube expression. None of the transgenic 
mice expressed the trans gene in the hair follicles. In an attempt to further llarrow down this 
region, we generated two constructs that contain either HSS-6 (VII) or HSS-7 (VIII). Four 
founders were obtained for constl1lct VIII, none of which expressed in the Schwann cells of 
the sciatic nerve. Seven founders were obtained for construct VII of which only one 
expressed in the sciatic nerve. In summary, these results show that a 4.3 kb fragment, 
containing HSS-6 and HSS-7 and located about 12 kb downstream of the Oc/-6 
transcription initiation site, is sufficient to drive transgene expression from the Ocl-6 
promoter. We now refer to this fragment as the Oc/-6 Schwarm cell enhancer (SCE). 
The Oct-6 SCE confers Schwal1ll cell specificity on the non-cell type specific hsp68 
promoter 
Although the 4.3 kb SCE is sufficient for Schwaml cell specific expression of the 
transgene, it is possible that specific Oc/-6 promoter proximal elements contribute to the 
SchWalm cell specificity of these transgenic constmcts. To test this we generated a 
construct in which the SCE is linked to the mouse minimal heat shock protein 68 (hsp68) 
gene promoter (constmct IX in Figure 2B). This promoter contains a TATA-box, a SPI 
site, a CCAA T box and three heat shock response elements downstream of the transcription 
initiation site. Others have shown that transgenic mice carrying hsp-68 promoter driven 
trans genes show expression patterns that differ from Jine to line, its specific pattern 
depending on the site of integration (Kothary et aI., 1989; Rossant et aI., 1991). We 
generated 3 lines and 6 founders with constmct IX. One of these lines and five founders 
express the transgene in the Schwalm cell lineage indicating that the SCE enhancer contains 
sufficient information to drive Schwallll cell specific expression from a basic promoter. 
Thus, it is unlikely that Oc/-6 promoter proximal elements contribute to full enhancer 
function oftheSCR 
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The SeE is conserved in humans 
The Ocl-6 gene is highly conserved among vertebrates and we have previously 
shown that the chicken and zebratish Ocl-6 genes arc expressed in Sehwann cells of both 
species (Levavasseur et aI., 1998). We also showed that the dynamics of Oct-6 expression 
in the chick Schwann cell lineage is identical to that in mouse and rat, suggesting 
conservation of regulatory mechanisms as well. We took advantage of the relatively short 
evolutionary distance between man and mice to isolate from a human cosmid library clones 
that cover the 3' part of the human Ocl-6 gene. We generated an extensive restriction map 
of this region and isolated a 5 kb DNA fragment that cross-hybridizes to probe # 15 and 
which we tentatively named human SCE (data not shown). This fragment was cloned in 
construct II, to generate construct X (Figure 2B) from which three transgenic lines were 
established. All three lines expressed the transgene at high levels in Schwann cells of the 
peripheral nerves (Figure 2C) indicating that the homologous human sequence has the same 
functional properties as the mouse SCE, corroborating the suggestion that Ocl-6 regulatory 
mechanisms in the Schwann cell lineage are conserved. 
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Figure 3 Developmental expression of 
reporter gene activity in sciatic nerves of 
Ocl-trg"o.'+ and SCE-LacZ mice. Sciatic 
nerves were isolated at various 
embryonic (E) and postnatal (P) stages, 
and stained for l3-gaiactosidasc activity. 
Whole mount X-gal stained sciatic 
nerves from Ocl_6fJ-g,u'+ animals are 
presented in panels A, C, E, G, I. and K. 
SCE-LacZ nerves are shown in B, D, F, 
H, J, and L. Strong X-gal staining is 
dark grey; no staining is white. Low 
levels of exprcssion could be dctcctcd at 
EI6 in both mouse Jines (A, B). High p-
galactosidase expression is observed 
between Et8 and Pl4 in both lines (C-
H). At P32 few expressing cells could 
still be detected in the SCE-LacZ line 
(J), while X-gal staining was absent in 
the sciatic nerves of Oct_6fJ-g·u'+ animals 
of the same age (I). LacZ expression 
could not be detected in ncrves of adult 
animals from both lines (K, L). Scale 
bar for each panel is JOO 11m. 
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The SCE is sufficieut to drive temporally correct expression in the Schwann cell 
lineage. 
Thusfar, our analysis has established that the Ocl-6 SCE is sufficient to induce 
expression in the Schwaml cell lineage. We then asked whether the SCE directed 
expression is also temporally correct and importantly, whether the SCE also mediates 
downregulation of the reporter gene in cells which have exited the promyelin stage. Within 
the Schwaml cell lineage of the mouse, Oct-6 protein expression can first be detected, using 
sensitive Oct-6 antibodies, in Schwann cell precursors that populate the sciatic nerve 
around embryonic day 12/13 (Blanchard et aI., 1996). Ocl-6 expression is strongly 
upregulated at later embryonic stages, peaks during early postnatal stages and is 
extinguished in fully differentiated cells. Previously, we and others have described the 
inactivation of the mouse Oct-6 locus by insertion of a {3-galactosidase-lleomycin fusion 
gene (f3-geo) (Benningham et aI., 1996; Jaegle et aI., 1996). Expression of this fusion gene 
can be easily visualized in the developing embryo using the X-gal substrate, and 
recapitulates the Oct-6 expression profile as determined with Oct-6 specific antibodies and 
Ocl-6 cRNA ill silu hybridization (see; Arroyo et aI., 1998). As can be seen in Figure 3, 
essentially the same ~-galactosidase expression profile is observed in nerves of transgenic 
mice c3lTying construct VI (the SCE-LacZ transgcne) as in nerves of Ocl_6f3-geQ!+ mice. 
Thus, the Ocl-6 SCE does drive dynamic expression in the Schwallll cell lineage in a 
temporal profile that is qualitatively identical to that of the eudogenous Oc/-6 gene. 
Importantly, the SCE-LacZ transgene is also downregulated in mature nerves. 
Figure 4 Induction of p·galactosidase expression in 
SeE-LaeZ transgenic Schwallll cells parallels induction 
of Oct-6 protein expression in response to Forskolin. 
Primary Schwann cell cultures were established from 
wild type and SeE-LaeZ transgenic animals at postnatal 
day 4. Cells were cultured in defined medium (OF) 
supplemented with 5% NOF-P conditioned medium and 
exposed to 10 flM Forskolin (panels A, C, E and) or 20 
flM Forskolin (panels B, D, F and H) for 48 hours (see 
Materials and Methods). (A, B) Phase contrast 
photographs of primary Schwaml cell cultures derived 
from wild type animals. (C, 0) DAPI staining of nuclei 
of the cells shown in A and B, respectively. (E, F) Many 
Schwaun cells express Oct-6 (white spots) when exposed 
to 20 11M Forskolin (F) while only few Schwann cells 
express Oct-6 when exposed to 10 ~tM Forskolin (E). 
Fibroblasts, which are easily recognised by their 
flattcned morphology and large nucleus, never express 
Oct-6. (G, H) Bright-field images of X-gal stained seE-
LacZ primary Schwann cells. In cultures exposed 10 20 
JlM Forskolin (H), many cells with a Schwann cell 
morphology show a X-gal precipitate (dark grey spots in 
the cells), while only few such cells are observed in the 
culture exposcd to IO JlM Forskolin (arrows in G). 
Fibroblasts, which are recognised by their flattened 
morphology and their pronounced nucleoli, do not 
express the transgclle. Cells were counter-stained with 
Eosin. 
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Schwann cells express the SCE-LneZ transgene in response to cAMP ill vitro 
Actively myelinating Schwann cells in early postnatal peripheral nerve express 
high levels of Oel-6 and myelin genes. Disruption of axonal contact, either through nerve 
transection or dissociation and culture of Schwann cells, results in a rapid downregulatiol1 
of Oel-6 and myelin gene expression (Scherer et aI., 1994). Previously it has been shown 
that elevation of intracellular levels of cAMP levels in cultured Schwarm cells leads to a 
rapid, but modest, induction of Oel-6 gene expression shortly followed by expression of 
myelin genes such as PO and P2 (Monuki et aI., 1989). These and related observations led 
to the suggestion that axonal signals operating during nerve development and regeneration 
are transduced, at least in part, through the adenylyl cyclase pathway. To test whether the 
cAMP signalling pathway could activate expression of the (3-galaelosidase trans gene 
through the SCE we established primary Schwarm cell cultures from postnatal day 5 sciatic 
nerves from wild type and SCE-LaeZ transgenic mice. Cultures were exposed to different 
concentrations of Forskolin, an activator of adenylyl cyclase. When Schwarm cells are 
brought into culture they rapidly downregulate expression of the endogenous Oel-6 gene 
and the transgene. However, when cultured for 48 hours in defined medium supplemented 
with 5% NDF-f3 conditioned medium, endogenous Oel-6 gene expression is re-induced in a 
Forskolin concentration dependent manner (compare panel E and F in Figure 4). Under 
these conditions LacZ expression is similarly induced in transgenic Schwann cells 
(compare panels G and H in Figure 4) suggesting that cAMP induction of Oel-6 gene 
expression ill vilro is mediated through the SCE. 
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Oct-6 SCE-LacZ Figure 5 Axonal regulation of reporter gene 
expression during nerve regeneration. 
Whole mount X-gal staining was pcrfoIIDed 
on cnlshed sciatic nerves of adult Oct-rrg,oI+ 
and SCE-LacZ animals at 4, 8, 16. and 32 
days (d) after crush injury. (A, B) Four days 
after crush, no staining was visible in the 
nerve of Oct·rrgw+ animals, while some 
patchy staining (grey) could be observed 
distal to the site of crush in the SCE·LacZ 
nerve. (C, D) At 8 days after crush, strong 
staining can be dctected in both mouse lines, 
but staining is more intense in the SCE·LacZ 
animal. (E, F) After 16 days, staining is 
already fading in the crushed Oct-6I!g<o/+ 
Sciatic nerve, while laeZ expression is still 
high in the SCE-LacZ nerve. (G, H) Only 
low levels of lacZ expression could be 
detected in the Oct·6 heterozygous animal 
32 days after cnlsh injury. Also, staining 
intensity in the SCE-l.acZ nerve at 32 days 
has decreased compared to 16 days after 
crush (F), Scale bar in (H) is Imm, and also 
applies to the other panels. 
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Induction of Ocl-6 gene expression in reactive Schwann cells during nerve 
regeneration is mediated through the SCE. 
Following nerve damage. axons disintegrate distal to the lesion resulting in loss of 
axon-Schwann cell contact and dedifferentiation of SChWall1l cells (Wallerian 
degeneration). Denervated myelinating Schwann cells cease expression of myelin related 
genes and reactivate expression of genes typical of immature cells such as the low affinity 
neurotrophin receptor p75 and GAP-43 (Scherer and Salzer. 1996). Upon regeneration 
axonal contact is restored and regrowing axon are ensheathed and remyelinated by 
Schwann cells whose differentiation recapitulates the events during Bannai development 
including the transient re-expression of OCI-6 (Scherer et aI., 1994; Zorick et aI., 1996). 
To test whether the SeE also mediates re-induction of Oct-6 expression in 
Schwann cells during regeneration we performed X-gal staining of whole sciatic nerves at 
4, 8, 16 and 32 days following cnIsh lesion of the nerve in Ocl-6,·g,.l+ and SCE-LacZ 
transgenic mice (Figure 5). Re-activation of Oct-6 expression in Oc!_6/3-geo/+ nerves occurs 
between day 4 and 8 post-crosh and correlates with the re-ensheathment aud remyelination 
of regenerating axons. Expression of the Ocl-6,g,0 allele is then gradually extinguished and 
only low levels of expression are observed in nerves 32 days post crush. In SCE-LacZ 
transgenic mice reactivation of expression is seen during the same interval as in OCI_trgeo/+ 
mice. Staining levels are most intense at 16 days postcrush after which staining levels begin 
to fade. The difference in staining intensity between the two different mouse lines probably 
reflects the difference in f3-galaclosidase copy numbers ( I in OCI_6,"g"h and 7 copies in 
SCE-LacZ mice). However, qualitatively the SeE driven transgene shows the same 
expression profile as the Ocl_6f!.g··o/+ mice. Thus, the SeE also mediates reactivation of Oct-
6 expression in SchwallIl cells during nerve regeneration. It is therefore likely that the same 
intracellular signalling pathway induces Ocl-6 gene expression during development as well 
as during regeneration. 
A SeE driven HA tagged Oc/-6 transgene rescues the peripheral nerve phenotype of 
Ocl-6 null mice. 
Since the SeE is sufficient to mediate temporal regulation of OCI-6 gene 
expression within the Schwann cell lineage it should be possible to rescue the peripheral 
nerve phenotype in Ocl-6 deficient mice by expressing a tagged OCI-6 gene under control 
of this enhancer element. To test this hypothesis, a DNA construct in which a triple HA-
tagged OCI-6 gene is linked 'to the SeE was used to generate three independent transgenic 
mouse lines, named HA-I, HA-2 and HA-3 carrying 12, 7 and 3 copies of the transgene 
respectively. Using antibodies against the Oct-6 protein and the HA tag, 
immunohistochemistry on sciatic nerves of new bom pups shows that all three lines 
expressed the transgene (data not shown). These lines were crossed with Ocl_~g,ol+ mice to 
generate compound heterozygotes and offspring were backcrossed to Oct_6fJ.geo/+ mice. 
Viable HAIOct_6fJ.-geo/jJ-geo animals were bom from each line and the survival rate of these 
animals was higher than Oct_rtgeo/fJ-geo animals as previously reported. Besides a slight 
reduction in size, HAIOcl_6~geo/~geQ animals appeared normal. 
114 
Figure 6 The SeE driven HA 
lagged Oc[~6 transgcne is expressed in 
Schwann cells and rescues the congenital 
hypomyelination phenotype in Oct_rrg,,<,~g·"(J 
animals. A. Developmental expression of 
HA-Oct-6 in the Schwann cells of Oct·6~gM~ 
g<'O animals (panel A, C and E) is both 
quantitatively and qualitatively 
indistinguishable from that of endogenous 
Oct-6 in Ocl-6tJ.-g<Q/+ animals (panel H, D and 
F). Both, the HA lagged Oct·6 protein 
encoded by the lronsgenc and the 
endogenous Oct-6 protein are detected here 
with an Oct-6 specific antibody (light grey 
signal). Po protein (light grey signal) could 
not be detected in sciatic nerves of Oct-61l-
K,:o.il-g<O animals at PI (panel G), while few 
Schwann cells express high levels of Po 
protein in nerves of Oct·6e-g,'(),'f (Ii) and 
HAIOct·6e-g,'()'i!-g<() (I) animals at this stagc. At 
PI I, high Ic\'cls of Po expression are seen in 
HAIOC1·~g.-'()'i!-g,o and OCl·6e-g,'U,~ nerves (K 
and L), whereas in thc OCf_6!J.-gCo.'iJ-g,'U only a 
small number of SchwalHl cells express high 
levels of the Po protein (J). In adult sciatic 
nervc high levels of Po protein cxpression are 
observed in Schwann cells of all three 
genetic backgrounds consistent with their 
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myelination status (M, N, 0; sec also 68). Ad 
Scalc bar represents to ~(m, B. Myelin 
appears on schedule in sciatic nerves of l/A-
Ocl-6 transgene exprcssing Ocf_6e-g·'()'i!-g,'() 
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micc. Myelin is clearly visible as dark grey rings around axons in micrographs of nerves stained with methylene 
blue. At PI no myelin could be detccted in Oct_6e-g,'o'-g.·() nerves (A), while few Scltwann cells have elaborated a 
myelin sheath around axons in HAIOct_6!J.-g'01l-gM and Ocf_~g'''''-f- mice (B and C, respectivcly). At Pi] myelin 
-fomtation is welI ad\'anced in nerves of HAJOct_6!J.-gCo.'$-g,'() and Oct_~g'''';f animals (E and F), while only a few 
myelin figures could be detected in nerves of Oct-6e-g,'o'$-g.'() animals. Although with considerable delay, 
myelination in Oct-~g<"'i!-g,'() animals does commence. The microscopic morphology of adult sciatic nerves of Oct-
rrg,'(j.1l-goYJ animals is nearly indistinguishable from that of adult HAIOct-r/g,o'iJ-g,'() and Oct·r/gC(J/f sciatic nerves (H 
and J). Scale bar represents to f.tm and applies to all panels. 
Pursuing our analysis with transgenic line HA-2, we observed that the expression 
profile of HA-Oct-6 in sciatic nerves of Oct_6fJ.geo/fJ.geo animals at PI, PII and in adults 
(Figure 6A. panels A, C and E) was indistinguishable from the endogenous Oct-6 
expression in OCI_6~g,ol+ animals (Figure 6A. panels B, D and F). From P I to P II many 
Schwann cells express the transgene in the OCI-6 null background, while in adult Ocl-6 null 
mice the trans gene is expressed in only a small number of cells. 
Previously we have reported that the expression of one of the major structural myelin 
proteins, Po, is delayed in Schwalm cells of Ocl-6 null mice (Jaegle et a!., 1996). We 
therefore examined whether the Po protein expression would be restored to normal in nerves 
from HA_210CI_6~g,olp.g,o mice. As is evident from Figure 6A (Panels G through 0) this is 
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indeed the case, suggesting that the Schwann cells of HA_210cl_6P-g"lP-g" animals are 
actively myelinating. Also, light microscopic examination and comparison of semi-thin 
sections of sciatic nerves derived from HA_210ct_6fJ-geol{J-geo, Oct_6fJ.geoljJ.geo and Oct_6fJ-geol+ 
animals show that myelination is restored in Ocl-6 null animals by SCE driven HA-Oct-6 
expression (Figure 6B), These data clearly demonstrate that the Ocl-6 Schwann cell 
enhancer is sufficient to mediate correct temporal expression at physiological relevant 
levels of the Ocl-6 gene during development as well as during nerve regeneration. 
Figure 7. Schematic representation of 
the cascade of inductive events 
governing myelination. Myelination is 
under control of continued axonal 
signaling. One important target of this 
signaling is the Oct-6 gene whose 
function is required for timely 
differentiation of myelinating Schwann 
cells (JaegJc ct aI., 1996; Bemlingham 
ct at, 1996). Axonal regulation of Oct-6 
gene expression is mediated through the 
SeE. A potential intra-cellular 
component of this signaling is the 
cAMP pathway. Oct-6 gene expression 
is extinguished through a mechanism 
that involves Oct-6 itself and 
progression of myelination (JaegJe and 
Meijer, 1998). An important target of 
Oct-6 signaling in promyelin cells is 
Krox-20 as Krox-20 upregulation is 
delayed in the absence of Oct-6 
(Mandemakcrs et al. in preparation). 
Krox-20 is required in promyelin cells 
for these cells to initiate myelination, 
possibly by directly regulating 
expression of the major myelin genes 
(Topilko et aI., 1994; Zorick et aI., 
1999). 
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Schwann cells are induced to adopt a one to one relationship with axons and 
initiate myelination under influence of continued axonal signaling. The exact molecular 
nahne of this signaling is not understood. However, one major target is the POU domain 
gene Ocl-6. Oct-6 function is required in Schwann cells for normal progression of cell 
differentiation and myelination. We describe a cis-acting element, the SCE, within the Ocl-
6 locus on which intra-cellular signaling pathways converge to activate Oct-6 gene 
expression in response to this elusive axonal signal (see Figure 7). 
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DNAse! hypersensitive sites afe associated with major regulatory elements in the Ocl-
610clls 
The mouse Ocl-6 gene is expressed in a highly dynamic and complex pattem 
during embryonic development (Alvarez-Bolado et aI., 1995; Zwart et aI., 1996). Qur 
preliminary experiments had shown that the gene promoter itself did not cany sufficient 
information to direct regulated expression in cell lines or transgenic mice (Mandemakers ct 
aI., 1999), suggesting that remote cis-acting elements regulate the Ocl-6 expression pattern. 
As a first approach we used DNAsel hypersensitivity mapping to identify potential cis-
acting elements in the Oc/-6 locus. DNAsel hypersensitive regions in chromatin are often 
associated with important gene regulatory sequences such as enhancers, promoters and 
locus control regions (LCR) (Felsenfeld et aI., 1996; Gross and GalTard, 1988; Svaren and 
Chalkley, 1990). Eight such sites were mapped in the Ocl-6 locus, six of which are only 
observed in Oc/-6 expressing cells. The relevance of these hypersensitive sites for regulated 
OCI-6 expression in the Schwann cell lineage was assessed in transgenic mice using the 
bacterial f3-galactosidase gene as a reporter. Differences in copy-number between our 
transgenes (usually multi-copy) and the one allele in the Oc/_6~g,ol+ mice resulted in 
quantitative differences in p-galactosidase expression levels. Hence, p-galactosidase 
expression was used only as a qualitative indicator for tempero-spatial expression of Ocl-6. 
We have madc no attempt to correlate expression level (p-galactosidase activity) with 
cOPY-Ilumber since most most animals were analyzed as founders and thus potentially 
mosaic. 
HSS-I is associated with the Oc/-6 gene promoter which consists of an atypical 
TATA box (TTTAA) at position -23 and a GCCAAT box at -80 relative to the 
transcriptional start site and is embedded in a CpG island that extends well into the coding 
region of the gene. The presence of this site, together with HSS-5, is not strictly cOlTelated 
with Oc/-6 gene expression. Both sites are also present in chromatin of cells that do hot 
express Oc/-6. The fact that this region is DNAsel hypersensitive might reflect the unusual 
chromatin conformation associated with regions of high CG content (Antequera and Bird, 
1999). Altematively, it is possible that HSS-I is related to proliferation as it has recently 
.been suggested that CpG islands are associated with origins of DNA replication (Antequera 
and Bird, 1999; Delgado et aI., 1998). However, HSS-I (and HSS-5) is also present in 
chromatin of non-proliferating brain and liver cells. A third possibility is that HSS-I is part 
of a different unidentified transcription unit in the vicinity of the Oc/-6 gene. Recently we 
have identified such a transcription unit 3' of the Oc/-6 gene. This gene, which overlaps 
with HSS-5, is expressed in heart, ES cells, testis and brainstem but not in liver (our 
unpublished observations). Thus, the relationship between HSS-I and this new unidentified 
gene remains obscure. 
The presence of HSS-2 is correlated with Oc/-6 expression in the panel of cell 
lines and tissues we examined. This site contains a previously identified estrogen and TPA 
responsive enhancer (Renner et aI., 1996). Estrogen and TPA were shown to synergistically 
enhance Oc/-6 expression in oligodendroglia cell lines. Subsequent cotransfection in these 
cell lines indicated that the synergistic effect ofTPA and estrogen on Oc/-6 expression was 
mediated through this enhancer. Earlier studies had shown that the estrogen receptor is 
expressed in Schwalm cells and oligodendrocytes and that estrogens have an effect on 
SchWalm cell proliferation and myelin gene expression (Jung-Testas and Baulieu, 1998). 
Together these results led Renner and colleagues to suggest that this element mediate 
e'slrogen iegidation of Oct-6 gene express'ion and' myelioge;mesls. However, our resiilts 
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demonstrate that this element is not required for regulated expression of the Oc/-6 gene in 
the Schwalm cell lineage ill vivo. 
HSS-3 and HSS-5 are both present in chromatin of the Schwalllloma cell line 
TR6B but are not sufficient or required to drive Schwann cell expression of the transgene 
that contains both these sites (constmct V). This constmct, together with constmct I and III, 
does however express in the hairfollicles, another prominent site of Oc/-6 expression (data 
not shown). It is therefore possible that either of the two sites, or both sites, is necessary for 
this aspect of the Oc/-6 expression pattern. 
Our analysis did not reveal any obvious function for HSS-4 and HSS-8. Both sites 
are dispensable for Schwann cell specific expression. It is possible that these sites are 
involved in some other aspect of the Oc/-6 expression pattern not analysed here. 
Within the CNS, Oc/-6 is prominently expressed in layer 2 and 5 of the cortex, the 
hippocampus and brainstem. None of the constmcts that we tested were consistently 
expressed in these areas of the CNS (data not shown). Instead, transgene expression in the 
brain was highly variable from transgenic animal to animal suggesting that these patterns 
mainly result from integration position effects. It is likely that these aspects of Oc/-6 
expression are regulated by elements outside the region tested. 
A 3' distal enhancer in the Oc/-6 locus mediates axonal regulation and Schwann cell 
specific expression in a promoter independent fashion 
Schwalm cell 'specific expression was observed with most constnlCts that 
contained HSS-6 and HSS-7. A DNA restriction fragment containing these hypersensitive 
sites was tenned the Oc/-6 Schwann cell enhancer (SCE) and was further shown to be 
sufficient to drive temporally correct expression of a trans gene, both during nonnal 
development as well as during nerve regeneration and ill vitro follow;ng stimulation by 
Forskolin. Apparently, Oc/-6 promoter specific sequences are not required as the SCE also 
drives Schwann cell specific expression from the hsp68 promoter. Furthermore, an HA-
tagged version of the Oc/-6 gene under control of the SCE rescues the peripheral nerve 
phenotype obselved in Ocl-6 null animals. These results provide strong evidence that the 
Oc/-6 SCE is sufficient to mediate all aspects of regulated Oc/-6 gene expression in the 
SchWalm cell lineage. Further deletion analysis of this fragment in which we separated 
HSS-6 and HSS-7 failed to give Schwarlll cell specific expression suggesting that both sites 
are necessary for full enhancer activity. In this respect the Oc/-6 SCE resembles other 
enhancers such as the 3' enhancer of the stem cell leukemia (SCL) gene which also consists 
of two hypersensitive sites. Both sites are required for full SCL enhancer function in mast 
cells and early haematopoietic progenitors (Fordham et a!., 1999; Sanchez et a!., 1999). In 
fact this is a rather common feature of many enhancers and locus control regions and 
reflects the modular nature of most of these elements in which bound nuclear factors need 
to interact to form a larger holo-complex to stimulate transcription from the linked 
promoter (Mannervik ct a!., 1999; Muller et a!., 1988). 
Despite our demonstration that the SCE is sufficient to drive all aspects of 
regulated Ocl-6 expression in the SchWalm cell lineage, not all trans genes containing the 
SCE do actually express in Schwalm cells. We generated 8 transgenic lines and 11 founders 
with various constructs that containedonly HSS-6 andHSS-7, in addition to either theOc/-
6 promoter or the hsp68 promoter. Of these II founders, 9 expressed the trans gene in the 
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Schwann cell lineage. It is possible that the two mice that do not express were in fact highly 
chimaeric, with no or only few transgenic cells contributing to the Schwalm cell lineage. 
Chimaerism, however cannot explain why three out of the 8 lines we generated do not 
express the transgene in Schwarm cells. This is not due to a partial deletion of the trans gene 
since Southem blotting confirmed the integrity of the transgene. Most likely these 
transgcncs integrated in an unfavourable chromatin region that is not accessible in Schwann 
cells. Apparently, the SCE cannot overcome this negative integration position effect. In this 
context it is of interest to note that all 6 transgenic lines generated with construct I and ill 
all express in the Schwann cell lineage. These constructs, contain in addition to HSS-6 and 
HSS-7 several other hypersensitive sites (see figure 2). It is possible that one of these sites 
contributes to the SCE to overcome negative position effects. Larger numbers of transgenic 
animals need to be generated and analysed to test tlils possibility. In addition, deletion of 
the SCE, through the route of homologous recombination in ES cells, will reveal whether 
HSS-6 and HSS-7 are required for Schwalm cell specific regulation or that additional 
Schwann cell specific elements are present in the Ocl-6 locus. 
The fact that Ocl-6 gene expression in Schwann cells is under control of axonal 
signals is perhaps most graphically illustrated during nerve regeneration when axonal 
contact with reactive Schwarm cells is restored and Ocl-6 gene expression is rapidly re-
induced (Scherer et aI., 1994 and Figure 5). Thus, axonal signals are ultimately relayed to 
the Ocl-6 SCE. This signaling does not involve the transcription factor Krox-20, as Krox-20 
null promyelin arrested Schwarm cells express high amounts ofOct-6 (Zorick et aI., 1999). 
It is therefore possible that Krox-20 is regulated in parallel with Ocl-6 or Krox-20 
regulation depends on Oct-6. The latter possibility appears to be the case as Krox-20 
upregulation is delayed in Ocl-6 null mice (our unpublished observations). One possible 
intra-cellular signalling pathway involved in upregulation of Ocl-6 is the adenylyl cyclase-
PKA pathway (Lemke and Chao, 1988; Mirsky and Jessen, 1996; Monuki et aI., 1989). 
Elevation of cAMP, through activation of adenylyl cyclase with Forskolin, in the presence 
of NDF-p leads to induction of Ocl-6 expression in cultured Schwalm cells and this 
induction is Forskolin dose dependent (Figure 6). The major target of cAMP signalling is 
PKA, which in turn activates the transcription factor CREB through phosporylation on 
position Ser-133 (Gonzalez and Montminy, 1989). Also, NDF-p signalling has been shown 
to result in phosphorylation of CREB through a P21ras and MAP kinase dependent 
pathway (Kim et aI., 1997; Tabemero et aI., 1998). Hence, it is possible that these pathways 
synergize in activation of CREB and stimulation of OCI-6 gene expression. As CREB is 
expressed in the Schwann cell lineage this is a likely candidate nuclear factor to bind to the 
Ocl-6 SCE. Indeed, potential CREB binding sites are present in the SCE while no such sites 
are found in the Oct-6 proximal promoter and this promoter is not active in Schwarm cells 
of transgenic mice. The involvement of the cAMP pathway in this activation ill vil'o is 
however unclear as it has been shown that cAMP levels increase in the distal nerve stump 
only after activation of Po expression (Poduslo et aI., 1995). A critical assessment of the 
role of the PKA pathway in myelination will require the Schwaml cell and stage specific 
inhibition of this pathway, for example by stage specific expression of a dominant negative 
form of the regulatory subunit of PKA. 
Further detailed characterisation of the Ocl-6 SCE will identify transcription 
factors that bind to this element and on which intra-cellular signaling pathways converge to 
regulate Ocl-6 gene expression and myelination. The identification of this unique enhancer 
does provide us with an important tool, not only to study those transcription factors and the 
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signaling pathways that regulate their activity, but also to manipulate the expression of 
trans genes in Schwann cells during a defined period of their differentiation. It is, in 
particular, this last characteristic that makes this human SCE element very attractive in 
future gene therapy strategies for SchWalm cells to be transplanted into lesioned nerves. 
Also, the demonstration here that an SCE driven Ocl-6 trans gene rescues the peripheral 
nerve phenotype of Oct-6 null animals provides an experimental setting for the ill vivo 
mapping of functional domains of the Oct-6 protein by transgene expression of various 
deletion mutants of the Oct-6 protein and to test possible Ocl-6 redundant genes (Jaegle and 
Meijer 1998). 
Recently a number of families have been described with hereditary 
myelinopathies associated with mutations in the Krox-20 (EGR2) gene (Warner et aI., 
1998). The search for mutations in this gene was directly motivated by the striking 
hypomyelination phenotype of Krox-20 null animals. To date, no mutations in the OCI-6 
genc have been described to be associated with hereditary myelinopathies. However, in the 
context of our findings, it is tempting to speculate that within the group of hereditary 
peripheral neuropathy patients not associated with mutations in any of the known genes 
such as PMP-22, Po and Krox-20, there might be patients that cany Illutations or deletions 
of the Ocl-6 Schwann cell enhancer. 
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Materials and Methods 
DNAseI hypersensitive site mapping 
Nuclei were prepared from mouse tissues and cell lines essentially as described in 
(Lichtsteiner et aI., 1987). Briefly, I gr of brain or liver tissue was homogenised in 12 ml of 
buffer A using a Teflon/glass motor driven homogeniser. (Buffer A; 2 M Sucrose, 10 mM 
Hepes-KOH pH 7.6, 15 mM KCI, 2 mM EDTA pH 8.0, 10 % glycerol. The following 
components were freshly added before use; 0.15 mM spemline, 0.5 mM spermidine, 0.5 
mM DTT, I mM PMSF, I mM Benzamidine, I llg/ml Antipain, 2 ~lg/ml Aprotinin, and I 
~lg!ml Leupeptin.) Nuclei were purified by centrifugation through a 0.5 ml cushions of 
buffer A for 45 minutes at 22000lpm at O'C in SW 41 Ultra clear centrifuge tubes. Nuclei 
(pellet) were washed once in 50 ml ofice-cold HS-buffer (IS mM Tris-HCI pH 7.4, 60 mM 
KCI, 15 mM NaCI. 0.2 mM EDTA pH 8.0, 0.2 mM EGTA pH 8.0, and 5 % glycerol, 
suppleillented with the same additives as for Buffer A). After centrifugation at O'C for 10 
niiiluiesat'i500'lpm, nuclei were resuspended in HS-buffer to a final concellirati"n of 
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approximately 3xlO'cellsiml. Cultured cells (AB-I ES, MES-68, MES-I, and TR6B cells) 
were collected, washed twice with ice-cold PBS and resuspended in 4 ml of ice-cold HS-
buffer. The cell suspension was diluted with 4 ml of HS-bufferI0.2% NP-40 (Roche) and 
forced through a 25G needle 5 to 10 times to dismpt the cell membrane. Nuclei were 
collected by a brief centrifugation step at 2500 lpm and resuspended to a final 
concentration of3xl07 cells/ml. From this point onwards, nuclei fro111 tissues and cultured 
cells were treated the same way. Limited DNasel digestion of chromatin was carried out in 
a final volume of Iml of HS-buffer containing 1.5x 10' nuclei, 20 mM MgCI" I mM CaC!, 
and different amounts of DNasel (Roche) varying from 0 to 30 units per sample. Nuclei 
were incubated for 30 minutes on ice. The reaction was stopped by adding an equal volume 
of 2x stopmix (0.2 M Tris-HCI pH 7.5, 0.4 M NaCI, I % SDS, 200 mglml Proteinase K), 
and further incubated overnight at 45°C. DNA was purified by phenollchloroform 
extraction, precipitated with 0.6 volume of isopropanol, washed with 70% ethanol and 
dissolved in 200 111 ofTE buffer. 10 I1g of DNA of each sample was digested with different 
restriction enzymes. Restriction fragments were resolved on 0.8 % agarose gels and blotted 
onto Hybond-N+ membrane (Amersham). The blots were hybridised with single copy 
probes derived from the Ocl-6 locus, two of which are shown in Figure IA. All other 
methods are described in (Sambrook et aI., 1989). 
Cloning and transgenesis. 
The LacZ reporter gene was isolated as a 3.4 kb fragment from plasmid p610ZA 
(Kothary et aI., 1989) in which the Dral site 60 bp downstream of the LacZ stopcodon was 
converted into a Bam HI site. This fragment was ligated into a unique Nsil site of the OCI-6 
CDR on a 7kb EcoRI genomic fragment, after the Nsil site was modified by blunting and 
addition of BandiI linkers. This resulted in the creation of constmct II (see Figure 2A), 
containing the Oct-6 promoter region directing the expression of a fusion gene encoding the 
first 22 amino acids ofOct-6, followed by a threonine, introduced by the cloning procedure, 
and the lacZ open reading frame. A cosmid clone containing the Ocl-6 gene plus 15 kb 
upstream and 15 kb downstream was isolated from a mouse 129 genomic library. The LacZ 
reporter gene was introduced into this cosmid by replacing a 5 kb NotI/EcoRI fragment 
containing the Ocl-6 CDR, by an 8 kb NotIlEcoRI tl'agment from constmct II that contains 
the OCI-6ILacZ fusion gene. The RecA-AC reaction (Koob et aI., 1992) was performed to 
facilitate this cloning step, which resulted in the generation of construct l. Construct III 
was generated by a partial BglII digest and religation of constmct I. The 13 kb Construct 
IV, containing HSS-I and HSS-2, was isolated directly from construct I by digestion with 
restriction enzyme Stul to completion. Constmct V was created by introducing, using the 
RecA-AC reaction, into cosmid 3 the 8 kb NotIlEcoRI Ocl-6/LacZ fusion gene. Construct 
VI (SCE-LacZ) was generated by introducing a 4.3 kb HpaIlMscl genomic fragment into 
the unique Stul site of construct II in the same orientation as in the OCI-610cus. This 4.3 kb 
fragment (SCE) contains HSS-6 and HSS-7, which are located downstream of the Ocl-6 
CDR. Constructs VII and VIII were generated by cloning a 2.7 kb HpaIlNdel fragment and 
a 1.6 kb NdeIlMscl fragment, derived from the 4.3 kb SCE of SCE-LacZ into the Stu! site 
of construct II, respectively. Hsp68-LacZ-SCE was generated by cloning the SCE into the 
SmaI site of p6IOZA, which contains the promoter of the mouse hsp68 gene, the E.coli 
LacZ reporter gene, and an SV 40 poly adenylation signal (Construct IX in Figure 2B) 
(Kothary eta!., 1989). The human homologue of·the··mouse·SCE was cloned as a 5kb 
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EcoRVlBamHI fragment from a cosmid containing the human Ocl-6 locus on the basis of 
its hybridizing with #15 (see Figure IA). The human SCE was ligated into the unique Stul 
site of construct II, resulting in huSCE-LacZ (Construct X). 
A fragment containing the sequence; 5-'TATGACGTCCCAGATTACGCAAGTTT 
GCCCGGGTATGATGTTCCTGATTATGCTAGCCTCCCGGGTTACGATGTGCCCGA 
CTATGCCTCACTTCCAGGC-3', coding for a triple repeat of an internal region of the 
influenza haemagglutinin (HA) protein (YDVPDYASLPG), was ligated in frame at the 
start codon of the OCI-6 CDR of the 7 kb genomic EcoRI fragment that contains the entire 
Ocl-6 transcription unit. This resulted in a HA tag/Ocl-6 fusion gene, which was 
subsequently isolated as a NotI/Swa! fragment and ligated into a NotI/Swa! digested SCE-
LacZ, replacing the OCI-6ILacZ fusion gene, generating HA-Oct-6. DNA fragments were 
excised from construct I to X using appropriate restriction enzymes, separated on agarose 
gels, isolated by electro-elution and purified using elutip-D-mini columns (Schleicher and 
Schull). The DNA was dissolved in injection buffer (10 mM Tris-HCI pH 7.5, 0.08 mM 
EDT A pH 8.0) and introduced, by pronuclear injection, into fertilised eggs derived from a 
FVBIN x FVBIN mating as described (Hogan et aI., 1994). Transgenic animals were 
analysed as founders or as lines. DNA samples of all animals were analysed by Southern 
blotting and hybridization to appropriate probes to confinn transgenesis. LacZ expression 
was visualised by whole mount X-Gal staining of EI8 embryos or nerves dissected from 
transgenic animals at different stages of postnatal development. 
Whole mount X-gal staining 
Embryos or dissected nerves (N. ischiaticus) were fixed for 30 minutes at room 
temperature (RT) in 2 % Formaldehyde (BDH), 0.2 % glutaraldehyde (Sigma), 2 mM 
MgCI,. 5 mM EGTA pH 8.0, 0.02 % NP-40 in Phosphate buffered saline (PBS). 
Subsequently, embryos were washed 3 times for 10 minutes at RT in PBS containing 0.02 
% NP-40. Staining was done overnight at RT in PBS containing I mg/ml 5-bromo-4-
chloro-3-indolyl-p-D-galactopyranoside (X-gal), 5 mM KJFe(CNJo, 5 mM 
K.,Fe(CN).,3H,O, 2 mM MgCI" 0.0 I % sodium deoxycholate, 0.02 % NP-40. Stained 
embryos were washed twice with PBS/O.02 % NP-40 and post fixed overnigllt in 4 % 
formaldehyde. 
Primary Schwann cell cultures 
Cultures of Schwann cells were set up as has been described before with some 
modifications (Brockes et aI., 1979; Kleitman et aI., 1991). Dissected nerves were collected 
in L-15 Leibovitz. Nerves were transferred to L-15 medium containing I mg/ml 
collegenase (Roche), teased with dissection needles and incubated for 30 min. at 37° C, 
with repeated pipetting to disrupt the nerves. Cells were washed once with L-15 containing 
10% fetal calf semm (FCS), and plated on uncoated tissue culture dishes in Cb medium 
(Einheber et aI., 1993), and incubated overnight at 3rC and 5% CO,. The next day, 
Schwann cells were harvested using the "Cold jet" method (Jirsova et aI., 1997), and plated 
on collagen coated coverslips. Cells were incubated for 48 Ins at 37°C and 5% CO, in 
either Cb medium (containing 10% FCS) or in Defined medium (DF) (Murphy et aI., 1996) 
supplemented with 5% NDF-P conditioned medium in the presence of 0, 10, or 20 f.lM 
Forskolin(Sigma). A CHO cell line expressing a soluble form ofNDF-p was cultured in 
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DMEMlFI2, 5% FCS for 7 days. Medium was collected and filter sterilized (NDF-~ 
conditioned medium). Cells were fixed in a solution containing 35 % acetone, 35 % 
methanol, 5 % acetic acid and 25 % H20 for 10 min. at room temperature and subsequently 
processed for immunochemistry or X-gal staining. 
Sciatic nerve crush 
Adult Ocl-r!-g"l+ and SCE-LacZ mice were anaesthetised with halothane and the 
sciatic nerve was exposed. The sciatic nerve was crushed by tight compression with 
flattened Biology forceps no. 5 for 10 seconds at mid-femoral level just before the point 
where the sciatic nerve bifurcates. The mice were sacrificed at 4, 8, 16 and 32 days after 
surgery, and their sciatic nerves were isolated and processed for whole mount X-gal 
staining, with the unlesioned contralateral nerve serving as a control for background X-gal 
staining. 
Immunohistochemistry 
Sciatic nerves were isolated from mice derived from matings between HAIOCI-6'" 
g'O/+ and OCI-6,"g"l+ at the desired developmental stages and fixed overnight at 4°C in 35 % 
acetone/35 % methanoll 5 % acetic acidl25 % H20. After dehydration and paraffin 
embedding 5Jlm sections were cut and mounted on SuperFrost*/plus glass slides (Menzel-
glaser). Sections were dewaxed, rehydrated and subjected to a microwave antigen-retrieval 
procedure (Evers et aI., 1998). All other procedures have been described (Jaegle et aI., 
1996; Zwart et aI., 1996). Primary antibodies used were; rabbit polyclonal anti-Oct-6 serum 
(Zwart et aI., 1996), goat anti-HA serum (Santa Cruz biotechnology), mouse monoclonal 
anti-Po (Archelos et aI., 1993) and mouse monoclonal anti-HA (l2CA5; Roche). 
Fluorochrome coupled secondary antibodies used were; goat-anti-rabbit Texas red 
(Molecular probes), goat-anti-mouse Oregon green (Molecular probes). Both used at 1:200 
dilution. Sections were examined using epifluorescence microscopy (Leitz). Images were 
captured with a Sony CCD camera and directly imported into Adobe Photoshop. 
Light microscopy 
Animals were perfused with PBS for 3 minutes, followed by fixative (3 % 
paraformaldehyde (Sigma) and I % glutaraldehyde buffered by 100 mM sodium cacodylate 
at pH 7.2) for 10 minutes. Sciatic nerves were isolated, washed with cacodylate buffer, 
osmicated in I % osmium tetroxide and embedded in Epon. Semithin sections (I Jlm) of 
Epon embedded Sciatic nerves were mounted on glass slides and stained with methylene 
blue. 
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Chapter 6 
One of the fnnctions of Schwann cells in peripheral nerve development is the 
elaboration of a myelin sheath around the axon. A large number of experiments have 
demonstrated that the axon determines whether a Schwallll cell will start the myelination 
process 1,2, One of the main questions in glial cell research is how axons and Schwarm 
cells communicate to initiate myelination. 
Concerning tbe nature of the axonal signal, there are two schools of thought: One 
proposes that an axonally derived factor interacts with a receptor on the Schwaml cell 
membrane to initiate myelination. This factor could be either membrane bound or secreted 
with limited diffnsion or half-life. Indirect evidence for this model comes from (ill vitro) 
experiments showing that axonal membrane fractions induce myelin gene expression in 
cultured rat Schwam! cells 3 In addition, activators of adenelyl cyclase can min:tic these 
effects 4. It is therefore possible that the putative myelin signal receptor belongs to the 
family of G-protein coupled receptors. 
Another group of researchers favours a more mechanical model in which a 
Schwann cell intrinsic mechanism monitors the curvature of the axonal surface. It is 
suggested that the less curved surface of larger calibre axons induce Schwann cells to single 
out these axons and initiate myelination. In contrast to the previous model this suggests that 
Schw3llll cells are able to myelinate independent ofaxons. Indeed, Ernyei et al 
demonstrated that Schwann cells are able to myelinate artificial fibres, such as glass, nylon 
or other synthetic fibres 5. However, Field et al and other researchers were unable to repeat 
these experiments 6. In addition, increasing axonal diameter of post-ganglionic neurons in 
the superior cervical ganglion by increasing targeted innervation size leads to myelination 
of these otherwise non-myelinated axons 2. However, these experiments are by no means 
conclusive as it cannot be ruled out that a larger target size induces, in addition to 
increasing axonal diameter, a myelin-inducing factor in these neurons. Whatever the exact 
nature of the axonal signal, it must be relayed to the nucleus of the Schw3llll cell to activate 
a co-ordinate programme of gene expression. 
Several transcription factors have been identified in SchWalm cells that mediate 
these signals. One of those proteins is the POU domain transcription factor Oct-6. Several 
experiments suggest that Oct-6 plays an important role in mediating axonal signalling. 
First, Oct-6 is expressed in SchWalm cells and its expression is dependent on axonal contact 
7. Second, in cultured rat Schwann cells, agents that elevate intracellular cAMP levels can 
induce Oct-6 and Oct-6 induction precedes that of major myelin genes, such as PO and 
MBP 4. These data suggest a role for Oct-6 as a nuclear regulator of myelination in 
response to axonal signalling. 
We and others demonstrated through targeted deletion of the Oct-6 gene in mice 
that Oct-6 is required for Schwann cell differentiation. In particular in the absence of Oct-6 
function, Schwann ceUs are transiently arrested at the promyelin stage 8,9. However, Oct-6 
does not appear to be essential for myelination, since myelination proceeds relatively 
normal afler a temporal delay of approximately two weeks afler birth in Oct-6 null mice 
(this thesis; chapter 2)8. These results underscore the importance of Oct-6 in Schwann cell 
differentiation. However many questions remain. For example, how does Oct-6 exactly 
exert its function or in other words: what arc the target genes of Oct-6? Second, what are 
the factors that eventually stimulate myelination in Oct-6 deficient Schwann cells two 
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weeks after birth? Third, how is Oct-6 itself regulated? These and related questions will be 
discussed in the following sections. 
6.1 Oct-6 function - identification oftarget genes 
As Oct-6 is a transcription t:1ctor, it is most likely that Oct-6 exerts its function by 
directly regulating transcription of genes essential for the myelination program to be set 
out. In chapter 2 we demonstrated that the major myelin genes (such as PO, PMP-22, MEP, 
CNP, and MAG) fail to be upregulated on schedule in Oct-6 -/- mice. POU domain binding 
sites have been demonstrated in the PO promoter and Oct-6 has been demonstrated to bind 
these sites in vitro 10,11, However in these reports Oct-6 repressed PO expression~ while ill 
vivo data from Oct-6 null mice suggest the opposite. Therefore, there is as yet no 
convincing evidcnce available to suggest that Oct-6 directly regulate these genes. 
The Oct-6 knockout data also contradict with the LiSCIP transgenic data, which 
suggested that Oct-6 acts as a repressor of the major myelin genes 12 Several suggestions 
were proposed to explain these conflicting results. For example, strong overexpression of 
the Oct-6 POU-domain might have non-specific effects on gene regulation by other POU 
proteins. This could either as a result of dishlrbance of the equilibria between transcription 
factors and co-factors which interact with them, or by the binding of the Oct-6 POU-
domain to less prefelTed binding sites, which are not bound by wildtype Oct-6 under 
normal conditions. Therefore, together with the observation that Oct-6 is alrcady expressed 
in Schwann cell precursors, it can be postulated that Oct-6 has two separate effccts during 
Schwann cell development: a positive effect in early development, and later as a ncgative 
regulator of myelination 13. 
Another explanation would be that ill vivo, the Oct-6 POU-domain would be 
sufficient for normal Oct-6 function during Schwann cell development, and that the 
POLiSCIP transgene would have a dominant positive effect instead of dominant negative. 
The phenotype of the transgenic mice could then be interpreted as Oct-6 over-expression 
mice 14. 
Recently, compelling evidence was generated supporting the latter explanation, by 
crossing the POLiSCIP transgene into the Oct-6 homozygous knockout background 
(Weinstein, unpublished results). Several of these mice survived after birth a demonstrated 
normal myelination, indicating that the Oct-6 POU-domain is able to activate the 
myelination process independent of wildtype Oct-6. This demonstrates that the trangene 
indeed functions as a dominant positive, but it docs not I'llie out the possibility that later in 
Schwann cell development Oct-6 might function as a repressor. 
Identification of unknown and known genes regulated by Oct-6 will be necessary 
to fhrther elucidate the role of Oct-6 in this process. One approach that our group currently 
takes is to compare Ihll-length cDNA pools derived from EI8.S sciatic nerves of Oct-6 
knockout to those of normal mice 15,16. This time point is chosen for the reason that 
wiJdtype and Oct-6 null nerves are indistinguishable at that stage. Furthermore, in normal 
nerves, EI8.S is the stage when peak Oct-6 expression levels are reached. This suggests that 
at this stage wehave the highestchance of finding differentially expressed genes. directly 
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regulated by Oct-6. Characterisation of cDNAs of differentially expressed genes, over- or 
underrepresented in the Oct-6 knockout nerves, will lead to the identification of potcntial 
direct target genes. 
Furthennore, identification of DNA sequences pulled down in a chromatin 
immuno-precipitation assay using Oct-6 antibodies after UV or formaldehyde cross-linking 
will reveal direct targets ofOct-6 regulation (reviewed in 17). However, the limited number 
of Schwann cells that can be obtained from neonatal rodent nerve makes this approach 
impractical. 
A genetic approach to detect Oct-6 target genes would be to identify genes 
affected in mouse mutants with a similar peripheral nerve phenotype as Oct-6 null mice. In 
principal such an approach would identify genes that are either upstream or downstream of 
an Oct-6 dependent pathway or the gene functions in a parallel non-redundant pathway. 
The mouse autosomal recessive mutation elaw paw (elp) fits these criteria 18. Homozygous 
clp/elp mice produce striking limb posture abnoffilalities together with delayed and 
abnormal myelination in the peripheral nervous system but not in the central nervous 
system 18. The clp defect has been mapped to mouse chromosome 7. Transplantation 
experiments of sciatic nerves from normal and clp/clp animals demonstrated that the elp 
mutation is a Schwalm cell autonomous mutation (our unpub1ished results). We have also 
shown that in clp/elp mice Oct-6 is expressed. This suggests that clp acts either downstream 
of Oct-6 in an Oct-6 dependent pathway, or functions in a parallel non-redundant pathway. 
Our group is currently in the process of characterising the gene (or genes) affected in clp 
mice using a positional cloning approach. 
Two known genes that have been identified as potential Oct-6 target genes by 
genetic approaches, are Krox-20 and Oct-6 itself. During Schwallll cell development and 
nerve regeneration, Oct-6 expression precedes that of Krox-20 19, Furthermore, there is ill 
vitro evidence that Krox-20 activates PO expression 20. These data are in agreement with 
the suggestion that Oct-6 is upstream of Krox-20 in the genetic hierarchy that governs 
myelination. The suggestion that Oct-6 regulates Krox-20 expression is supported by the 
following observations. First, Oct-6 expression is normally induced at the promyelinating 
stage in homozygous Krox-20 knockout animals 20. Second, Krox-20 expression is absent 
in transiently arrested Schwann cells at the promyelin stage of homozygous Oct-6 knockout 
mice (Mandemakers and Meijer, unpublished results). Finally, the presence of two potential 
POU specific octamer binding sites in the Krox-20 promoter region, in agreement with 
direct regulation of Krox-20 by Oct-6 21. The relevance of these sites, however, remains to 
be determined. Thus, these data support a model in which Oct-6 is required for activation of 
the Krox-20 gene expression, which in turn activates, possibly together with Oct-6, the 
major myelin genes (See Fig. I). 
The suggestion that Oct-6 is involved in regulation of its own transcription came 
from the following observation. The p-galactosidase gene in the targeted Oct-6 
transcription unit was used to determine the activity of the Oct-6 locus in neWb0111 and 
adult heterozygous and homozygous Oct-6 knockout animals. Although the Oct-6 locus 
was normally activated in nerves of newborn pups of both genetic backgrounds, only the 
locus in the nerves of heterozygous Oct-6 knockout mice was properly down regulated in 
adult animals. Nevertheless, myelination had proceeded normally in adult mice of both 
genetic b"ckgrouuds 14, Thus, these results suggest that Oct-6 itself is involved in the down 
••• n ,., ••••• " • •••• n. 
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regulation of its own expression (directly or indirectly) as Schwann cells proceed to 
myelinate their axons. Potential mechanisms of how Oct-6 is involved in its own down 
regulation will be discussed in section 6.3.2 
6.2 Oct-6 redundant factors 
Another conclusion that can be drawn from our analysis ofOct-6 null mice is that 
Oct-6 does not appear essential for myelination per se. After a temporal delay, Oct-6 null 
Schwaml cells evcntually initiate the myelination programme 8 One can think of several 
possible explanations for these observations. All of these explanations assume that a factor 
must exist that can partially substitute for Oct-6 function. The first possibility is that this 
factor binds to the same DNA recognition sequences as Oct-6 and contains a similar protein 
domain able to activate or repress the same target genes as Oct-6 does. This would most 
likely be another closely related POU-domain transcription £1ctor. The temporal delay in 
myelination in Oct-6 null mice could result then either from a reduced output of target 
genes or a temporal difference in expression between those factors and Oct-G. Until 
recently, the only other POU domain factor present in Schwann cells, in addition to Oct-6, 
is the ubiquitously expressed Oct-I protein 22,23 As both factors bind to similar DNA-
binding sequenccs, it is possible that Oct-I partially replaces Oct-6 function. Such 
functional redundancy between POU factors has been demonstrated also in other systems, 
such as in the oligodendrocyte lineage 24. If indeed Oct-I does regulate normal Oct-6 
targets, it probably does so inefficiently. A delayed build up of physiologically relevant 
levels of target proteins would then explain the delayed onset of myelination. 
Recently, we have identified another DNA-binding protein in chicken sciatic 
nerves, which binds the same recognition sequence as Oct-6 (See chapter 3, Fig. 3). This 
protein is also present in mouse sciatic nerves and its expression profile conelates with the 
delayed onset of myelination in Oct-6 -J- mice (our unpublished results). We are currently 
characterising this interesting candidate OctM 6 redundant fhctor. 
Second, it is still possible that the Oct-6 redundant factor is not a POU domain 
protein, but an unrelated transcription factor that binds to distinct cis-acting elements of 
Oct-6 target genes. This could be a factor, normally required for maintenance. of 
transcriptional regulation of genes, initially activated or tumed off by Oct-6. Expression of 
this unknown factor should be initiated at the time when Schwallll cells of Oct-6 null mice 
start to myelin ate (i.e. two weeks after birth). 
6.3 Oct-6 regulation 
As mentioned earlier, previous results suggest that axonal signalling is 
required for activation of Oct-6 expression in Schwallll cells, while at least Od-6 itself is 
required for silencing its own locus. Identification of the cis-acting elements mediating 
these events is an important step in decoding the complex signalling pathways between 
Schwann .. cells and axons .. goveming myelination and Oct-6 down regulation, The 
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identification of such a Schwam! cell specific regulatory element in the Ocl-6 locus and 
discussion is presented in chapter 5. In the next sections I will elaborate filrther on Oct-6 
gene regulation and the role of the SCE. 
6.3.1 Oct-6 regulation: activation 
The Oct-6 Schwam! cell specific enhancer (SCE) directs spatially and temporally 
CO!Tect expression of Oct-6 both during normal peripheral ne!ve development and 
regeneration (chapter 5). The SCE can also activate reporter gene expression in the 
presence of a heterologous promoter, indicating that all essential cis-acting elements that 
mediate Oct-6 activation reside within the SCE. The SCE contains two DNaseI 
hypersensitive sites (HSS) (HSS-6 and HSS-7), which is indicative for potential cis-acting 
regulatory elements 25. Preliminary results have demonstrated that both HSS are also 
present in P4 peripheral nerves, supporting their involvement in Oct~6 activation 
(Mandemakers, unpublished results). Failure of these sites to individually generate 
Sehwaml cell specific expression suggests that both sites are required for full enhancer 
activity (see chapter 5). 
Our transgenic experiments demonstrate that the SCE is sufficient to drive 
Schwann cell specific expression of a transgene, but does not exclude the possibility that 
additional elements with sinlilar properties reside elsewhere in the OCI-6 locus. Targeted 
deletion of the SCE is required to determine whether it is indeed the major Schwann cell 
specific element in the OCI-6 locus or whether there are other elements within the locus that 
direct Schwann cell specific expression of Oct-6. We have now generated mice in which 
the SCE is deleted and preliminary results demonstrate that the SCE is indeed essential'for 
Schwalill cell specific expression of Oct-6 (W.Mandemakers and M.Ghazvini, unpublished 
results). In these mice Oct-6 expression in Schwam! cells is lacking, while Oct-6 expression 
in other tissues appears unaffected. We are also in the process of generating null mutants of 
·HSS6 and HSS7 individually, to determine the relevance of these sites illl'ivo. 
The SCE homologous region in humans is also able to drive Schwann cell specific 
expression of a transgene in mice, indicating that the important sequences mediating Oct-6 
activation are conserved during evolution. Sequence comparison between the mouse and 
human SCE demonstrated high sequence conservation in both HSS regions (Mandemakers, 
unpublished results). The high similarity between these two sequences does not facilitate 
easy identification of essential DNA-binding sites, required for Oct-6 activation. This 
would require the identification of and sequence comparison with the SCE homologous 
region of evolutionary more distant species, such as chicken and zebra fish, in which Oct-6 
function in Schwam! cells is conserved (chapter 3)26. 
In a parallel approach we are filrther n",Towing down the HSS-6 and HSS-7 
chromatin regions in Schwann cells using a PCR-based DNaseI HSS mapping method 
27,28. Subsequently, ill viva footprinting will determine the critical DNA binding 
sequences in the resulting smallest HSS region. The role of these binding sites in Ocl-6 
activation will be tested by ill vivo mutagenesis or deletion in mice using homologous 
recombination in ES cells 29,30. Both approaches will lead to the identification of DNA-
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binding site of known and unknown transcription factors, essential for Oct-6 activation 
during Schwann cell development. The identity of this 
putative regulator (X) could be revealed, by peptide sequencing of Schwann cell specific 
factors interacting with the corresponding DNA-binding site. One of the requirements for 
Oct-6 to be directly regulated by this factor X would in the first place be the loss of Oct-6 
expression in X-null Schwaml cells. Another requirement would be that the region to which 
factor X binds in the Oct-6 SCE, should be specifically pulled down in chromatin 
immulloprecipitation assays 17, Although laborious and time-consuming, these approaches 
would provide the most compelling evidence that this factor is indeed involved in 
activation of Oct-6 expression. 
In summary, the SCE contains all the cis-acting elements required for timely and 
spatially conect activation of Oct-6 expression in Schwann cells upon axonal contact. 
Identification of transcription factors that bind to these elements is in progress. 
6.3.2 Oct-6 regulation: down regulation 
Although the SCE mediates activation of Oct-6 during development, it is unclear 
whether it is also sufficient for down regulation of Oct-6. Experiments presented in chapter 
5 demonstrate that a reporter driven by the SCE is correctly down regulated. However this 
constmct still contains the endogenous Oct-6 promoter. It is therefore possible that the 
endogenous Oct-6 promoter is required for correct down regulation of Oct-6. We are 
currently testing this possibility by determining whether the laeZ reporter gene driven by 
the heterologous HSP68 promoter and SCE is properly regulated in adult transgenic 
animals of constmct IX (see chapter 5). Presence of lacZ expression in adult mice of this 
line would suggest that the endogenous Oct-6 promoter is required for down regulation of 
the locus. 
As mentioned before, Oct-6 itself is required for the proper down regulation of its 
own locus (see section 6.1). Auto-regulatory loops have been described for other POU 
domain proteins, however those are all positive regulatory loops 31-35. Negative feedback 
loops have been described for many proteins such as P53, TIM, and goosecoid 36-38. For 
almost as many genes that are subjected to auto-repression, a similar number of 
mechanisms have been proposed to bring about repression of an active locus (reviewed in 
39,40). The mechanism involved in Oct-6 auto-inhibition remains to be determined. 
Another factor potentially involved in down regulation of Oct-6 is Krox-20. In the 
occasional Krox-20 knockout animals surviving postnatally, Oct-6 expression remains at 
high levels, while in normallittermates Oct-6 expression is down regulated after two weeks 
20. This observation suggests that continuous expression ofKrox-20 is another requirement 
for Oct-6 silencing to oCCUI'. However, an equally plausible explanation is that high levels 
ofOct-6 expression observed in postnatal stages of Krox-20 knockout nerves is attributable 
to the block at the promyelinating stage of Schwarlll cell development 20. Furthemlore, 
although late, Krox-20 expression is apparently nonnal in the nerves of few surviving adult 
Oct-6 homozygous knockout animals, in which myelination has proceeded normally 
(Mandemakers and Meijer, unpublished results) 14. Together with the fact that the Oct-6 
locus is not down regulated in these mice, these data argue against a direct role for Krox-20 
'in extingiifshillg'Oct:6"e'xpression 14. 
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Alternatively, it is possible that Oct-6 is down regulated during a natTow window 
of normal postnatal development, possibly by a factor that is only transiently present. 
Hence, either by itself or via interaction with either Oet-6 or Krox-20, this factor could bind 
to Oct-6 cis-acting regulatory elements and repress transcription. This could explain the 
lack ofOct-6 down regulation in both Oct-6 and Krox-20 knockouts. In the case of the Oct-
6 knockout, either the lack of Oct-6 or too late expression of Kl'ox-20 would disable the 
formation of the hypothetical Oct~6 repressive complex, resulting in constitutive activation 
of the Oct-6 locus. In the Krox-20 knockout, the lack of Krox-20 could interfere with the 
formation of this complex, which leads to the absence of Oct-6 down regulation. The 
presence of such a developmentally restricted factor might also explain why, in case of 
nerve regeneration, Oet-6 is not down regulated for at least 60 days after nerve damage 7. 
The existence of such a temporally restricted factor could be tested in clp/elp 
animals, since they display a similar delay in myelination as in Oct-6 null mice. High levels 
of Oct-6 expression in adult elp/elp mice would give more support for the presence of such 
a factor. We are currently investigating this possibility. 
In addition, the transcription factor SoxlO has been demonstrated to interact with 
both Oct-6 and Krox-20. However, SoxlO is continuously expressed during SchWalm cell 
development, mling out the possibility that it is the transient cofactor 
41 Two other interesting candidates would be the cofactors NAB I and NAB2, which 
repress transcriptional activation by Krox-20 42,43. Preliminary results from our group 
demonstrated that both NAB I and NAB2 are expressed in mouse sciatic nerves. Their 
expression pattern in SchWalm cell differentiation remains to be determined 
(W.Mandemakers, unpublished results). 
At present it is unresolved whether the Oet-6 SCE or its promoter is sufficient for 
the down regulation of Oct-6 in myelinating Schwann cells. Although various mcchanisms 
can be proposed, it is certain that expression of OctR 6 and progression into myelination is 
required for shutting off Oct-6 expression. 
·6.4 Model and final considerations 
From the data presented and discussed in the previous sections the following 
model emerges (Fig. I). Following acquisition of a one-to-one relationship with an axon the 
Schwann cell is signalled to initiate the myelination program. One of the first targets of this 
signaling is upregulation of Oct-6 gene expression, an event that is mediated through the 
Oct-6 Schwalll} cell enhancer (SCE). The transacting factors binding to this regulatOlY 
element have not been identified as yet. Subsequently, Oct-6 regulates expression of a set 
of downstream genes, which possibly ineludes Krox-20, elp and the major myelin genes, 
driving the differentiation of these cells. Recently we have obtained additional evidence to 
suggest that Oct-6 act as a forward drive for myelination. As myelination proceeds, Oct-6 
expression is extinguished in myelinating Schwann cells. The exact mechanism by which 
down regulation of Oct-6 is achieved, and whether it acts on the SCE or the Oct-6 
promoter, remains to be established. However, it is clear from our experiments that at least 
the expression of Oet-6 itself, and possibly Krox-20, is required to silence the Oet-6 locus. 
The fact that myelination does proceed in the absence of Oct-6, albeit with considerable 
delay, suggests the existence of an Oct-6-like or redundant factor. The identity of the 
redundant factor is as yet unknown although we havel'ecently identified a strong candidate, 
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Our results, described in this thesis, firmly establish the Oct-6 POU domain 
protein as an important intracellular regulator of myelination and identifY the SCE as a 
major target of axonal signalling. The specific properties of the SCE make it an attractive 
target for therapeutic intervention in a clinical setting. This suggestion is based on a number 
of observations. Nerve regeneration following damage, takes months before cOlmections 
with target organs are restored. A plethora of studies has been performed to identifY 
neurotrophic factors that increase the speed of regeneration (reviewed in 31). Factors 
involved in Oct-6 activation might also improve nerve regeneration. For example, it has 
been shown that premature and over-expression of the POU domain of Oet-6 ("SCIP) in 
Schwalm cells results in accelerated nerve regeneration following crush damage 44, Thus, 
therapeutic agents that modulate Oct-6 gene expression might prove beneficial in 
stimulating nerve regeneration. Also, the SCE might prove a valuable tool in gene therapy 
approaches in myelin related diseases. For instance, viral vectors in which the SCE directs 
the expression of nerve regeneration promoting factors might have important advantages 
over more conventional vectors. It is anticipated that after regeneration is completed 
transgene expression is extinguished while in vectors that use constitutive promoter 
expression is sustained (chapter 5) 45,46 . 
'. 
................ 
'" ..... 
...................... 
Pro·myelinating Schwann cell 
Oct·6 activation 
Myelinating Schwann cell 
Oct-6 repression 
Figure 1: Activation (a) and repression (b) ofOct-6 during different stages of Schwa nil cell development and the 
involvement of the SCE in Ihis process. For details see text. Abbreviations: SCE, Sehwann cell enhancer; X?, 
unknown factor;?, unknown factor; clp?, claw paw gClle(s); RER, rough endoplasmatic reticulum. 
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Summary 
The developmental and proper function of peripheral nerves in the vertebrate 
nervous system depends on the intimate interactions and continuous signalling between the 
Schwalm cell and its associatcd nerve fiber(s). One important function of the Schwann cell 
is the elaboration and maintenance of the myelin sheath, a highly specialised laminar 
membranous organelle. A major consequence of the myelin sheath is that axonal 
depolarisation is restricted to the nodes of Ranvier, resulting in a saltatory mode of electric 
impulse propagation that is approximately a hundred times faster than the conduction 
velocity of a non-myelinated nerve fiber with the same diameter. Myelin is one of nature's 
most recent inventions, and clearly played an essential role in the evolution of compact 
nervous systems in larger animals. The myelin sheath is of vital importance to the 
organism, as the destmction or instability of the sheath leads to impaired nerve function and 
severe neurological problems. Prime examples of such neurological diseases are multiple 
sclerosis, the inflammatory neuropathy Gui1lain-Barre syndrome or the genetic diseases 
Charcot-Marie-Tooth, Dejerine-Sottas and Pelizaeus-Merzbacher. 
Pioneering work by Aguayo and collegues havc indicated that the myelination 
program of Schwann cells is under control of the associated axon. The axonal 'instruction' 
has to be relayed to the Schwann cell nucleus where a genetic program is deployed that 
results in the elaboration of the myelin sheath. 
In this thesis, experiments are described that identifies the POU domain 
transcription factor Oct-6 as a key regulator of this genetic program. Activation of Oct-6 is 
under the control of an axonal signal, which converges on a remote cis-acting element 
within the Oct-6 locus. This element is sufficient to activate the Oct-6 gene in a temporally 
correct fashion, both during nerve development and regeneration. In addition, we show that 
Oct-6 gene expression is under control of a negative feedback loop that attenuates the leyel 
of Oct-6 expression. The importance of this negative feedback loop is underscored by the 
observation that even mild overexpression of the gene in myelinating cells results in 
hypermyelination and abnormal nerve function. Furthermore, we show that transcriptional 
silencing of the Oct-6 gene in myelinating Schwann cells is dependent on both Oct-6 itself 
'and myelination as such. 
It is anticipated that our identification of Oct-6 as a key regulator of peripheral 
nerve myelination and our description of the major Oct-6 regulatOlY sequences will open up 
new avenues for the development of therapeutic strategies to ameliorate the devastating 
effects of impaired peripheral nerve function and enhance the rate and extend of nerve 
regeneration following trauma. 
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Signalen uit de omgeving van gewervelde dieren, zoals de mens, worden door 
zintuigen (horen, zien, voelen, miken, proeven) via zenuwhanen doorgegeven aan het 
centrale zenuwstelsel. Het centrale zenuwstelsel verwerkt deze informatie en stuurt signalen 
bijvoorbeeld naar bepaalde spiergroepen om een gepaste reactie teweeg te brengen. De 
meest basale vorm van deze interactie tussen het organismc en zijn omgeving wordt een 
reflexboog genoemd en vindt bijvoorbeeld plaats als men in een punaise trapt en men 
onwillekeurig het been optrekt. De reactie op een stimulus kan echter ook bei"nvloed 
worden door bepaalde hersengebieden die bijvoorbeeld betrokken zijn bij emotionele 
processen. Dit vindt bijvoorbeeld plaats als men eten wil serveren in een dure schaal die 
ontzettend heet blijkt te zijn als men hem oppakt. In een reflex zou men de dure schaal los 
laten en kapot laten vallen, maar door emotionele signalen uit de hersenen wordt de 
reflexboog onderdmkt en probeert men een gulden midden weg te vinden om de handen 
niet te verbranden en de dure schaal te sparen. Deze reacties tonen onder andere aan dat 
verschillende gebieden van het centrale zenuwstelsel op een nauwkeurige manier met 
elkaar verbonden Zijll. 
Het zenuwstelsel van gewervelde dieren bestaat uit een aaneenschakeling van 
honderden miljoenen cellen, neuron en. Neuronen zijn met elkaar, met zintuigen, met 
spieren of met de organen verbondell via lange uitlopers die axonen worden genoemd. 
Buiten de beschermende omhulling van de schedel en wervelkolom zijn axonen gebundeld 
in een beschermende bindweefsel laag. Deze stmchmr wordt een zenuwhaan genoemd en 
kan zijn opgebouwd uit honderden axonen. In het menselijk lichaam kunnen axonen meer 
dan een meter lang zijn, zoals bepaalde axollen die in zenuwbanen van het ruggenmerg tot 
in de tenen lopen. Tevens maken neuron en ook contact met elkaar via kartere uitlopers, 
dendrieten. Het zenuwstelsel is grofweg op te splitsen in het centrale zenuwstelsel (de 
hersenenen en het mggenlllerg) en het perifere zenuwstelsel, wat aile neuron en' en 
zenuwenballen omvat die buiten het centrale zenuwstelsel vallen. 
De aaneengeschakelde neuronen geven impulsen door via een elektrochemisch 
proces. Bijvoorbeeld, het lieht van een computer beeldscherm aetiveert lichtreceptoren die 
,achter in het oog liggell. Deze Iichtreceptoren zijn verhonden met axonen van neuronen 
(sensorische neuronen) in de hersenen. Stimulering van lichtreceptoren veroorzaakt een 
verandering van de verdeling van geladen deeltjes binnen en buiten de celmembraan van 
het axon. Deze verandering, depolarisatie, zorgt dat een elektrische stroom ontstaat wat zich 
via een domino-effect over de hele lengte van het axon van het oog naar het cellichaam van 
het sensorische neuron in de hersenen verplaatst. Aan het andere uiteinde van het neuron 
bevinden zich dendrieten, die contact maken met andere neuron en. Op de plaatsen waar het 
sensorische neuron contact maakt met het volgende neuron (synapsen) scheidt het 
sensorische neuron, in reactie op de depolarisatie, biologisch actieve stoffen uit die weer 
een depolarisatie kunnen veroorzaken in het volgellde neuron. Op deze manier worden 
impulsen van receptor tot neuron en van neuron tot neuron doorgegeven. Uiteindelijk zal 
het resulteren in activatie van neuronen (motoneuronen) die de impulsen doorgeven aan 
spieren in de vingertoppen, die er voor zorgen dat bepaalde toetsen op het toetsenbord 
worden ingedrukt. 
Van het moment van ac!ivatie van lichtreceptoren in het oog tot het moment dat de 
vingertoppen het toetsenbord raakt, duurt ongeveer een duizendste van een seconde. Deze 
hoge snelheid van impulsoverdracht zorgt dat gewervelde dieren snel klllmen reageren in 
bljvootbeeld l"veilsbedteigenMsituaties: Eenllatilaillahpassmgetl iil lietzeilu\,"stelsel-zorgC 
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voor een hogere snelheid van impulsoverdracht in axonen. Ten eerste zorgt een grotere 
diameter van het axon voar een hogere snelheid. De grotere diameter zorgt voor cen lagere 
weerstand, waardoor de impuls zich sneller langs de lengte van het axon kan YClpiaatsen. 
Deze aanpassing is vooral duidelijk in ongewervelde dieren zoals inktvissen, waar axonen 
een diamcter van ongevecr 1 nun kUllllen bereiken. In vergeIijking zijn de dikste axonen in 
het menselijk lichaam 20 !lm (50 maal zo klein!). Desalniettemin, is de snelheid van 
impulsoverdracht in axonen met dezelfde diameter in gewervelde dieren 100 maal zo hoog 
als in ongewervelde dieren. Dit verschil wordt veraorzaakt door een andere aanpassing van 
het zennwstelsel, wat aileen in hogere klasscn van dc gewervelde dieren, zoals de mens, 
heef! plaatsgevonden. 
Deze aanpassing bestaat nit het aanbrengen van een eiwit- en vetrijke isolatielaag 
rand de axon en, welke myeline wordt genoemd. Er zijn twec typen cellen geassocieerd met 
axonen die deze isolatielaag aanmaken. In het centrale zenuwstelsel zijn dat de 
oligodendrocyten en in het perifere zenuwstelsel zijn dat de Schwann cellen. Omdat dit 
proefschrif! over Schwann cellen handelt, zullen in het vervolg de oligodendrocyten slechts 
zijdelings ter sprake komen. Schwann cellen wikkelen zich meerdere malen rand cen axon, 
vergelijkbaar met het aanleggen van een bandage rond een arm of been. Het aantal lagen 
wat geVOlTIld wordt door de Schwann eel mcmbraan en de lengte daarvan hangt samen met 
de dikte van het axon. Hoe dikker het axon, hoe meer Iagen een Schwann eel vonnt en hoe 
langer het omwikkelde segment. In tegenstelling tot oligodendrocyten, maakt een Schwaml 
eel contact met maar een axon. Er zitten echter meerdere Schwann eellen dicht 
aaneengesloten langs een axon, waardoor ze een bijna ononderbroken isolatielaag rond het 
axon vonnen. De enige plaatsen waar het axon niet bedekt is door de isolatielaag, is tussell 
twee Schwann cellen in. Deze openingen in de myeline laag zijn vernoemd naar hun 
ontdekker en worden knopen van Ranvier genoemd. Depolarisatie van een gemyelineerd 
axon kan allen bU deze knopen van Ranvier plaats vinden, waardoor een impuls zich 
'sprongsgewijs' langs het axon verplaatst. Deze sprongsgewijze impuls geleiding gaat vele 
malen sneller dan geleiding volgens een domino-effect zoals bij een niet gemyelineerd 
axon. Echter beschadiging of instabiliteit van de myeline laag leidt tot een verslechterde 
geleiding van signalen langs deze zenuwbanen, hetgeen resulteert in ernstige neurologische 
problemen. Bekende voorbeelden van ziektes waarbij de myeline laag is aangedaan zijn 
onder andere de autoimmuun ziektes multiple sclerose (MS) en Guillain-Barre of de 
genetische afwukingen Charcat-Marie-Tooth (CMT), Dejerine-Sattas en Perlizaeus-
Merzbacher. 
Naast het aanleggen van de myelinelaag ZUn Schwann cellen betrokken bij 
processen die bijvoorbeeld leiden tot de fomlatie yan perifere zenuwen tijdens de 
embryonale onn.vikkeling, maar ook tijdel1s de regeneratie van perifcre zenuwell ua een 
beschadiging. Het laatst genoemde feit is uniek VOOI' perifere zenuwen. In het centrale 
zenuwstelsel van volwassen dieren herstellen zenuwbanen maar zeer beperkt of helemaal 
niet na een beschadiging, zoals bijvoorbeeld na cen dwarslaesie in het ruggenmerg. Er zijn 
el1kele fhctoren die hierbij een ral spelen waar nn niet verder op ingegaan wordt. Echter, in 
het perifere zenuwstelsel zijn axonen weI in staat om na beschadiging terug te groeien naal' 
hun aorspronkelijke contactplaats, wat kan leiden tot volledig hers tel van de verloren 
functies. SchwaHn cellen spelen een belangrijke rol in dit proces, onder andere doordat ze 
groeifactoren voor neuranen uitscheidcll waardoor axonen kunnen tcrug groeien naar hun 
doel. Dit aspect van Schwann cellen heeft veel aandacht van klinische onderzoeksgraepen, 
omdat·, factoren ·die"het" herstel ,van" perifere "zenuwen .. versnellenMmisschien" ook ,kunnen. 
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worden toegepast om herstel van schade in het centrale zenuwstelsel te bevorderen. Het is 
daarom van belang om de rol van Schwann cellen in processen zoals zenuwherstel en het 
aanmaken van een myeline laag tot op moleculair niveau te onderzoeken. 
Een eerste vereiste vocr een Schwann celom een myeline laag aan te leggen is 
contact met een axon. Een tweede vereiste is dat de diameter van het axon groot genoeg 
moet zijn. Als de diameter van het axon kleiner is dan I ~lIn, dan wordt het axon niet 
gemyelineerd. Naast deze vereisten is er nag weinig bekend over hoe het axon een 
Schwalm cel instmeert om een myeline laag te vormen. Dit proefschrift toont aan dat de 
Schwann cel intrinsieke factor Oct-6 een belangrijke ral speelt in het aanleggen van de 
Myeline laag. 
Zoals aile andere cellen in het lichaam van gewervelde dieren bestaat een 
Schwam} cel uit verschillende compartimenten, zoals bijvoorbeeld het endoplasmatisch 
reticulum of de celkern. De celkem bevat een groot aantal lange strengen moleculen die 
DNA worden genoemd. DNA is opgebouwd uit 4 bouwstenen (basen) welke in een 
specifieke volgorde met elkaar verbonden zijn. In deze specifieke voIgorde van basen ligt 
de genetische informatie van het organisme opgeslagen. In bepaaIde delen van het DNA 
codeert een specifieke volgorde van basen, een gen, voar een bepaald eiwit. Ben gen kan 
worden herkend door specifieke eiwitten (algemene transcriptiefactoren) die er voor zorgen 
dat de code van het gen wordt 'overgeschreven' (transcriptie) waardoor een boodschapper 
moIecuul (mRNA) ontstaat wat weer door andere eiwitten kan worden vertaald (translatie) 
in het eiwit waarvoor het gen codeer!. Het vertaalde eiwit kan bijvoorbeeId een functie 
hebben in aile cellen van het organisme, zoals DNA hersteI eiwitten. Echter, het kan ook 
een eiwit zijn wat aileen aanwezig behoort te zijn in Schwann cellen, zoals myeline 
eiwitten, of in rode bloed cellen, zoals de eiwitten die hemaglobine vonnen. Om te 
voorkomen dat bijvoorbeeld hemoglobine eiwitten in Schwann cellen aanwezig zijn en 
myeline genen in bloedcellen, hebben cellen een aantal regulatie mechanismen ontwikkeld. 
Een belangrijke rol in deze is weggelegd voor de zogenaamde weefsel specifieke 
transcriptiefactoren. Deze factoren zijn aanwezig in celtypes waar ze aileen die genen 
reguleren die een DNA code hebben die door deze transcriptiefactoren kunnen worden 
herkend. Een voorbeeld van zo'n weefselspecifieke transcriptie factor in Schwann cellen is 
het POU domein eiwit Oct-6. Het POU domein van Oct-6 is een deel van het eiwit wat een 
specifieke DNA code kan herkennen en daaraan binden om vervolgens met andere delen 
van het Oct-6 eiwit transcriptie van een gen te reguleren (bijvoorbeeld: aan of uit zetten). 
De aanwezigheid (expressie) van Oct-6 zelf in Schwarm cellen is ook strikt gereguleerd. 
Tijdens de embryonale ontwikkeling is Oct-6 aileen aanwezig in cellen die op het punt 
staan om een myeline laag om het axon te leggen. Zodra de myeline laag wordt aangelegd 
wordt Oct-6 als het ware weer uitgeschakeld. Een vergelijkbaar proces vindt plaats in 
SchWalm cellen na beschadiging van perifere zenuwen in volwassen dieren. 
Na beschadiging van een perifere zenuw vindt een ingenieus proces van 
regcneratie plaats. Een neuron verliest het axon tot voorbij de schade, maar hehoud het 
axon wat nog verbonden is met het cellichaam van het neuron tot vlak voor de plaats van de 
beschadiging. De Schwaml cellen die in contact waren met het verloren stuk axon verliezen 
hUlll1lyeline laag en gaan weer op embryonale Schwallll cellen lijken. Deze Schwann ceIIen 
scheiden factoren uit die het telUggroeien van het axon bevorderen. Zodra het axon weer in 
contact komt met die Schwam} cellen, wordt Oct-6 in die cel aangezet en uiteindelijk zal 
die eel een myeline laag am het axon aanbrcngen. Zoals eerder vermeldt zal dit aileen 
plaatsyillden als.het.axon.dik.genoeg.is. 
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Het lijkt er dus op dat Oct-6 expressie in een Schwa1ll1 cel belangrijk is am een 
axon te myelineren. Tevens is uit eerder onderzoek in ratten en Illuizen gebleken dat, tot ntl 
toe, Oct-6 het eerste eiwit is dat wordt aangeschakeld in een Schwann cel die uiteindelijk 
zal gaan myelineren. Deze observaties brengen onder andere de volgende vragen ter berde. 
Ten eerste, wat is de functie van Oct-6 in een Schwalm cel? Is het betrokken bij de aanleg 
van myeline of misschien bij een ander aspect van Schwann eel functie. Ten tweede, wat 
zijn de signal en die er voor zorgen dat Oct-6 wordt aangeschakeld in Schwa1ll1 cellen die 
gaan myelineren en wordt uitgeschakeld in cellen die een myeline laag hebben gevormd? 
De experimenten die in dit proefschrift beschreven staan hebben tot doel een antwoord te 
vinden op deze vragen. 
In hoofdstuk 2 is met een bepaalde techniek, homologe recombinatie, het Oct-6 
gen venvijderd uit het DNA van aIle cellen van de muis en vervangen door een inactief gen. 
Deze muizen kunnen geen OctR 6 eiwit meer aanmaken. Vit ons onderzoek is gebleken dat 
de Schwarlll cellen in die muizen niet goed meer functioneren. De myeline laag wordt weI 
aangemaakt, maar met een vertraging van ongeveer twee ,veken in verhouding tot even 
oude muizcn die hct Oct-6 eiwit nag weI kUl1l1en aanmakell. Verder, zij er waarschijnlijk 
andere factoren die op Oct-6 lijken en die de functie van Oct-6 in afwezigheid van Oct-6 
ovememen, waardoor Schwann cellen in afwezigheid van Oct-6 uiteindelijk alsnog gaan 
myelineren. 
Experimenten beschreven in hoofdstuk 3 tonen aan dat Oct-6 oak in Schwann 
cellen voorkomt in dieren die evolutionair gezien vcr van de muis afstaan, zoals de kip en 
de zebravis. Ten eerste duidt deze conservering van Oct-6 expressie er op dat oak de 
fimctie van Oct-6 bewaard is gebleven. Ten tweede is het mogelijk dat oak de signalen die 
ervoor zargen dat Oct-6 specifiek in SchWalm cellen wordt aan- en uitgeschakeld tijdens de 
evolutie zijn geconserveerd. Experimenten in hoofdstuk 4 en 5 hebben tot doel am 
duidelijkheid te verschaffen over hoe Oct-6 specifiek in Schwarm cellen wordt aan- en 
uitgeschakeld. 
Experimenten gedaan in reageerbuizen (ill vitro) en in muizen (ill vivo) in 
hoofdstuk 4 tonen aan dat codes in het DNA vlak voor het Oct-6 gen (promotor) waar 
transcriptiefactoren aan kunnen binden, bctrokkcn zijn bij de actlvatie van het Oct-6 gen, 
maar niet voldoende zijn om Oct-6 specifick in Schwann cellen aan te schakelen. Deze 
observatie komt vooral naar voren in de ill vivo experimenten. Hierbij is met behulp van 
moleculair biologische technieken een gen uit een bacterie, lacZ genaamd, aan het Oct-6 
gen gevoegd. Stukken DNA van verschillend grootte die dit 'fusie-gen' bevatten zijn 
vervolgens doormiddel van microinjectie ingebracht in bevruchte eiceHen van de muis. De 
muizen die uit deze eicellen geboren worden en het filSie-gen in zich hebben worden 
transgene muizen genoemd. Als het stuk DNA waarap het fusie-gen ligt codes bevat voor 
transcriptiefactoren die nodig zijn voor spccifieke expressic in Schwann cellen, dan kan het 
fusie-gen in SchWalm cellen tot expressie komen. Dit kan dan eenvoudig bepaald worden 
door gebruik te maken van de activiteit van het lacZ gen. Dit gen is instaat am een 
kleurloos substraat om te zetten in een onoplosbare blauwe neerslag wat eenvoudig te 
detecteren is. Omdat bacterieel lacZ nonnaailliet in de muis aanwezig is, wordt de blauwe 
neerslag aileen gevonnd in de weefsels waar het transgen aetief is. Muizen die cell transgen 
bevatten wat aIleen bestaat uit de Oct-6 promotor en het fusie-gen op een stuk DNA wat is 
opgebouwd uit ongeveer 7.000 basen, vertonen geen blauwe kleuring in de Schwalm cellen. 
Echter, in muizen die transgeen zijn voor een fusie-gen wat op een stuk DNA ligt van 
32000 . .basell.kleurell de Schwallll.cellen weI blauw .. Te"ensverd;yijntdeblallwek.le.uLwe.er. 
in myelineerende Schwann eellen van volwassen transgene muizcn. Rieruit valt op te 
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maken dat, op een stuk DNA waar het Oct-6 gen ongeveer in het midden ligt, de DNA 
codes (sequenties) waaraan transcriptiefactoren kunnen binden die zorgen dat Oct-6 
specifiek in Schwann cellen wordt aan- en uitgeschakeld zich buiten de 7000 basen, maar 
binnen die 32000 basen moeten bevinden. De locaties van die sequenties zijn nauwkeuriger 
bepaald in hoofdstuk 5. 
Door stap voor stap het stuk DNA van 32000 basen klciner te maken, hebbcn we 
in hoofdstuk 5 een regia van ongeveer 4000 basen kunnen identificeren, wat voldoende is 
am, net als normale Oct-6 gen, het trallsgell specifiek in Schwaml cellen aan- en uit te 
schakelen zowel tijdens de embryonale ontwikkeling als na zenuw beschadiging. Dit 
fragment hebben we de Schwann cel enhancer (SeE) gedoopt. De SeE ligt op enige 
afstand achter het Oct-6 gen. Het vergelijkbare stuk DNA uit het genoom van de mens is 
eveneens in staat om het transgen specifiek in muizen Schwann cel1en tot expressie te 
brengell. Deze resultaten duiden er op dat in de seE de DNA sequenties waaraan 
transcriptiefactoren kunllell billden tijdens de evolutie geconserveerd zijn. Een aanwijzing 
voor de aanwezigheid van dergelijke sequentics in de SeE komt uit experimentell waarin 
we het genoom van muizen cellen hebben behandeld met een enzym, DNAse, wat het DNA 
specifiek op plaatsen knipt waar normaal transcriptie factoren binden. Uit deze 
expcrimenten komt naar voren dat er twee DNAse gevoelige regio's in het DNA'van de 
seE aanwezig zijn. Deze DNAse gevoelige regio's zijn potentieel de seqnenties waaraan de 
transcriptiefactoren kunnen binden die er voor zorgen dat Oct-6 specifiek in Schwarm 
cellen tot expressie komt. Muizen die een transgen dragen met slechts een beide DNAse 
gevoelige regio's van de seE vertonen geen blauw kleuring in Schwailll cellen, wat er op 
duidt dat beide regio's tezamen nodig Zijll om Schwann cel specifieke expressie te 
bewerkstelligen. 
In hoofdstuk 6 trekken we de conclusies uit de resultaten van het onderzoek 
beschreven in dit proefschrift en doen we een aantal suggesties over hoe we dit onderzoek 
kunnen voortzetten. Ten eerste kan geconcludeerd worden dat Oct-6 een belangrijke rol 
speelt tijdens de Schwann cel ontwikkeling door het myelinatie proces tijdig te laten 
beginnen. Waarschijnlijk reguleert Oct-6 genen die het myelinatie proces ten uitvoer 
moeten brengen. Ons huidig onderzoek is er op gericht om deze genen te identificeren. 
Vervolgens blijkt dat DNA sequenties in de seE van belang zijn am het Oct-6 gen zelf 
tijdig aan- en uit te schakelen. Toekomstig onderzoek is er onder andere op gericht om de 
DNA sequenties in de seE waaraan transcriptie factoren binden nauwkeurig te bepalen. 
Vervolgens zullen die transcriptiefactoren worden gekarakteriseerd die Oct-6 specifiek in 
Schwann cellen activeren en oak weer uit schakelen. We hopen dat ons onderzoek 
uiteindelijk zal leiden tot beter begrip over de functie van Schwann cellen en tot de 
ontwikkeling van therapieen die de desastreuze effecten van de eerder genoemde zicktes 
kunnen tegen gaan en het herstel van zenuwen in het perifere en centrale zenuwste)sel na 
beschadiging kunnen bevorderen. 
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